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Chapter 1  1 
Chapter 1: 
Synthesis and optical properties of building blocks based on photochromic 
spirobenzopyrans and spiroxazines 
 
1.1. Introduction 
 
1.1.1. Definition of photochromism 
Photochromism is a reversible transformation of a chemical species induced in one or both 
directions by absorption of light between two forms A and B, which have different absorption 
spectra. Literally, the term describes a photoinduced change in color (greek: phos = light, 
chroma = color). The difference of the two forms A and B in their optical properties is 
accompanied by different physical properties, such as refractive indices, dielectric constants, 
etc. At least one reversible process is induced by photoexcitation. The thermodynamically 
stable A is transformed into B by irradiation. The reverse reaction can occur photochemically 
(P-type photochromism) or thermally (T-type photochromism).
[1]
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Figure 1.1. Absorption spectra for a typical AB photo- or thermochromic system
[2]
 
 
The transformations involve the transition from a colorless to a colored state, rather than the 
interconversion between two colored forms. Most common photochromic molecules have a 
colorless or pale yellow form A and a colored form B. However, photochromic 
transformations are always accompanied by absorbance changes in the visible region. Thus, 
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visible absorption spectroscopy is the most convenient analytical method to study 
photochromic processes. After the photoinduced absorbance change the photochromic 
compound B may fade thermally back to its original state A when the irradiation is stopped. 
Thermally stable photochromic molecules will remain in their photogenerated state B after the 
irradiation is terminated.
[3]
 In both cases, returning to their initial state A can be achieved by 
decolorizing (bleaching) using visible irradiation, or generally, using irradiation at a different 
wavelength.   
 
1.1.2. Photochromism in nature 
Important biological processes are triggered by light signals and controlled by the nature of 
the light source (i.e., wavelength and incident flux). The common feature of all these systems 
is the participation of chromophores (photosensor), which upon light absorption, trigger-on 
(switch on) a series of chemical transformations that are recognized by the surrounding 
biomembrane or protein assemblies. In response to the light-induced chemical 
transformations of the chromophore, secondary biotransformations are then initiated and 
complex biological events, such as neural responses or ion pumps are activated. Various 
biological levels, such as movement of motile organisms or intracellular movement, reveal 
macroscopic translocations that are initiated by light-triggered processes.
[4]
  
The process of vision is one of the most powerful and remarkable examples for a light-
triggered complex mechanism. It involves concatenation of chemical transformations to 
transduce visual information into a nerve impulse using a naturally optimized, biological 
photoswitch.
[5]
 It is essential for humans and animals to recognize the outer information with 
their visual system, where it is processed both in the retina and in the brain. In the retina, 
optical inputs reach visual pigments and in the following lead to a photo-induced 
isomerization of retinal.
[6]
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Figure 1.2. Crystal structure of bovine rhodopsin (from: PDB, File: 1L9H) 
 
The chromophore 11-cis-retinal is bound via a protonated Schiff base to the protein opsin. 
Together they form the holoprotein rhodopsin, the human retina visual pigment. The 
absorption of photons results in the conversion of 11-cis retinal to 11-all-trans retinal.
[7]
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Scheme 1.1. 11-cis-retinal to 11-trans retinal isomerization 
 
This photoswitching changes the molecular shape and releases all-trans-retinal, which leads to 
further transformations that produce a sequence of chemical signals.
[5a]
 The cis-trans 
isomerization interacts with different protein structures, and induced conformational changes 
in the protein subsequently switch on amplified subsequent biochemical transformations. As a 
result, the initial optical information from the environment is converted by a biological 
organic photochromic system into an electrical signal (nerve pulse) that is transmitted to the 
brain by the optical nerve where it is further processed.
[6]
      
 
1.1.3. Organic photochromic systems 
Representative examples of photochromic systems are based on transformations that are 
generally unimolecular or bimolecular reactions. Unimolecular photochromic processes 
involve the interconversion of two isomers, A to B,  and can be based on photoinduced ring 
opening/closing,
[8]
 cis-trans isomerizations
[9]
 or intramolecular proton transfer.
[10]
 On the 
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other hand, bimolecular photochromic processes are less common than unimolecular 
photochromic processes and rely either on the photoinduced cycloaddition of two identical 
reactants into a single product
[11]
 or on the photoinduced transfer of an electron from a donor 
to a complementary acceptor.
[12]
  
 
1.1.3.1. Cis-trans isomerizations in Stilbenes and Azobenzenes 
As it was already shown before, the basic process of vision is based on the cis-trans 
isomerization of retinal. The isomerization involves a 180° rotation around a carbon-carbon 
double bond, inducing conformational changes and eventually creating a nerve pulse for 
visual perception. Based on cis-trans isomerizations, stilbene derivatives have been studied 
for thermally irreversible optical switching systems.
[13]
 
 
NN
N N
N N
N N
trans cis
rotation
inversion
 
 
Scheme 1.2. Transition states involved in cis-trans photoisomerization in azobenzene
[4]
 
 
Similar to stilbene derivatives, azobenzenes are prototypes of cis-trans photochromes. 
Azobenzenes can exist in two isomeric forms, E (trans) and Z (cis) form, which display a 
difference in UV-absorption spectra. Due to their relatively easy synthetic accessibility and 
chemical robustness, azobenzenes
[14]
 and other cis-trans photochromes
[15]
 are widely used 
photochromic compounds in chemical biology.  
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1.1.3.2. Photocyclizations 
Photochromic valence tautomerism is defined as a reversible change in color due to a shift in 
the position of bonds in a molecule. There, the photochemical and thermal ring opening and 
closing are governed by the Woodward-Hoffmann rules.
[16]
 
 
 
 
Scheme 1.3. Isomerization of 1,3,5-hexatriene and 1,3-cyclohexadiene 
 
Photochromic systems include fulgides
[17]
, diarylethenes
[18]
 and azulenes
[19]
. In 
spirobenzopyrans and spiroxazines, the photochemical reversibility is based on heterolytic 
bond cleavage and a cycloreversion process.
[20]
  
 
Fulgides 
Fulgides are derivatives of dimethylenesuccinic anhydrides that are substituted with an 
aromatic ring. Literally, fulgides (lat.: fulgere = to glisten) were isolated as fine glittering 
crystals.
[1]
 The switching process in fulgides is based on a reversible photochemical 
conrotatory electrocyclization, similar to the 1,3,5-hexatriene cyclization. When irradiated 
with UV light, the mostly colorless fulgide is transformed into a colored dihydronaphthalene. 
The reverse reaction can be induced by irradiation with visible light.
[21]
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Scheme 1.4. Fulgide to dihydronaphthalene transformation 
 
Unwanted side reactions in fulgides are the photochemical isomerization of the Z-isomer to 
the E-isomer, sigmatropic proton shifts leading to undesirable side products (the hydrogen 
drawn in the dihydronaphthalene structure can shift to other positions) and disrotatory ring 
opening due to the competing fast thermal reverse reaction. Structural improvements such as 
the replacement of hydrogen atoms by alkyl groups can suppress the sigmatropic shift and the 
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thermal reverse reaction can be slowed down to a large extent by the introduction of aromatic 
heterocycles like furyl and thienyl groups.
[22]
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Scheme 1.5. Structurally improved fulgide 
 
Introduction of a methyl substituent R4 into the 2-position of the 3-thienyl group of the 
fulgide does not only eliminate the irreversible photochemical and thermal hydrogen-shifts, 
but also prevents the thermal disrotatory ring opening because of steric interactions between 
the R3 and R4 methyl groups that would arise. Conrotatory ring opening back to the E-fulgide 
remains unaffected. For example, the dihydrobenzo[b]furan is thermally stable up to 160 °C, 
and was converted back into the E-fulgide quantitatively upon exposure to visible light.
[23]
 
 
Diarylethenes 
In addition to cis-trans isomerization, stilbene derivatives can undergo a reversible cyclization 
reaction upon UV irradiation. The formation of the unwanted phenanthrene derivative can be 
excluded by the substitution of methyl groups from the two hydrogens that are sensitive to 
oxidative elimination.
[24]
 The most commonly used diarylethenes are 
diarylperfluorocyclopentenes. Thermally stable diarylethenes use furan or thiophene groups 
instead of phenyl rings and the photochromism is based on a six-electron rearrangement.
[18]
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Scheme 1.6. Example of a diarylethene photoswitch 
 
Azulenes 
Photochromism in azulene derivatives is based on a 10-electron cycloreversion. The 
reversible switching of a dihydroazulene (DHA) into a vinylheptafulvene (VHF) by 
irradiation has been described. 
[25]
  
Chapter 1  7 
 
h
NC
CN
NC
CN
R1
R2 R1
R2
DHA VHF  
 
Scheme 1.7. DHA-VHF cycloreversion 
 
The rearrangement could be rendered visibly by a change of color from yellow to red as a 
result from the shift of the absorption band at 350-360 nm to 460-490 nm. The VHF reverts 
thermally back to the DHA chromophore within seconds to days, depending upon the 
substitution patterns and temperature.
[19]
 
 
Anthracene 
Over the last seventy years, a number of polycyclic aromatic hydrocarbons (PAH) have 
become infamous as biological pollutants and contaminants.
[26]
 Therefore, research has been 
stimulated, especially in the field of development of analytical methods to detect traces, 
which often use the efficient light emission properties of PAH.
[27]
 Among PAH, anthracene 
and its derivatives were extensively studied. Other then the before mentioned switches, 
anthracene and its derivatives represent bimolecular photochromic systems. Upon UV 
irradiation (?max = 366 nm) a [4+4]-cycloaddition switches the anthracene monomer into its 
dimer.
[28]
 The photochromic properties of anthracenes are of special interest in the field of 
optical and electronic switches.
[11]
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Scheme 1.8. Photodimerization of 9-substituted anthracene derivative. Head-to head (hh) and 
head-to-tail (ht) photodimers (from Lit 
[11]
) 
 
Interestingly, the two monomers can associate with a head-to-head (hh) or a head-to-tail (ht) 
mutual orientation, leading to the hh and ht photodimers, but steric hindrance can lead to the 
preferential ht oriented dimers. From the anthracene-dimer, the back reaction can then be 
induced by light or by temperature. Also, intramolecular photodimerization of anthracene has 
been used for molecular or ionic receptors
[29]
 and for the design of binary optical memory.
[30]
 
 
Spirobenzopyrans and Spiroxazines 
Spirobenzopyrans (also: spiropyrans) and spiroxazines (also: spirooxazines) belong to the 
very large group of photochromic switches that are based on ring opening and ring closing 
reactions by photo-induced electrocyclic reactions. Spirobenzopyrans consist of conjugated 
rings and a pyran fragment. The pyran moiety itself usually belongs to a larger aromatic 
system, whereas the other heterocyclic part is often based upon mono or bi-heteroatomic 
azaheterocycles. The two heterocyclic parts are linked together by a common spiro carbon 
atom. This aligns the two halves of the molecule in two orthogonal planes.
[31]
 
 
N O
X
 
 
Scheme 1.9. General structure of spiropyrans (X = CH) and spiroxazines (X = N) 
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Photochromism of spirobenzopyrans has first been investigated in 1952 by Hirshberg and 
Fischer. Based on their photoswitching properties, research has been carried out with 
spirobenzopyrans for applications as molecular logic elements
[32]
, light-actuated 
nanovalves
[33]
 and manipulation of in vitro selection processes by light-regulation.
[34]
 
Hirshberg already suggested an idea of using the photoswitching process as basis for 
photochemical erasable memory devices in his early work
[35]
. More than 30 years later the use 
of spirobenzopyrans has been demonstrated for bit-oriented three-dimensional optical data 
memory systems.
[36]
   
The photochromic and thermochromic behaviour of spirobenzopyrans is due to the 
interconversion between the closed form SP and the open merocyanine dye MC. In the closed 
SP form, the spirobenzopyrans usually have an absorption maximum in the UV range. UV 
irradiation then leads to the open MC, which can revert by irradiation with visible light and 
thermally to the closed SP.  
 
N O NO2 N
O
NO2
SP MC
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Scheme 1.10. Interconversion of SP and transoid MC form 
 
Upon UV irradiation, the C-O bond in the spirobenzopyran form (SP) is heterolytically 
cleaved. The cleavage then allows the molecule to unfold and the ring-opening leads to 
structural changes facilitating the photomerocyanine form (MC).
[20]
 The bond cleavage 
between the spiro carbon and oxygen is assumed to lead to the formation of primary 
photoproducts, with orthogonal parent geometry, but different stereoisomers of cisoid 
configuration. This is followed by a geometrical change to form a planar transoid, isomerized 
configuration of merocyanine. The transition itself, from SP to the zwitterionic MC form 
occurs on a picosecond to nanosecond time-scale.
[17]
 The isolated systems, which are 
orthogonal and non-interacting in the SP form, and show no absorption in the visible 
spectrum, become extensively conjugated in the colored MC form.  
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Figure 1.3. Absorption spectra for a spirobenzopyran in MeCN
[37]
 
 
The zwitterionic MC form shows a strong and characteristic absorption band in the visible 
wavelength range due to its extended conjugation of the ?-electron system as compared to the 
unfolded SP form with orthogonal geometry.
[38]
  
The electronic distribution in the photoproduct, the transoid merocyanine, can be symbolized 
by repartition of the delocalized ?-electrons with an excess of positive charge on the 
heterocycle, and an excess of negative charge on the phenolic oxygen.  
Corresponding to the experimental situation, the dipolar zwitterionic merocyanine form with 
localized charges and the nonionic quinoid form may have important contributions. This 
already shows that the photochromic equilibrium is more complex, and for complete 
understanding it would be necessary to also take the different geometries and electronic 
structures into account.
[31]
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Scheme 1.11. Charge distribution of the colored MC form and two possible states for 
zwitterionic and apolar quinoid MC   
 
However, the zwitterionic MC form can be stabilized in polar solvents, which lead to a larger 
energy of activation and therefore to a slower back reaction to the closed SP form. The 
rearrangement from open MC to closed SP form in a back reaction can occur, since the 
carbon-oxygen cleavage is photochemically and/or thermally reversible. Hence, the colored 
MC can revert back to SP either via thermal process or a second photochemical step that is 
triggered by absorption of light at the wavelength of ?max of the colored form of the MC.[3, 20] 
The spiro carbon atom itself is a stereogenic center in the spirobenzopyrans. But as a 
consequence of the achiral nature of the merocyanine form, the photochromic process always 
leads to racemization.
[39]
 However, when a chiral substituent remote from the spiro center is 
present, diastereoisomers of spiropyrans can also be isolated.
[40]
  
Similar to spirobenzopyrans, the photochromic properties of spiroxazines are based on the 
cleavage and reformation of the carbon oxygen bond of the oxazine ring. The ring-opened 
merocyanine absorbs in the region of 600 nm and is recognized by the blue color. 
Spiroxazines have excellent resistance to light-induced degradation and show a high number 
of photoswitching cycles.
[41]
 Thus, the vast majority on spiroxazines are published in patents 
and patent applications. They have been successfully applied, for example in optical filters, 
lenses and eyewear.
[42]
 Applications of photochromic systems such as spirobenzopyrans, 
azobenzenes and other photo-responsive molecules in chemical biology and nanotechnology 
are discussed in Chapter 3.  
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In order to endow biomolecules with the photochromic switch, a versatile and improved 
synthetic route for spirobenzopyrans that are fitted up with iodo, hydroxyl, azido, ethynyl or 
carboxylic acid groups is reported. These spirobenzopyrans represent important building 
blocks that can be used for cross-linking or bioconjugation reactions to attach the 
photochromic compound to biopolymers or functional ?-systems.  
 
 
1.2. Results and Discussion 
 
Our synthetic strategy was to synthesize the functionalized spiroindolinobenzopyran switches 
by using the following assemblies:  
- N-alkylation of indolines with a linear C3-linker bearing a hydroxyl or iodo group 
(R
1
), followed by alkali treatment and condensation with salicylaldehyde derivatives; 
further transformations should be carried out at the C3-linker (R
1
) 
- Preparation of functionalized salicylaldehydes (R2, R3, R4) and condensation with 
Fischer’s base or the corresponding quaternary salt 
- Modification at the indoline section (R) and formation of a spirobenzopyran 
 
N
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R
N O
R1
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R1 R1
R4
R2 R3
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Scheme 2.1. Route for functionalization of spirobenzopyran switches 
 
In general, Fischer’s base or other N-alkylated indolenines are obtained from their 
corresponding quaternary salt by deprotonation at the C2-methyl group. The indolenines can 
be isolated or generated in situ and then condensation with salicyclaldehyde derivatives is 
usually carried out in dry ethanol under reflux. The nucleophilic attack of Fischer’s base or an 
Chapter 1  13 
indolenine at the carbonyl group forms an aldol product, followed by dehydration and ring-
closure. Detailed mechanisms are reported in the literature.
[43]
  
 
1.2.1. Synthesis of N-methylated spiroindolinobenzopyran  
The synthesis of spirobenzopyrans started with the N-alkylation of 2,3,3-trimethylindolenine 
1 with iodomethane under reflux in acetonitrile for 24 hours and afforded the indolium iodide 
2 as fuzzy powder in 74 % yield. Interestingly, synthesis of 2 was also performed using 
conditions from the literature.
[44]
 Therefore, the corresponding starting materials were stirred 
at room temperature in nitromethane for 12 hours. Unlike the excellent yield reported in the 
literature (96 %), the desired product could not be isolated in any satisfactory amounts. In the 
second step, the indolium salt 2 was deprotonated at the C2-methyl position with use of 
potassium hydroxide. The product 3 (Fischer’s base) was easily extracted from the reaction 
mixture with use of diethyl ether, and the organic layer turned pink within few minutes. A red 
oil was obtained after the solvents were evaporated in vacuo. Although Fischer’s base is 
commercially available, distillation prior to use was crucial. Experiments for the preparation 
of spirobenzopyrans using “red” Fischers’s base always gave black-brown products that 
required multiple recrystallizations in ethyl acetate with charcoal, and gave the desired 
products only in low yields. However, after deprotonation of 2 with potassium hydroxide and 
distillation, 3 was afforded as colorless oil in 77 % yield (Scheme 2.2). 
 
a) b)
N N
I
N
1 2 3  
 
Scheme 2.2. Synthesis of  3. Reagents and conditions: a) CH3I (1.1 eq.), MeCN, reflux, 24 h, 
74 %; b) KOH (3.3 eq.), r.t., 3 h, 77 %. 
 
Equimolar amounts of 2-hydroxy-5-nitrobenzaldehyde and 3 were then reacted, either under 
reflux or ultrasonic irradiation
[45]
, to give the N-methylated spirobenzopyran 4. Reaction 
control by TLC revealed that ultrasonic irradiation decreased the reaction time and both 
reaction setups gave the desired product 4 in excellent yield (Scheme 2.3).   
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Scheme 2.3. Synthesis of 4. Reagents and conditions: 2-hydroxy-5-nitrobenzaldehyde (1.0 
eq.); a) EtOH, reflux, 4 h, 97 %; b) EtOH, ))), 80 min, 94 %. 
 
1.2.2. Synthesis of N-methylated spiroxazine 
Spiroxazines are aza analogs of spirobenzopyrans since the CH at the 3-position is replaced 
by a nitrogen atom. Spironaphthoxazines are generally prepared similar to spirobenzopyrans 
but with 1-nitroso-2-naphthol derivatives instead of salicylaldehydes, also in methanol or 
ethanol under reflux.
[46]
 We investigated the use of ultrasonic irradiation as an alternative to 
reflux conditions for the preparation of an N-methylated spiroxazine 5. Therefore, equal 
amounts of 3 and 1-nitroso-2-naphthol were subjected to ultrasonic irradiation in MeOH. The 
reaction was followed by TLC and appearance of a green-brown spot clearly indicated 
formation of the photochromic spiroxazine 5. After 2 hours the reaction was stopped and 5 
was obtained after flash chromatography in 65 % yield as lustrous orange solid (Scheme 2.4). 
Comparison with yields reported in literature (reflux
[47]
: 47 %, microwave
[48]
: 67 %) show 
that ultrasonic irradiation can be used as a suitable method for the preparation of 5. 
 
3
+
a)
N O
N
N
ON
HO
5  
 
Scheme 2.4. Synthesis of 5. Reagents and conditions: a) MeOH, ))), 2 h, 65 %. 
 
1.2.3 Synthesis and photoswitching of N-methylated spirobenzopyran carboxylic acid 
Functional molecules with carboxylic groups play a major role in biotechnological 
applications, especially as precursors for labeling procedures.
[49]
 Formation of stable amide 
bonds in labeling applications can be performed by using NHS-esters, with carboxylic acids 
as precursors. With use of NHS and an activating agent like DCC or EDC, the synthesized 
activated NHS-esters, i.e. the photochromic switches will react readily with amino functions 
of various biomolecules.
[50]
 The synthetic approach for the potentially useful building block 9 
involved three steps. First, 7 was prepared in a Fischer indole synthesis. Therefore, 
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commercially available 4-hydrazinylbenzoic acid 6 was reacted with 3-methyl-2-butanone in 
ethanol with sulfuric acid to give 7 as orange-yellow solid in 63 %. N-Alkylation of 7 with an 
excess of iodomethane under reflux in chloroform gave the corresponding carboxy-indolium 
iodide 8 in 81 % yield. For the preparation of 9, 2-hydroxy-5-nitrobenzaldehyde and a slight 
excess of piperidine was then reacted with 8 under reflux for 18 hours.
[50]
 Upon cooling, the 
product precipitated and recrystallization from ethanol afforded the desired product (94 %). 
However, the last reaction step for the formation of 9 was also performed under ultrasonic 
conditions and gave 9 already after 60 minutes irradiation in nearly quantitative yield as 
orange-green crystals (Scheme 2.5).  
 
N
HOOC
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HOOC
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N O NO2
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c) or d)
6 7 8
9  
 
Scheme 2.5. Synthesis of 9. Reagents and conditions: a) 3-methyl-2-butanone (1.1 eq.), 
H2SO4, EtOH, reflux, 16 h, 63 %; b) CH3I (2.1 eq.), CHCl3, reflux, 18 h, 81 %; 2-hydroxy-5-
nitrobenzaldehyde, (1.0 eq.) c) piperidine (1.0 eq.), reflux, 18 h, 94 %, d) piperidine (1.2 eq.), 
))), 60 min, 98 %. 
 
The irradiation of a solution of 9 in ethanol visualizes the photochromic switching (Figure 
2.1). First, the solution was bleached with an amber LED (? = 590 nm) to switch 9 to its SP 
form. Then, the sample was irradiated with UV light (? = 312 nm) for 30 seconds and an 
absorption spectrum was recorded (MC 1). This UV irradiation was iterated three times (MC 
2-MC 4).  
 
16  Chapter 1 
 
300 400 500 600 700
0,0
0,2
0,4
0,6
A
b
s
o
rb
a
n
c
e
? / nm
 SP
 MC 1
 MC 2
 MC 3
 MC 4
 
Figure 2.1. Absorption spectra of 9 in ethanol (c = 100 µM) 
 
Irradiation with 312 nm leads to a color change of the solution, which turns from colorless to 
red-pink. Here, the colorless SP form of 9 is switched into its corresponding 
photomerocyanine state. The inspection of the absorption maximum (?max = 549 nm) over 
time displays the achievement of a photostationary state under the employed irradiation 
conditions after 2 minutes (Figure 2.). The photoswitching process can also be monitored by 
differential absorption spectra. The inset shows the decrease of absorption bands in the UV 
range at 224 nm and 272 nm, while two new significant absorption bands arise at 369 nm and 
549 nm that can be attributed to the open merocyanine form.    
 
0 20 40 60 80 100 120
0,0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
300 400 500 600 700
-0,4
-0,2
0,0
0,2
0,4
0,6
? Abs
? / nm
A
b
s
o
rb
a
n
c
e
 @
 5
4
9
 n
m
t / sec
 
Figure 2.2. Increase of ?max during irradiation with ? = 312 nm  
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1.2.4. Synthesis and optical properties of spirobenzopyrans with a linear C3-linker with 
hydroxyl group 
Spirobenzopyrans with the general structure 12 were prepared (Scheme 2.6). They are all 
decorated with a propanol-chain at the indole-N, bear two methyl groups at the 3-position at 
the indole-half and are distinguished by variation of substituent groups and positions in the 
benzopyran section.  
 
12
N O
HO
R1
R2R3
 
 
Scheme 2.6. General structure of spirobenzopyran 12 with substituent variations R
1
, R
2
, R
3
 
 
As depicted in Scheme 2.6, the N-alkylation of 1 with 3-iodopropanol in chloroform under 
reflux for 24 hours gave in very good yield the corresponding indolium iodide 10 that carries 
the propanol-linker. Deprotonation of 10 with potassium hydroxide provided the stable 
tricyclic oxazino indole 11 after flash chromatography in 43 % yield. 11 was characterized by 
2D NMR and structural evidence was also confirmed by X-ray analysis, after we were able to 
grow colorless crystals of 11 from a concentrated solution in ethyl acetate.  
 
N
a) b)
N
HO
I N
O
1 10 11
 
 
Scheme 2.7. Synthesis of 11. Reagents and conditions: a) I(CH2)3OH (1.1 eq.), CHCl3, reflux, 
24 h, 99 %; b) KOH (2.4 eq.), r.t., 2 h, 43 %. 
 
18  Chapter 1 
 
 
 
Figure 2.3. X-ray crystal structure of compound 11. 
 
The spirobenzopyran 12 a (Scheme 2.6, R
1
 = NO2, R
2
, R
3
 = H) was synthesized, according to 
the most common protocol. Thus, 2-hydroxy-5-nitrobenzaldehyde and 11 were refluxed in 
ethanol. First, a synthetic protocol comparable to the literature was performed. Therein, the 
related compound, bearing an ethanol-linker, instead of a propanol-linker, is synthesized by 
refluxing the corresponding starting materials in ethanol for 3 hours and obtained as a purple 
solid in 81 % yield.
[51]
 However, our synthetic approach only gave 12 a in a poor yield of 16 
%. Prolonged heating was also tested (24 hours reflux), and increased the yield to 54 %. 
However, heating for more than 24 hours did not increase the yield further, but increased the 
formation of side-products that complicated further purification. A reasonable synthetic 
method to increase the yield of the reaction was the use of ultrasonic irradiation, since it is 
known to be a valuable tool for the performance of aldol-condensations.
[45, 52]
 We used 
equimolar amounts of 11 and 2-hydroxy-5-nitrobenzaldehyde, and exposed this mixture in 
ethanol to ultrasonic irradiation. The formation of the photochromic product was already 
detectable after few minutes. TLC was used to monitor the performance of the reaction and 
after 1 hour the product spot intensity was steady in successive controls. Then, standard 
workup and purification by flash chromatography provided the desired product 12 a with an 
increased yield of 84 % (Scheme 2.8).   
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Scheme 2.8. Synthesis of 12 a. Reagents and conditions: a) EtOH, reflux, 3 h, 16 %; b) EtOH, 
24 h, 54 %; c) EtOH, ))), 1 h, 84 %. 
 
Unlike the before mentioned N-methylated spirobenzopyrans, those with the general structure 
12 afforded special attention during workup. The existence of the C3-linker with the hydroxyl 
group showed that these spirobenzopyrans could not be recrystallized as nicely as the N-
methylated compounds, even in solvent mixtures.
[53]
  
However, purification employing flash chromatography was possible, but we had to act with 
caution running the column.
[54]
 If the crude products were applied as a dry-load the desired 
product stuck to the silica gel and would only elute upon addition of ammonium acetate to the 
mobile phase. The usually blood-red color of the dry-load (and eluting sections) showed that 
the very polar silica gel led to an increase of the colored, zwitterionic merocyanine form and 
therefore to a mixture of the two forms that would smear all over the column. Concurrently, 
the use of ammonium acetate also led to a broadening of the eluting band. When using dry-
vacuum flash chromatography we observed identical problems as with dry-loading.
[53a, 55]
 
Likewise, preparative thin layer chromatography has also been performed. In the dark, the 
method showed promising results for purification since the retention factors are directly 
comparable to the ones obtained through TLC. Handling of the plates in the dark and a 
limited capacity of ~ 50 mg crude product load per plate for best purification results led us to 
optimize flash chromatography, but without use of ammonium acetate.
[53a]
 The fact that the 
desired photochromic compounds can consist of a mixture of isomeric spirobenzopyrans and 
merocyanines also signify the difficulty in handling.   
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Image 2.1. Visual representation of isomerization of a typical spirobenzopyran 12 during 
flash chromatography under normal laboratory ambient light 
 
Image 2.1 shows the isomerization during flash chromatography. For illustrative purpose of 
the challenges during separations, an already purified spirobenzopyran of general structure 12 
has been applied representatively. Under dark room conditions, the smooth transition between 
the yellow band and the red band vanishes (i.e., the yellow band gets more intense and 
sharper). Variation of product loading methods and eluent gradient mixtures, overall 
remaining time on the column and change of incident light showed that pure 
spirobenzopyrans of general structure 12 could be isolated with a high recovery after 
chromatography, when the crude product was loaded in as little dichloromethane, hexane or 
heptane as possible and not as dry-load.  All further steps were also carried out in the absence 
of diffuse or direct daylight (i.e., at least darkroom or better, dark conditions), eluting the 
desired spirobenzopyran in less than 45 minutes to prevent isomerization to the more polar 
merocyanines. Drying of the solvents that are used as the mobile phase and very affectionate 
increase of solvent polarity during gradient elution also contributed to major improvements. 
As a result of these wayside findings, we applied this general strategy also for purification of 
the following spirobenzopyran derivatives, whenever recrystallization did not afford the pure 
products.   
To expand the range of substituents at the salicylaldehydes used for the formation of 
spirobenzopyran compounds 12, two ethynyl-salicylaldehydes were synthesized.
[56]
 Since 
terminal alkynes have caused a stir with respect to “click” reactions, ethynyl-modified 
spirobenzopyrans constitute reasonable building blocks.
[57]
 The methoxy substituent also has 
the potential to expand photochromic spirobenzopyrans to form complexes with certain metal 
ions in solution in their respective merocyanine form.
[58]
  
Chapter 1  21 
The synthesis started from 5-bromosalicylaldehyde (or its 3-methoxy derivative, respectively) 
with a Sonogashira cross-coupling reaction with little excess of ethynyltrimethylsilane, while 
copper iodide and PdCl2(PPh3)2 were used as catalysts. The TMS-protected products 13 a and 
14 a were obtained in good yields and consequent desilylation went smoothly by using a 
freshly prepared solution of Bu4NF in tetrahydrofuran to provide 13 b and 14 b as solids in 
excellent yields (Scheme 2.9). 
 
HO
O
TMSHO
O
Br HO
O
R R R
13a: R = H
14a: R = OCH3
13b: R = H
14b: R = OCH3
a) b)
 
 
Scheme 2.9. Preparation of 13 b and 14 b. Reagents and conditions: a) R = H: (CH3)3SiCCH 
(1.6 eq.), PdCl2(PPh3)2 (3.2 mol-%), CuI (3.5 mol-%), NEt3, 80 °C, 3 h, 88 %; R = OCH3: 
(CH3)3SiCCH (1.6 eq.), PdCl2(PPh3)2 (3.4 mol-%), CuI (3.9 mol-%), NEt3, 80 °C, 3 h, 73 %; 
b) R = H: Bu4NF (1.9 eq.), THF, r.t., 30 min, 92 %; R = OCH3: Bu4NF (1.9 eq.), THF, r.t., 30 
min, 94 %. 
 
With reasonable quantities of 11 and differently substituted salicylaldehydes in hand, the 
previously described protocol for 12 a using ultrasonic irradiation was applied to the synthesis 
of other photochromic spirobenzopyrans and results are listed below (Table 2.1). 
 
 
Compound R
1
 R
2
 R
3
 Yield (%) 
12 a NO2 H H 84 
12 b H H H 87 
12 c Cl H H 78 
12 d OCH3 H H 54 
12 e Br H Br 93 
12 f C?CH H H 68 
12 g C?CH H OCH3 75 
12 h Br H H 52 
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12 i NO2 H OCH3 83 
12 j Br H OCH3 76 
12 k H OCH3 H 82 
 
Table 2.1. Substituents and yields of spirobenzopyrans 12 a - 12 k 
 
As Table 2.1 shows, eleven differently substituted spirobenzopyrans, based on the general 
structure 12, were obtained with the use of ultrasonic radiation. The reaction times were 1-2 h 
in EtOH and 12 a - 12 k were afforded in acceptable to excellent yields, ranging from 52-93 
%. It can be assumed that, basically, ultrasound simply involves a more intimate mixing of the 
starting materials and therefore enhances the reaction rates. This effect has also been observed 
for other organic reactions.
[52]
  
 
As Table 2.2 shows, the synthesized spiropyrans 12 a - 12 k have different substitution 
patterns at their extended aromatic pyran part, including electron-withdrawing and -donating 
substituents. 
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Figure 2.4. UV/Vis absorption of the merocyanines 12 a - 12 k (100 µM in ethanol, after 
irradiation at ? = 312 nm) 
 
Accordingly, solutions of the spiropyrans in ethanol were bleached with visible light with use 
of a high-power output amber LED (? = 590 nm) until no significant change in the visible 
range could be detected. In the following, the samples were irradiated with UV light (? = 312 
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nm) and the photocoloration properties were then measured immediately after saturation of 
the merocyanines.   
 
Compound R
1
 R
2
 R
3
 ?max* 
12 a NO2 H H 549 
12 b H H H 577 
12 c Cl H H 592 
12 d OCH3 H H 606 
12 e Br H Br 586 
12 f C?CH H H 586 
12 g C?CH H OCH3 606 
12 h Br H H 586 
12 i NO2 H OCH3 568 
12 j Br H OCH3 599 
12 k H OCH3 H 554 
 
Table 2.2. Substituents and ?max of merocyanine forms of 12 a - 12 k. *: 100 µM in ethanol, 
after irradiation at ? = 312 nm. 
 
Spirobenzopyran 12 b carries hydrogen atoms at the positions R
1
, R
2
 and R
3
 and can be taken 
as reference compound to depict substituent effects. 12 b has ?max of 577 nm in ethanol, and 
from this we can conclude some trends. First, inductively electron-withdrawing groups which 
are electron-donating through resonance (e.g. the Cl and Br groups in 12 c, 12 e and 12 h) 
have a minimal bathochromic effect. The ethynyl substituent (12 f) also leads to a small 
bathochromic shift. Additional substitution with the electron-donating methoxy-substituent 
(12 d, 12 g and 12 j) enlarges the bathochromic shift by resonance (e.g. for 12 d to 12 b, ?? = 
29 nm). Although 12 k has one methoxy substituent, a small hypsochromic effect is observed. 
This can be explained by its meta-position, relative to the O
-
 of the corresponding 
merocyanine form. The hypsochromic shift is more distinct with the strong electron acceptor 
group NO2. Albeit spirobenzopyran 12 i has the electron-donating methoxy group, the more 
distinctive electron-drawing of the nitro group leads to a hypsochromic effect. Compared to 
12 b, the spirobenzopyran 12 a displays the strongest hypsochromic shift (for 12 a to 12 b, ?? 
= 28 nm) since 12 a features only the strong electron-withdrawing nitro group.  
The different substituents did not only effect the positioning of the absorption maximum of 
the merocyanine form, but also the stability. Although all of the above described compounds 
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are photochromic and absorption spectra could be recorded for the photomerocyanine form 
using fast scans, most of them also reverse extremely rapid back to their spirobenzopyran 
form. Preferentially electron donating groups destabilize the merocyanine and reverted 
quickly back to their corresponding spiropyran form. On the other hand, due to their nitro 
groups, the photochromic spiropyrans 12 a and 12 i show reasonable stability and strong 
extinction of the merocyanine at 549 nm or 568 nm, respectively. 
 
The reversibility of the photoinduced switching was confirmed, representatively for 12 h as 
shown in Figure 2.5. Therefore, a solution of 12 h was irradiated with visible light (1). 
Following, irradiation with UV light led to the formation of the colored photomerocyanine 
form with ?max 586 nm (2). The closing to form the colorless spiropyran (3) and switching to 
the open merocyanine (4) was repeated photochemically.    
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Figure 2.5. UV/Vis absorption of 12 h (100 µM in EtOH). 1: After irradiation with ? = 590 
nm, 2: After irradiation with ? = 312 nm for 270 sec, 3: After irradiation with ? = 590 nm for 
270 sec, 4: After irradiation with ? = 312 nm for 270 sec 
 
The UV induced ring-opening was also followed for 12 a (Figure 2.6). A solution of the 
spirobenzopyran was first bleached with visible light (1) and then irradiated with UV light (? 
= 312 nm). The inset displays the absorption change at ?max 549 nm and shows that with the 
used irradiation setup the photostationary state is reached after 2.5 minutes. 
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Figure 2.6. UV/Vis absorption of 12 a (100 µM in EtOH). 1: After irradiation with ? = 590 
nm, 2: After irradiation with ? = 312 nm for 42 sec, 3: After irradiation with ? = 312 nm for 
78 sec, 4: After irradiation with ? = 312 nm for 154 sec, 5: After irradiation with ? = 312 nm 
for 228 sec 
 
Moreover, the photo-induced ring opening of spirobenzopyran 12 a with different UV 
wavelengths was investigated and is displayed in Figure 2.7. 
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Figure 2.7. Change of ?max (557 nm) of 12 a (100 µM in MeCN) using ? = 312 and 366 nm. 
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A bleached solution of 12 a in acetonitrile was irradiated with ? = 366 nm (t = 0) and 
absorption at ?max (557 nm) was recorded after 5 and 10 minutes irradiation time. Then, the 
formed merocyanines were switched back by irradiation with visible light for 22 minutes. 
Respectively, the sample was then irradiated with ? = 312 nm for 5 and 10 minutes and 
showed a more than 5-fold increase at the absorption maximum. Bleaching with visible light 
for 22 minutes reveals the reversibility of the photoswitching cycle for 12 a. Finally, the 
photostationary state could again be reached successfully after repeated irradiation with ? = 
312 nm for 5 minutes. 
 
Likewise, the solvatochromism of 12 a was investigated. It is known that position, shape and 
intensity of UV/Vis/NIR absorption spectra may be influenced by solvents.
[59]
 The 
solvatochromic behaviour of a dye molecule (i.e. its tendency to undergo a bathochromic or 
hypsochromic shift with increasing polarity), depends largely on the change in dipolar 
characteristics between the ground and first excited states. For a weakly polar molecule, with 
low polarity in the ground state and increased polarity in the excited state, a bathochromic 
shift results, and this is termed positive solvatochromism. Conversely, for a highly polar 
molecule in the ground state with reduced polarity in the excited state, a hypsochromic shift is 
observed (negative solvatochromism).
[59-60]
 In principle, a merocyanine dye could exhibit 
either type of behaviour since the ground state could have an electronic configuration 
corresponding largely to the nonpolar amino-keto form or to the dipolar zwitterionic form. 
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Figure 2.8. Normalized absorption spectra of 12 a in different solvents after UV irradiation 
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Figure 2.8 shows the normalized absorption spectra of 12 a in different solvents after UV 
irradiation (? = 312 nm). The maximum absorption band of the merocyanine form of 12 a 
undergoes a large blue-shift with increasing solvent polarity (66 nm from toluene to MeOH). 
As a polarity parameter, the change in transition energy has been established as the ET value 
of the solvents.
[59]
 The reasonable linear plot of 12 a (Figure 2.9) was obtained on plotting 
?max versus the solvent parameter ET.[61] It clearly shows that upon polarity increase, a 
hypsochromic shift of 12 a is observed (i.e. negative solvatochromic).  
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Figure 2.9. Linear plot on plotting ?max versus solvent parameter ET 
 
This observation indicates a highly polar ground state, i.e., one approaching the electronic 
distribution of the zwitterionic form. The observed negative photochromism of 12 a implies 
that the ground state of the merocyanine form is relatively polar.
[43b]
 Hence, polar solvents 
will stabilize the ground state of the colored form more than the excited state. For further 
investigations of the system, theoretical calculations of ?-dipole moments may be carried out. 
These dipole moments could then indicate qualitatively the polarities of the ground and first 
excited states.
[62]
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Image 2.2. Visual representation of solvatochromism of 12 a. Top image: after irradiation 
with visible light, Lower image: after irradiation with UV light; Solvents in both images: 
MeOH-DMF-EtOAc-Dioxane-THF-Toluene (from left to right). 
 
Based on the relatively good stability of the merocyanine form, compared to the other 
spirobenzopyrans included in this series, the fluorescence spectra of 12 a were measured in 
three different solvents. Therefore, solutions of the corresponding spirobenzopyran 12 a were 
switched by irradiation with UV light into the merocyanine form until no further changes 
were observed and the solutions were directly measured. The merocyanines are excited (in 
MeOH: 526 nm, EtOH: 538 nm, MeCN: 553 nm) and show emission at 629 nm, 626 nm and 
637 nm, respectively. Interestingly, these results reveal the large Stokes shift of the 
merocyanine form of 12 a (?? = 99 nm, in MeOH).  
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Figure 2.10. Fluorescence emission spectra of 12 a (10 µM) after irradiation 
 with UV light (? = 312 nm) 
 
 
 
Image 2.3. Visual representation of red emission of 12 a in MeOH 
during irradiation with UV light (? = 312 nm) 
 
1.2.5. Synthesis of spirobenzopyrans and spiroxazine with linear C3-linker with iodo 
group  
With use of the significantly facilitated and effective synthetic protocol that was used to 
survey the preparation of 12, spirobenzopyrans with the general structure 17 were prepared 
(Scheme 2.10). The compounds are similar to 12, but have an iodopropyl residue at the 
indole-N, instead of a propanol chain. This modification opens the possibility for practical 
transformations, e.g. into its azide or trimethylammonium derivatives.  
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Scheme 2.10. General structure of spirobenzopyran 17 with substituent variations R
1
, R
2
, R
3
 
 
The N-alkylation of 1 with 1,3-diiodopropane was performed in acetonitrile under reflux for 
48 hours and afforded 15 in 77 % yield. The indolium iodide 15 was subsequently 
deprotonated at the C2-methyl position with use of sodium hydroxide to afford the 
methyleneindoline 16 in 91 % yield (Scheme 2.11). Although, the product was successfully 
characterized by NMR and mass spectrometry, it needs to be mentioned that 
methyleneindolenine 16 is fairly unstable. Thus, 16 always needed to be freshly prepared for 
further use, otherwise formation of unwanted by-products occurred and led to very difficult 
separations and lowered yields.  
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Scheme 2.11. Synthesis of Iodopropylmethyleneindolenine 16. Reagents and conditions: a) 
I(CH2)3I (3.5 eq.), MeCN, reflux, 48 h, 77 %; b) NaOH (30 eq.), 80 °C to r.t., 1 h, 91 %. 
 
Finally, a general procedure was used for the preparation of 17. There, solutions of the freshly 
synthesized 16 and the corresponding salicylaldehydes were subjected to ultrasound radiation 
in ethanol (Scheme 2.12). 
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Scheme 2.12. General synthesis of 17. Reagents and conditions: a) EtOH, ))), 50 - 65 min,  
58-94 % 
 
TLC was employed to check the reaction progress and revealed that the reaction succeeded 
after 50 to 65 minutes, followed by standard work-up procedure and purification by flash 
chromatography. The synthesized spirobenzopyrans 17 a - 17 f are listed below (Table 2.3). 
 
Compound R
1
 R
2
 R
3
 Yield (%) 
17 a NO2 H H 94 
17 b Cl H H 74 
17 c Br H Br 83 
17 d Br H OCH3 80 
17 e NO2 H OCH3 68 
17 f C?CH H H 58 
 
Table 2.3. Substituents and yields of spirobenzopyrans 17 a - 17 f 
 
Interestingly, sonication of 16 with 5-(diethylamino)-2-hydroxybenzaldehyde did not yield 
the desired product 17 g, but 17 g* in 87 % yield (Scheme 2.13). It was formed already during 
the synthesis and detectable as a blazing pink spot on TLC plate. After chromatography, we 
were able to isolate and characterize 17 g* by MS and 2D NMR experiments. In methanol, 17 
g* has ?max at 542 nm and an emission maximum ?em 585 nm.  
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Scheme 2.13. Formation of 17 g*. Reagents and conditions: EtOH, ))), 1 h, 87 % 
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Figure 2.11. Normalized absorption and fluorescence emission spectra of 17 g* in MeOH 
 
Based on these results a hypothetical, but reasonable mechanism for the formation of 17 g* is 
shown (Scheme 2.14). Nucleophilic addition of the heterocyclic enamine to the formyl group 
of the salicylaldehyde and a H-shift gives an adduct. Dehydration forms an isomer of the 
merocyanine. After charge redistribution this leads to a nucleophilic attack of the potentially 
negative carbon to cleave off I
-
 and formation of the six-ring. Finally, the concerted 
rearomatization and elimination of HI lead to the zwitterionic 17 g*.  
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Scheme 2.14. Supposed mechanism for the formation of 17 g* 
 
The application of ultrasonic irradiation was also used to prepare the iodopropyl-substituted 
spiroxazine derivative 17 h. The reaction was carried out in ethanol, where 16 and 1-nitroso-
2-naphthol (1.1 eq.) were irradiated for an overall of 2 hours with ultrasound (Scheme 2.15). 
Unlike the formation of the spirobenzopyrans 17 a - 17 f, unreacted starting material was still 
found in the crude product. Since further product formation was not observed after 2 hours, 
we may assume that experiments with change of the ultrasound frequency may lead to a 
higher reaction rate and better yields. However, after flash chromatography the desired 
product 17 h was obtained as a yellow powder in 25 % yield. 
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Scheme 2.15. Synthesis of spiroxazine 17 h. Reagents and conditions: a) EtOH, ))), 2 h, 25 % 
 
1.2.6. Functional transformation using trimethylamine 
For the study of non-covalent spirobenzopyran DNA interactions use of trimethylammonium 
equipped spirobenzopyrans has been suggested.
[63]
 For future studies we therefore substituted 
the iodide residues of 17 a - 17 e successfully with the cationic trimethylammonium residue 
(Table 2.4). There, the iodopropyl-spirobenzopyrans 17 were stirred in an ethanol solution 
with excess of trimethylamine (66 eq.) for 60 - 64 hours (Scheme 2.16). The products 
crystallized nicely and were isolated in high yields. 
 
a)
18
N O
Me3N
R1
R2R3
17
N O
I
R1
R2R3
I
 
 
Scheme 2.16. General synthesis of 18. Reagents and conditions: a) NMe3 (66 eq.), EtOH, r.t., 
60-64 h, 79-91 % 
 
Compound R
1
 R
2
 R
3
 Yield (%) 
18 a NO2 H H 79 
18 b Cl H H 91 
18 c Br H Br 88 
18 d Br H OCH3 85 
18 e NO2 H OCH3 89 
 
Table 2.4. Substituents and yields of spirobenzopyrans 18 a - 18 e 
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1.2.7. Synthesis of spirobenzopyran and spiroxazine azides  
To apply spirobenzopyran and spiroxazine systems as photochromic labels, functional groups 
need to be attached to them. One of the most popular functional groups used for a bio-
orthogonal labeling strategy are terminal alkynes and azides.
[64]
 Colloquial use of the term 
“click”-reactions mainly refers to the established procedures for 1,4-regioselective preparation 
of triazoles, by reacting alkynes and azides under copper-(I) catalysis.
[65]
 Beside the aspect of 
bio-orthogonality, the “click”-reactions also provide a broad range for the coupling of azides 
and functional ?-systems, often bearing alkynyl functionalities and will be further discussed 
in Chapter 2. 
Thus, the three azides of potentially interesting photo-responsive molecules were synthesized.  
Therefore, the corresponding iodides were subjected to an excess of sodium azide in 
dimethylformamide and stirred at room temperature. After nucleophilic substitution, the 
desired products were obtained in very good yields (Scheme 2.17).  
 
17
N O
I
R1
R2R3
a)
17 g
N O
N
I
N O
N3
R1
R2R3
or b)
N O
N
N3
19 / 20
21
c)
 
 
Scheme 2.17. Synthesis of spiropyran / spirooxazine azides. Reagents and conditions: a) for 
19 (R
1
 = NO2, R
2
, R
3
 = H), NaN3 (4.1 eq.), DMF, r.t., 19 h, 83 %; b) for 20 (R
1
 = C?CH, R2, 
R
3
 = H), NaN3 (5.7 eq.), DMF, r.t., 48 h, 96 %; c) for 21, NaN3 (4.0 eq.), DMF, r.t., 48 h, 84 
%. 
 
In addition to their synthetic access, the applicability of the spirobenzopyran azide 19 for the 
preparation of molecular dyads (Chapter 2) and labeling of DNA (Chapter 3) was also 
investigated. 
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1.3. Conclusion 
 
Several new spirobenzopyrans and spiroxazines were synthesized and the reaction yields were 
improved with use of ultrasonic irradiation. Functional modifications at the photochromic 
molecules were introduced using an alkyl linker bearing hydroxyl or iodo groups at the N-
indole sections or carboxylic acid incorporation, also at the indole moiety. The compounds 
were also equipped with trimethylammonium, azido and ethynyl groups that could be useful 
in combination with functional ?-systems or biopolymers. The reversibility of the 
photoswitching was demonstrated for representative compounds. Influence of different 
substitution patterns at the phenolic moiety have been discussed, including electron-
withdrawing and -donating substituents. The visible absorption spectra of the corresponding 
merocyanines formed by photo-induced ring opening were examined. The solvatochromic 
behaviour of a merocyanine with a strong electron-withdrawing group was examined in 
various solvents and showed negative solvatochromism. 
 
 
1.4. Experimental Section 
 
Reagents, solvents and reaction processing 
Unless otherwise specified, reagents and starting materials were purchased from commercial 
suppliers and used without further purification. PdCl2(PPh3)2 was prepared according to the 
literature.
[66]
 Dry solvents were prepared according to procedures reported in the literature.
[53a, 
67]
 Unless otherwise emphasized, all reactions were carried out at room temperature in 
degassed solvents and under N2 or Argon atmosphere. Reactions using ultrasound were 
carried out in deoxygenated solvents with use of a Sonorex Super RK510 ultrasonic system 
with superaudio frequency of 35 kHz. Synthetic steps involving indole or spirobenzopyran 
units were performed in the dark or under fluorescent lamps (Conrad Elektronik 590208 - 62). 
 
Chromatography 
Flash chromatography and dry column flash chromatography were performed on silica gel 
(Merck Silica Gel Si 60 40-63 µm and Acros silica gel, 35-70 µm, 60 A) according to the 
reported methods.
[53a, 54a, 55, 68]
 Preparative TLC was carried out on glass plates coated with 
silica gel (Merck Silica Gel 60, 20 x 20 cm, F254, thickness 2mm). TLC was carried out with 
use of alumina plates coated with silica gel (Merck Silica Gel 60 F254, thickness 0.25 mm) and 
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compounds were visualized by UV light (? = 254, 366 nm), MeOH/H2SO4 stain (5 vol-% 
H2SO4) and standard staining solutions (p-Anisaldehyde stain, Vanillin Stain, 
Phosphomolybdic acid stain).
[53a]
    
 
NMR 
NMR spectra were measured at the University of Regensburg, Zentrale Analytik, on Bruker 
Avance 300 (
1
H: 300.1 MHz, 
13
C: 75.5 MHz, T = 300 K), Bruker Avance 400 (
1
H: 400.1 
MHz, 
13
C: 100.6 MHz, T = 300 K) and Bruker Avance 600 (
1
H: 600.1 MHz, 
13
C: 150.1 MHz, 
T = 300 K) instruments. The solvent for each spectrum is reported. Chemical shifts are 
reported in ?/ppm relative to external standards and coupling constants J are given in Hz. 
Signal characterization: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = 
double doublet, dt = double triplet, ddd = double double doublet. The solvent used is reported 
for each spectrum. The relative number of protons is determined by integration. Error of 
reported values: 0.01 ppm (
1
H NMR), 0.1 ppm (
13
C NMR), coupling constant 0.1 Hz. The 
assignment of 
1
H NMR spectra was aided by COSY experiments. The assignment of 
13
C 
NMR spectra was aided by DEPT 90, DEPT 135, HSQC, HMBC and NOESY experiments. 
 
MS 
Mass spectra measurements were performed at the University of Regensburg, Zentrale 
Analytik Massenspektrometrie, with Finnigan MAT SSQ 710 A (EI-MS and CI-MS), 
ThermoQuest Finnigan TSQ 7000 (ESI-MS), Finnigan MAT 95 (EI-MS, FAB-MS and 
HRMS). 
 
IR 
IR spectra were recorded with a Bio-Rad FT-IR Excalibur FTS 3000 MX spectrometer. 
 
UV/Vis and fluorescence spectroscopy 
Unless otherwise specified, spectroscopic measurements were performed at 20 °C and quartz 
glass cuvettes (Starna, 10 mm) were used. UV/Vis spectra were recorded with a Cary BIO 50 
and Cary BIO 100 UV/Vis/NIR spectrometer (Varian) with temperature-controlled 6x6 
cuvette holder. Fluorescence measurements were performed with a Fluoromax-3 Fluorimeter 
from Jobin-Yvon with slit width 2-5 nm, with Peltier-element (LFI-3751) for temperature 
control and are corrected for the Raman emission from the solution.  
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X-ray crystallography 
The X-ray crystal structure measurement was performed at the University of Regensburg, 
Zentrale Analytik NWF IV, with use of a STOE-IPDS diffractometer. Further details are 
given in the appendix.  
 
Light sources 
For irradiation experiments a UV hand-held lamp (Herolab, 6 W, ? = 312 nm), a UV hand-
held lamp (Faust, 2 x 4 W, ? = 366 nm) and a Luxeon III Star high-power LED (? = 590 nm / 
amber) were used. 
 
 
1,2,3,3-tetramethyl-3H-indolium iodide 
 
N
I
 
 
Freshly distilled 2,3,3-Trimethylindolenine (2.38 mL, 14.88 mmol) was dissolved in dry 
MeCN (9.0 mL) and Iodomethane (1.0 mL, 16.16 mmol) was added. The mixture was 
refluxed under nitrogen atmosphere at 85 °C for 24 hours. Following, the mixture was stirred 
at room temperature for another two hours and cooled to 5 °C. The pink reaction mixture was 
filtered and the remaining precipitate was washed repeatedly with hexane, chloroform and 
ether until the crystals were ivory. Following, the crystals were triturated with Et2O and dried 
in a desiccator to afford 1,2,3,3-tetramethyl-3H-indolium iodide as a white fuzzy powder 
(3.312 g, 74 %). 
 
1
H NMR (300 MHz, DMSO-d6) ? = 7.96-7.89 (m, 1 H, H-Ar), 7.87-7.80 (m, 1 H, H-Ar), 
7.67-7.57 (m, 2 H, H-Ar), 3.99 (s, 3 H, NCH3), 2.79 (s, 3 H, 2-Me), 1.54 (s, 6 H, 3-Me) - 
13
C 
NMR (75 MHz, DMSO-d6) ? = 195.9 (Cquat.), 142.0 (Cquat.), 141.5 (Cquat.), 129.2 (+, CH), 
128.7 (+, CH), 123.2 (+, CH), 115.1 (+, CH), 53.8 (Cquat.), 34.8 (+, CH3), 21.6 (+, CH3, 
C(CH3)2), 14.3 (+, CH3) - MS (ESI): m/z (%): 174.0 (100) [M
+
] 
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1,3,3-trimethyl-2-methyleneindoline 
 
N
 
 
1,2,3,3-tetramethyl-3H-indolium iodide (3.500 g, 11.63 mmol) and an aqueous KOH solution 
(38.8 mmol, 38.8 mL) were stirred at room temperature for 3 hours. Following, the solution 
was extracted with Et2O (120 mL), the organic layer was dried over anhydrous MgSO4 and 
the solvent was removed under reduced pressure. The remaining red oil was purified by 
distillation to afford 1,3,3-trimethyl-2-methyleneindoline as a colorless oil (1.564 g, 77 %).  
 
1
H NMR (300 MHz, CDCl3) ? = 7.17-7.07 (m, 2 H, H-Ar), 6.76 (dd, 1 H, J = 4.2, 10.6 Hz, H-
Ar), 6.55 (d, 1 H, J = 7.8 Hz, H-Ar), 3.85 (s, 2 H, 2-CH2), 3.05 (s, 3 H, NCH3), 1.36 (s, 6 H, 
3-CH3) - MS (EI, 70 eV): m/z (%): 160.2 (100) [M
+
-CH3
.
], 175.2 (63) [M
+.
] 
 
 
1',3'-dihydro-1',3',3'-trimethyl-6-nitro-spiro[2H-1-benzopyran-2,2'-[2H]indole] 
 
N O NO2
 
 
Route A: 
A Schlenk flask was charged with a solution of 2-hydroxy-5-nitrobenzaldehyde (1.510 g, 
9.035 mmol) in dry EtOH (40 mL), degassed and heated to reflux. Following, 1,3,3-trimethyl-
2-methyleneindoline (1.564 g, 9.04 mmol) in dry EtOH (5.0 mL) was added over 5 minutes. 
The reaction mixture was refluxed for 4 hours, then under vigorous stirring allowed to cool to 
room temperature and stirred for additional 14 hours. The solvent was removed under reduced 
pressure and the remaining purple-red soild was purified by column chromatography on silica 
gel (acetone). Finally, the purified orange-brown solid was triturated with Et2O to afford 1',3'-
dihydro-1',3',3'-trimethyl-6-nitro-spiro[2H-1-benzopyran-2,2'-[2H]indole] as pale red crystals 
(2.818 g, 97 %). 
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Route B: 
A flask was capped with rubber septa and flushed with nitrogen. The flask was charged with 
1,3,3-trimethyl-2-methyleneindoline (1.125 g, 6.43 mmol) and dry EtOH (52 mL). 
Furthermore, 2-hydroxy-5-nitrobenzaldehyde (1.077 g, 6.44 mmol) was added and the 
solution was degassed. The mixture was sonicated at 35 kHz for 80 minutes, the product was 
allowed to crystallize in the freezer, filtered off and washed with cold EtOH. The precipitate 
was dried in vacuo and the remaining residue was recrystallized in EtOAc to yield 1',3'-
dihydro-1',3',3'-trimethyl-6-nitro-spiro[2H-1-benzopyran-2,2'-[2H]indole] as pale red crystals 
(1.946 g, 94 %). 
 
1
H NMR (300 MHz, CDCl3) ? = 8.00 (m, 2 H, H-Ar), 7.20 (m, 1 H, H-Ar), 7.09 (d, 1 H, J = 
7.2 Hz, H-Ar), 6.90 (m, 2 H, H-Ar), 6.75 (d, 1 H, H-Ar), 6.56 (d, 1 H, H-Ar), 5.86 (d, 1 H, H-
Ar), 2.75 (s, 3 H, NCH3), 1.30 (s, 3 H, 3-CH3), 1.20 (s, 3 H, 3-CH3) - MS (EI, 70 eV): m/z 
(%): 322.0 (100) [M
+.
], 307.0 (36) [M
+
-CH3
.
] 
 
 
1,3-dihydro-1,3,3-trimethyl-spiro[2H-indole-2,3'-[3H]naphth[2,1-b][1,4]oxazine]  
 
N O
N
 
 
A Schlenk flask was charged with 1-Nitroso-2-naphthol (808 mg, 4.67 mmol) and dry MeOH 
(50 mL). The solution was deaerated and freshly prepared 1,3,3-trimethyl-2-
methyleneindoline (825 µL, 4.66 mmol) was added under a nitrogen atmosphere. The mixture 
was sonicated for 2 hours at 35 kHz, then the solvent was removed under reduced pressure 
and the residue was dried in vacuo. Purification by gradient flash chromatography on silica 
gel (Hexane/THF 30:1 to 20:1) afforded 1,3-dihydro-1,3,3-trimethyl-spiro[2H-indole-2,3'-
[3H]naphth[2,1-b][1,4]oxazine as a lustrous orange solid (995 mg, 65 %). Rf = 0.25 
(Hexane/THF 25:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 8.57 (d, 1 H, J = 8.5 Hz), 7.75 (d, 2 H, J = 6.2 Hz), 7.67 (d, 
1 H, J = 8.9 Hz), 7.59 (ddd, 1 H, J = 1.2, 6.9, 8.3 Hz), 7.41 (ddd, 1 H, J = 1.2, 6.9, 8.1 Hz), 
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7.22 (dd, 1 H, J = 1.2, 7.7Hz), 7.10 (dd, 1 H, J = 0.9, 7.2 Hz), 7.02 (d, 1 H, J = 8.9 Hz), 6.91 
(dt, 1 H, J = 0.7, 7.4 Hz), 6.59 (d, 1 H, J = 7.8 Hz), 2.78 (s, 3 H), 1.37 (s, 3 H), 1.36 (s, 3 H) - 
13
C NMR (75 MHz, CDCl3): ? = 150.8 (+, CH), 147.6 (Cquat.), 144.1 (Cquat.), 135.9 (Cquat.), 
130.8 (Cquat.), 130.3 (+, CH), 129.3 (Cquat.), 128.0 (+, CH), 127.8 (+, CH), 127.1 (+, CH), 
124.2 (+, CH), 122.9 (Cquat.), 121.5 (+, CH), 119.9 (+, CH), 116.8 (+, CH), 110.9 (+, CH), 
107.2 (+, CH), 98.6 (Cquat.), 51.8 (Cquat.), 29.7 (+, CH3), 25.5 (+, CH3), 20.8 (+, CH3) - MS 
(CI, 70 eV): m/z (%): 328.2 (100) [M
+.
], 313.1 (76) [M
+
-CH3
.
] - HRMS (EI-MS) calcd. for 
C23H20N2O [M
+.
]: 328.1576, found: 328.1573 
 
 
2,3,3-trimethyl-3H-indole-5-carboxylic acid 
 
N
HOOC
 
 
To a solution of 4-hydrazinylbenzoic acid (11.702 g, 76.91 mmol) in EtOH (23 mL), 3-
methyl-2-butanone (9.1 mL, 85.05 mmol) and concentrated H2SO4 (2.2 mL) were added and 
the reaction mixture was heated under reflux for 16 hours. The solution was allowed to cool 
to ambient temperature and filtered. The filtrate was concentrated in vacuo to its half volume, 
washed with saturated aqueous K2CO3 solution (200 mL) and extracted with CH2Cl2 (2 x). 
The aqueous layer was extracted with Et2O and the organic layers were pooled. Removal of 
the solvents gave an amber-orange oil and concentrated HCl was added until pH 5 to 
precipitate the product. 2,3,3-trimethyl-3H-indole-5-carboxylic acid was obtained as orange-
yellow solid (9.916 g, 63 %).  
 
MS (EI, 70 eV): 203.1 (100) [M
+.
] 
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5-carboxy-1,2,3,3-tetramethyl-3H-Indolium iodide  
 
N
HOOC
I
 
 
A solution of 2,3,3-trimethyl-3H-indole-5-carboxylic acid (3.305 g, 16.27 mmol) in CHCl3 
(22 mL) was treated with iodomethane (2.1 mL, 33.73 mmol) and held at reflux for 18 hours. 
The mixture was slowly cooled to 0 °C, diluted by addition of cold hexane and filtered. The 
precipitate was washed with cold hexane (20 mL), dried in vacuo and 5-carboxy-1,2,3,3-
tetramethyl-3H-Indolium iodide was obtained as a pale fawn solid (4.579 g, 81 %)  
 
1
H NMR (300 MHz, DMSO-d6): ? = 8.38 (s, 1 H, arom., H-4), 8.19 (d, 1 H, J = 8.3 Hz, arom. 
H-6), 8.02 (d, 1 H, J = 8.4 Hz, arom. H-7), 3.99 (s, 3 H, NCH3), 2.81 (s, 3 H, CH3), 1.56 (s, 6 
H, 2 x CH3) - MS (ESI): m/z (%): 221.1 (100) [MH
+
], 262.1 (37) [MH
+
+MeCN] 
 
 
1',3'-dihydro-1',3',3'-trimethyl-6-nitro-spiro[2H-1-benzopyran-2,2'-[2H]indole]-5'-
carboxylic acid  
 
N O NO2
HOOC
 
 
Route A: 
A Schlenk flask was charged with 5-carboxy-1,2,3,3-tetramethyl-3H-Indolium iodide (592 
mg, 1.72 mmol), dry EtOH (23 mL) and dry piperidine (170 µL, 1.72 mmol) under an argon 
atmosphere. Following, 2-hydroxy-5-nitrobenzaldehyde (285 mg, 1.71 mmol) was added and 
the solution was degassed. The reaction mixture was refluxed for 18 hours, then very slowly 
cooled to room temperature and in addition placed in a freezer over night to give an olive-
green precipitate. The solvent was filtered off and the precipitate was washed with cold EtOH 
and MeOH. Finally, the solid was recrystallized in EtOH and dried in vacuo to yield 1',3'-
dihydro-1',3',3'-trimethyl-6-nitro-spiro[2H-1-benzopyran-2,2'-[2H]indole]-5'-carboxylic acid 
as smooth orange-green crystals (588 mg, 94 %). 
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Route B: 
A flask was capped with rubber septa and flushed with argon. The flask was charged with 5-
carboxy-1,2,3,3-tetramethyl-3H-Indolium iodide (340 mg, 0.985 mmol) and dry EtOH (11 
mL). Furthermore, piperidine (120 µL, 1.212 mmol) and 2-hydroxy-5-nitrobenzaldehyde (164 
mg, 0.981 mmol) were added and the solution was degassed via freeze-pump-thaw (3 cycles). 
The mixture was sonicated at 35 kHz for 60 minutes, then the solvents were removed under 
reduced pressure, and the remaining residue was triturated over night with Et2O to yield 1',3'-
dihydro-1',3',3'-trimethyl-6-nitro-spiro[2H-1-benzopyran-2,2'-[2H]indole]-5'-carboxylic acid 
as subtle orange-green crystals (354 mg, 98 %). 
 
1
H NMR (300 MHz, DMSO-d6): ? = 8.15 (d, 1 H, J = 2.8 Hz, H-5’), 7.99 (dd, 1 H, J = 2.8, 
9.0 Hz, H-7’), 7.81 (dd, 1 H, J = 1.6, 8.2 Hz, H-8’), 7.65 (d, 1 H, J = 1.6 Hz, H-4), 7.17 (d, 1 
H, J = 10.4 Hz, H-4’), 6.85 (d, 1 H, J = 9.0 Hz, H-6), 6.64 (d, 1 H, J = 8.2 Hz, H-7), 5.96 (d, 1 
H, J = 10.4 Hz, H-3’), 2.75 (s, 3 H, NCH3), 1.23 (s, 3 H, CH3), 1.12 (s, 3 H; CH3) - 
13
C NMR 
(75 MHz, DMSO-d6): ? = 158.8 (COOH), 151.1 (Cquat.), 135.7 (Cquat.), 130.6 (+, CH), 128.2 
(+, CH), 125.4 (+, CH), 122.6 (+, CH), 122.4 (+, CH), 121.3 (Cquat.), 120.5 (+, CH), 118.5 
(Cquat.), 115.1 (+, CH), 105.8 (+, CH), 105.7 (Cquat.), 51.3 (Cquat.), 47.2 (Cquat.), 38.6 (Cquat.), 
27.7 (+, CH3), 24.9 (+, CH3), 18.9 (+, CH3) - IR (neat): ? [cm-1] = 2970, 2359, 1738, 1366, 
1350, 1228, 1217 - MS (ESI): m/z (%): 367.0 (100) [MH
+
], 408.0 (21) [MH
+
+MeCN] 
 
 
1-(3-Hydroxypropyl)-2,3,3-trimethyl-3H-indolium iodide 
 
N
HO
I
 
 
Under nitrogen atmosphere freshly distilled 2,3,3-Trimethylindolenine (1.5 mL, 9.34 mmol) 
was dissolved in chloroform (17 mL). The solution was degassed via freeze-pump-thaw (3 
cycles), 3-Iodo-1-propanol (1.00 g, 10.44 mmol) was added and refluxed under nitrogen for 
24 hours. The reaction mixture was slowly cooled to room temperature and the solvent was 
removed under reduced pressure. The remaining purple oil was washed with petrolether and 
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triturated with Et2O to afford 1-(3-Hydroxypropyl)-2,3,3-trimethyl-3H-indolium iodide as a 
purple solid (3.224 g, 99 %). 
 
1
H NMR (DMSO-d6, 300 MHz): ? = 8.01-7.91 (m, 1 H), 7.90-7.81 (m, 1 H), 7.67-7.57 (m, 2 
H), 4.56 (t, 2 H, J = 6.9 Hz), 3.55 (t, 2 H, J = 5.5 Hz), 2.87 (s, 3 H), 2.11-1.97 (m, 2 H), 1.54 
(s, 6 H) - 
13
C NMR (DMSO-d6, 75 MHz): ? = 196.4 (Cquat.), 141.7 (Cquat.), 141.0 (Cquat.), 129.2 
(+, CH), 128.8 (+, CH), 123.4 (+, CH), 115.4 (+, CH), 57.8 (-, CH2), 54.1 (Cquat.), 45.7 (-, 
CH2), 29.6 (-, CH2), 21.8 (+, CH3), 14.3 (+, CH3), 5.4 (+, CH3) - MS (ESI, DCM/MeOH + 10 
mmol/L NH4Ac): m/z (%) = 218.0 (100) [M
+
]  
 
 
(S)-3,4,10,10a-Tetrahydro-10,10,10a-trimethyl-2H-[1,3]oxazino[3,2-a]indole  
 
1
2
3
4
5
6
7
8
9
1011
12
13
14
N
O
 
 
1-(3-Hydroxypropyl)-2,3,3-trimethyl-3H-indolium iodide (3.093 g, 8.97 mmol) was 
suspended in degassed water (53 mL) and finely ground potassium hydroxide (1.226 g, 21.85 
mmol) was added. The reaction mixture was stirred at room temperature under nitrogen for 2 
hours. Dichloromethane (50 mL) was added and the mixture was stirred for additional 30 
minutes. The aqueous layer was separated and extracted with dichloromethane (2 x 45 mL). 
The combined organic layers were washed with brine, water and dried over anhydrous 
Na2SO4. The solvent was removed under reduced pressure and the residue was dried under 
vacuum. The crude product was purified by gradient flash chromatography on silica gel 
(Hexane/EtOAc 4:1 to 1:1) to afford (S)-3,4,10,10a-Tetrahydro-10,10,10a-trimethyl-2H-
[1,3]oxazino[3,2-a]indole as colorless crystals (0.835 g, 43 %). Rf = 0.47 (Hexane/EtOAc 
4:1). Crystals suitable for X-ray analysis were grown by slow evaporation of EtOAc at r.t. 
from a concentrated solution of the purified product. 
 
1
H NMR (600 MHz, CDCl3): ? = 7.13 (t, 1 H, J = 7.7 Hz, CH-C3), 7.08 (d, 1 H, J = 7.3 Hz, 
CH-C5), 6.81 (t, 1 H, J = 7.2 Hz, CH-C4), 6.59 (d, 1 H, J = 7.8 Hz, CH-C2), 4.08 (dt, 1 H, J = 
2.6, 12.4Hz, CH2-C9), 3.72 (dd, 1 H, J = 5.2, 11.8 Hz, CH2-C9), 3.66 (dd, 1 H, J = 4.6, 14.6 
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Hz, CH2-C11), 3.54 (m, 1 H, CH2-C11), 2.02-1.92 (m, 1 H, CH2-C10), 1.56 (s, 3 H, CH3-
C14), 1.30 (s, 3 H, CH3-C12), 1.20 (d, 1 H, J = 13.4 Hz, CH2-C10), 1.07 (s, 3 H, CH3-C13) - 
13
C NMR (150 MHz, CDCl3): ? = 148.1 (C1), 139.2 (C6), 127.2 (C3), 122.0 (C5), 119.2 (C4), 
108.6 (C2), 98.3 (C8), 61.0 (C9), 48.0 (C7), 39.1 (C11), 26.7 (C13), 21.7 (C10), 18.6 (C12), 
13.0 (C14) - MS (CI, 70 eV): m/z (%): 218.2 (100) [MH
+
] - HRMS (EI-MS) calcd. for 
C14H19NO [M
+.
]: 217.1467, found: 217.1472 
 
 
2-Hydroxy-5-(2-(trimethylsilyl)ethynyl)benzaldehyde  
 
HO
O
TMS
 
 
A Schlenk flask was charged with 5-Bromosalicylaldehyde (1.529 g, 7.61 mmol) and dry 
NEt3 (28.0 mL) under an atmosphere of N2 and the solution was stirred for 5 minutes at room 
temperature. Following, 170 mg PdCl2(PPh3)2 (170 mg, 0.24 mmol) and CuI (50 mg, 0.26 
mmol) were added and the solution was degassed. Under a slow flow of argon 
Ethynyltrimethylsilane (1.66 mL, 11.98 mmol) was added quickly and the reaction mixture 
was heated at 80 °C for 3 hours. The reaction mixture was slowly cooled to room temperature, 
dry THF (80 mL) was added and stirred at room temperature for 1 hour. The mixture was 
concentrated in vacuo, diluted with CH2Cl2, washed with water. The aqueous phase was 
extracted with CH2Cl2, the organic layers were combined and dried over anhydrous Na2SO4. 
The solvent was evaporated and the remaining solid was purified by gradient flash 
chromatography on silica gel (Hexane/THF 40:1 to 10:1) to yield 2-Hydroxy-5-(2-
(trimethylsilyl)ethynyl)benzaldehyde as colorless crystrals (1.452 g, 88 %). Rf = 0.25 
(Hexane/THF 40:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 11.13 (s, 1 H), 9.88 (s, 1 H), 7.73 (d, 1 H, J = 2.0 Hz), 7.63 
(dd, 1 H, J = 2.1, 8.7 Hz), 6.96 (d, 1 H, J = 8.7 Hz), 0.28 (s, 9 H) - 
13
C NMR (CDCl3, 75 
MHz): 196.1 (+, CH), 161.6 (Cquat.), 140.2 (+, CH), 137.5 (+, CH), 120.4 (Cquat.), 118.0 (+, 
CH), 115.2 (Cquat.), 103.2 (Cquat.), 93.9 (Cquat.), 0.0 (+, CH3) - IR (neat): ? [cm-1] = 2970, 2360, 
1738, 1466, 1373 - MS (EI, 70 eV): m/z (%): 218.0 (32) [M
+.
], 203.0 (100) [M
+
-CH3
.
] - 
HRMS (PI-MS) calcd. for C12H14O2Si [M
+.
]: 218.0763, found: 218.0766  
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5-Ethynyl-2-hydroxybenzaldehyde 
 
HO
O
 
 
To a solution of 2-Hydroxy-5-(2-(trimethylsilyl)ethynyl)benzaldehyde (1.396 g, 6.40 mmol) 
in dry THF (40 mL), a freshly prepared solution of Bu4NF in dry THF (12 mL, 12.00 mmol)  
was added. The reaction mixture was stirred at room temperature for 30 minutes, and water 
(35 mL) was added. The mixture was extracted with Et2O (2 x 40 mL), the yellow-green 
organic layers were combined and dried over anhydrous Na2SO4, the solution was filtered and 
concentrated in vacuo. Purification was performed by flash chromatography on silica gel 
(Hexane/THF 20:1) and 5-Ethynyl-2-hydroxybenzaldehyde was isolated as a ivory-colored 
solid (860 mg, 92 %). Rf = 0.35 (Hexane/THF 20:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 11.15 (s, 1 H), 9.88 (s, 1 H), 7.74 (d, 1 H, J = 2.1 Hz), 7.64 
(dd, 1 H, J = 2.1, 8.7 Hz), 6.98 (d, 1 H, J = 8.7 Hz), 3.06 (s, 1 H) - 
13
C NMR (75 MHz, 
CDCl3): ? = 195.0 (+, CH), 160.7 (Cquat.), 139.2 (+, CH), 136.5 (+, CH), 119.4 (+, CH), 117.1 
(Cquat.), 112.9 (Cquat.), 80.8 (+, CH), 28.7 (Cquat.) - MS (EI, 70 eV): m/z (%): 146.1 (100) [M
+.
], 
145.1 (54) [M
+
-H], 117.1 (10) [M–CHO
+
] 
 
 
2-Hydroxy-3-methoxy-5-(2-(trimethylsilyl)ethynyl)benzaldehyde 
 
HO
O
Si
O
 
 
A Schlenk flask was charged under argon atmosphere with 5-Bromo-2-hydroxy-3-
methoxybenzaldehyde (934 mg, 4.04 mmol), PdCl2(PPh3)2 (97 mg, 0.14 mmol) and CuI (30 
mg, 0.16 mmol), and dry NEt3 (18 mL) was added. The mixture was degassed via freeze-
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pump-thaw (3 cycles) and Ethynyltrimethylsilane (0.88 mL, 6.35 mmol) was added under 
argon atmosphere. The reaction mixture was heated at 80 °C for 3 hours, slowly cooled to 
room temperature, CH2Cl2 (20 mL) and water (20 mL) were added and the mixture was 
stirred for 30 minutes. The mixture was extracted with CH2Cl2, washed with brine and water 
and the aqueous layer was extracted with CH2Cl2. The organic layers were combined and 
dried over anhydrous MgSO4, filtered and the solvent was evaporated under reduced pressure. 
The residue was dried in vacuo over night and the remaining solid was purified by flash 
chromatography on silica gel (CH2Cl2/MeOH 20:1) to give 2-Hydroxy-3-methoxy-5-(2-
(trimethylsilyl)ethynyl)benzaldehyde as fawn crystals (730 mg, 73 %). Rf = 0.25 (CH2Cl2) 
 
1
H NMR (300 MHz, CDCl3): ? = 11.23 (s, 1 H), 9.87 (s, 1 H), 7.35 (d, 1 H, J = 1.8 Hz), 7.16 
(d, 1 H, J = 1.5 Hz), 3.92 (s, 3 H), 0.58 (s, 9 H) - 
13
C (75 MHz, CDCl3): ? = 196.2 (+, CH), 
152.1 (Cquat.), 148.2 (Cquat.), 128.6 (+, CH), 120.4 (+, CH), 120.4 (Cquat.), 114.7 (Cquat.), 93.7 
(Cquat.), 56.4 (+, CH3), 29.8 (Cquat.), 0.0 (+, CH3) - MS (EI, 70 eV): m/z (%): 249.0 (87) 
[MH
+
], 266.1 (100) [M+NH4
+
] - HRMS (PI-MS) calcd. for C13H16O3Si [M
+.
]: 248.0869, 
found: 248.0862 
 
 
5-Ethynyl-2-hydroxy-3-methoxybenzaldehyde 
 
HO
O
O
 
 
2-Hydroxy-3-methoxy-5-(2-(trimethylsilyl)ethynyl)benzaldehyde (701 mg, 2.83 mmol) was 
dissolved in dry THF (18 mL) and a freshly prepared solution of Bu4NF in dry THF (5.34 
mL, 5.34 mmol) was added. The reaction mixture was stirred at room temperature for 90 
minutes and the solvent was evaporated under reduced pressure, diluted with CH2Cl2 and 
washed with water. The aqueous phase was extracted with CH2Cl2, the organic layers were 
combined, dried over anhydrous MgSO4 and the solvent was evaporated under reduced 
pressure. The residue was dried in a vacuum desiccator over night and purified by gradient 
flash chromatography on silica gel (Hexane/EtOAc 5:1 to 2:1) to give 5-Ethynyl-2-hydroxy-
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3-methoxybenzaldehyde as a fawn-yellow solid (470 mg, 94 %). Rf = 0.27 (Hexane/EtOAc 
5:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 11.26 (s, 1 H), 9.88 (s, 1 H), 7.37 (d, 1 H, J = 1.8 Hz), 7.18 
(d, 1 H, J = 1.6 Hz), 3.93 (s, 3 H), 3.05 (s, 1H) - CI-MS (NH3): m/z (%): 177.2 (12) [MH
+
], 
194.2 (100) [M+NH4
+
] 
 
 
General procedure A for synthesis of 3-propanol-spirobenzopyrans: 
A Schlenk flask was charged with a deoxygenated 0.06 M solution of 3,4,10,10a-Tetrahydro-
10,10,10a-trimethyl-2H-[1,3]oxazino[3,2-a]indole in freshly distilled EtOH. Following, the 
salicylaldehyde (1.0 eq.) was added under nitrogen atmosphere and the reaction mixture was 
sonicated at 35 kHz. The progress of the reaction was monitored by TLC until the starting 
materials disappeared or spot intensity of the product remained constant in successive 
controls. After completion of the reaction, EtOH was removed under reduced pressure, the 
residue was taken up in CH2Cl2 and dried over anhydrous Na2SO4. The solution was filtered 
and the solvent was evaporated under reduced pressure. The residue was dried in vacuo and 
the crude product was purified by flash chromatography on silica gel.  
 
General procedure B for synthesis of 3-propanol-spirobenzopyrans: 
A flask was capped with rubber septa and flushed with nitrogen for ten minutes. The flask 
was charged with a deoxygenated 0.1 M solution of 3,4,10,10a-Tetrahydro-10,10,10a-
trimethyl-2H-[1,3]oxazino[3,2-a]indole in dry EtOH. The salicylaldehyde (1.0 eq.) was added 
under nitrogen atmosphere and the mixture was sonicated at 35 kHz. Progress of the reaction 
was monitored by TLC until the starting materials disappeared or spot intensity of the product 
remained constant in successive controls. Following, EtOH was removed under reduced 
pressure, and the residue taken up in CH2Cl2 and washed with water. The organic layer was 
dried over anhydrous Na2SO4, the solvent was removed under reduced pressure, dried in 
vacuo and the crude product was purified by flash chromatography on silica gel. 
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3',3'-Dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol 
 
N O
HO
NO2
 
 
The compound was prepared following general procedure B and isolated as a pale purple 
solid. Ultrasonic irradiation time: 60 min. Yield: 84 %. Eluent for flash chromatography: 
Hexane/EtOAc 1:1 Rf = 0.43 (Hexane/EtOAc 1:1) 
 
1
H NMR (600 MHz, CDCl3): ? = 8.00 (td, 2 H, J = 2.7, 7.9 Hz), 7.19 (dt, 1 H, J = 1.2, 7.7 
Hz), 7.09 (dd, 1 H, J = 0.8, 7.2 Hz), 6.91 (d, 1 H, J = 10.3 Hz), 6.88 (dt, 1 H, J = 0.8, 7.5 Hz), 
6.75 (d, 1 H, J = 8.9 Hz), 6.65 (d, 1 H, J = 7.8 Hz), 5.88 (d, 1 H, J = 10.4 Hz), 3.71 (t, 2 H, J = 
6.0 Hz, CH2-propyl), 3.40-3.34 (m, 1 H, CH2-propyl), 3.29-3.23 (m, 1 H, CH2-propyl), 1.98-
1.90 (m, 1 H, CH2-propyl), 1.84-1.77 (m, 1 H, CH2-propyl), 1.29 (s, 3 H, CH3), 1.19 (s, 3 H, 
CH3) - 
13
C NMR (150 MHz, CDCl3): ? = 159.6 (Cquat.), 147.0 (Cquat.), 141.0 (Cquat.), 136.0 
(Cquat.), 128.2 (+, CH), 127.8 (+, CH), 125.9 (+, CH), 122.7 (+, CH), 121.8 (+, CH), 121.7 (+, 
CH), 119.6 (+, CH), 118.5 (Cquat.), 115.5 (+, CH), 106.9 (+, CH), 106.8 (Cquat.), 60.7 (CH2-
propyl), 52.6 (Cquat.), 40.7 (CH2-propyl), 31.6 (CH2-propyl), 25.9 (+, CH3), 19.9 (+, CH3) - IR 
(neat): ? [cm-1] = 2970, 2359, 1738, 1479 - MS (ESI): m/z (%): 367.0 (100) [MH+] - HRMS 
(EI-MS) calcd. for C21H22N2O4 [M
+.
]: 366.1580, found: 366.1572 
 
 
3',3'-Dimethyl-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol  
 
N O
HO  
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The compound was prepared following general procedure A and isolated as glistening blue 
foam. Ultrasonic irradiation time: 60 min. Yield: 87 %. Eluent for flash chromatography: 
Hexane/EtOAc 3:1 Rf = 0.20  
 
1
H NMR (300 MHz, CDCl3): ? =  7.17 (dt, 1 H, J = 1.3, 7.7 Hz), 7.13-7.02 (m, 3 H), 6.89-
6.79 (m, 3 H), 6.70 (d, 1 H, J = 8.1 Hz), 6.62 (d, 1 H, J = 7.7 Hz), 5.68 (t, 1 H, J = 12.5 Hz), 
3.71 (t, 2 H, J = 6.0 Hz), 3.45-3.33 (m, 1 H), 3.29-3.17 (m, 1 H), 2.02-1.73 (m, 2 H), 1.31 (s, 3 
H), 1.17 (s, 3 H) - 
13
C NMR (75 MHz, CDCl3): ? = 154.2 (Cquat.), 147.5 (Cquat.), 136.7 (Cquat.), 
129.8 (+, CH), 129.4 (+, CH), 127.6 (+, CH), 126.8 (+, CH), 121.7 (+, CH), 120.1 (+, CH), 
119.6 (+, CH), 119.1 (+, CH), 118.5 (Cquat.), 115.1 (+, CH), 106.6 (+, CH), 104.6 (Cquat.), 61.1 
(-, CH2), 52.0 (Cquat.), 41.0 (-, CH2), 31.7 (-, CH2), 25.8 (+, CH3), 20.3 (+, CH3) - - IR (neat): ? 
[cm
-1
] = 2970, 2359, 1738, 1481, 1366 - MS (CI, 70 eV): m/z (%): 322.2 (100) [MH
+
] - 
HRMS (EI-MS) calcd. for C21H23NO2 [M
+.
]: 321.1729, found: 321.1726 
 
 
3',3'-Dimethyl-6-chloro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol  
 
N O
HO
Cl
 
 
The compound was prepared following general procedure A and isolated as blue foam. 
Ultrasonic irradiation time: 60 min. Yield: 78 %. Eluent for flash chromatography: 
Hexane/EtOAc 3:1 Rf = 0.25 
 
1
H NMR (300 MHz, CDCl3): ? = 7.17 (t, 1 H, J = 7.6 Hz), 7.11-6.97 (m, 3 H), 6.90-6.74 (m, 2 
H), 6.68-6.57 (m, 2 H), 5.76 (d, 1 H, J = 10.3 Hz), 3.70 (t, 2 H, J = 5.9 Hz), 3.43-3.30 (m, 1 
H), 3.29-3.15 (m, 1 H), 2.01-1.74 (m, 2 H), 1.28 (s, 3 H), 1.16 (s, 3 H) - 
13
C NMR (75 MHz, 
CDCl3): ? = 152.7 (Cquat.), 147.4 (Cquat.), 136.4 (Cquat.), 129.4 (+, CH), 128.5 (+, CH), 127.7 
(+, CH), 126.3 (+, CH), 124.7 (Cquat.), 121.7 (+, CH), 121.0 (+, CH), 119.8 (Cquat.), 119.2 (+, 
CH), 116.4 (+, CH), 106.7 (+, CH), 105.0 (Cquat.), 61.0 (-, CH2), 52.2 (Cquat.), 40.9 (-, CH2), 
31.7 (-, CH2), 25.8 (+, CH3), 20.2 (+, CH3) - IR (neat): ? [cm-1] = 2970, 2363, 1738, 1476, 
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1371, 1217 - MS (CI, 70 eV): m/z (%): 356.2 (100) [MH
+
] - HRMS (EI-MS) calcd. for 
C21H22ClNO2 [M
+.
]: 355.1339, found: 355.1336 
 
 
3',3'-Dimethyl-6-methoxy-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol 
 
N O
HO
O7
5
6
17
1312
15
8
18
 
 
The compound was prepared following general procedure A and isolated as pale blue foam. 
Ultrasonic irradiation time: 60 min. Yield: 54 %. Eluent for flash chromatography: 
Hexane/EtOAc Rf = 0.23 
 
1
H NMR (600 MHz, CDCl3): ? = 7.21 (ddd, 1 H, J = 1.3, 7.5, 7.8 Hz, C7-CH ), 7.13 (ddd, 1 
H, J = 0.5, 1.3, 7.2 Hz, C5-CH), 6.89 (ddd, 1 H, J = 1.0, 7.2, 7.5, C6-CH), 6.84 (d, 1 H, J = 
10.2 Hz, C17-CH), 6.72 (dd, 1 H, J = 2.9, 8.8 Hz, C13-CH), 6.69 (d, 1 H, J = 8.8 Hz, C12-
CH), 6.67 (d, 1 H, J = 2.9 Hz, C15-CH), 6.66 (dd, 1 H, J = 1.0, 7.8 Hz, C8-CH), 5.77 (d, 1 H, 
10.2 Hz, C18-CH), 3.79 (s, 3 H, OCH3), 3.73-3.67 (m, 2 H, CH2-propyl), 3.46-3.40 (m, 1 H, 
CH2-propyl), 3.30-3.24 (m, 1 H, CH2-propyl), 2.01-1.92 (m, 1 H, CH2-propyl), 1.89-1.79 (m, 
1 H, CH2-propyl), 1.37 (s, 3 H, C3-Me), 1.23 (s, 3 H, C3-Me) - 
13
C NMR (75 MHz, CDCl3): ? 
= 153.0 (Cquat.), 148.1 (Cquat.), 147.4 (Cquat.), 136.5 (Cquat.), 129.1 (C17), 127.4 (C7), 121.5 
(C5), 120.4 (C18), 118.8 (C6), 118.7 (Cquat.), 115.4 (C12), 115.2 (C13), 111.4 (C15), 106.4 
(C8), 104.2 (Cquat.), 60.7 (-, CH2-propyl), 55.6 (OCH3), 51.7 (Cquat.), 40.7 (-, CH2-propyl), 
31.5 (-, CH2-propyl), 25.6 (+, CH3), 20.2 (+, CH3) - IR (neat): ? [cm-1] = 2970, 2357, 1738, 
1481, 1366 - MS (CI, 70 eV): m/z (%): 352.2 (100) [MH
+
] - HRMS (EI-MS) calcd. for 
C22H25NO3 [M
+.
]: 351.1834, found: 351.1833 
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3',3'-Dimethyl-6,8-dibromo-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol 
 
N O
HO
Br7
5
6
17
13
15
8
18
Br
 
 
The compound was prepared following general procedure A and isolated as dark blue foam. 
Ultrasonic irradiation time: 60 min. Yield: 93 %. Eluent for flash chromatography: 
Hexane/EtOAc 2:1 Rf = 0.33 
 
1
H NMR (400 MHz, CDCl3): ? = 7.45 (d, 1 H, J = 2.3 Hz, C13-CH), 7.15 (ddd, 1 H, J = 1.3, 
7.5, 7.8 Hz, C7-CH), 7.12 (d, 1 H, J = 2.3 Hz, C15-CH), 7.06 (ddd, 1 H, J = 0.5, 1.3, 7.3 Hz, 
C5-CH), 6.84 (ddd, 1 H, J = 0.9, 7.3, 7.5 Hz, C6-CH), 6.73 (d, 1 H, J = 10.3 Hz, C17-CH), 
6.61 (dd, 1 H, J = 0.9, 7.8 Hz, C8-CH), 5.76 (d, 1 H, J = 10.3 Hz, C18-CH), 3.74-3.67 (m, 2 
H, CH2-propyl), 3.41-3.31 (m, 1 H, CH2-propyl), 3.29-3.20 (m, 1 H, CH2-propyl), 1.98-1.87 
(m, 1 H, CH2-propyl), 1.84-1.73 (m, 1 H, CH2-propyl), 1.30 (s, 3 H), 1.17 (s, 3 H) - 
13
C NMR 
(100 MHz, CDCl3): ? = 149.8 (Cquat.), 147.0 (Cquat.), 136.1 (Cquat.), 134.8 (C13), 128.3 (C15), 
127.8 (C17), 127.6 (C7), 122.2 (C18), 121.6 (C5), 121.3 (Cquat.), 119.2 (C6), 111.8 (Cquat.), 
110.1 (Cquat.), 106.6 (C8), 106.4 (Cquat.), 60.9 (-, CH2-propyl), 52.2 (Cquat.), 40.6 (-, CH2-
propyl), 31.5 (-, CH2-propyl), 25.5 (+, CH3), 20.5 (+, CH3) - IR (neat): ? [cm-1] = 2970, 2357, 
1738, 1445, 1366, 1217 - MS (CI, 70 eV): m/z (%) = 478.0 (59) [MH
+.
], 480.1 (100), 482.1 
(55)  
 
 
3',3'-Dimethyl-6-ethynyl-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol  
 
N O
HO  
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The compound was prepared following general procedure A and isolated as pale blue foam. 
Ultrasonic irradiation time: 120 min. Yield: 68 %. Eluent for flash chromatography: 
Hexane/EtOAc 3:1 Rf = 0.20 
 
1
H NMR (300 MHz, CDCl3): ? = 7.28-7.16 (m, 3 H), 7.13-7.07 (m, 1 H), 6.92-6.80 (m, 2 H), 
6.70-6.62 (m, 2 H), 5.81-5.74 (d, 1 H), 3.77-3.69 (m, 2 H), 3.45-3.33 (m, 1 H), 3.31-3.20 (m, 
1 H), 3.00 (s, 1 H), 2.02-1.78 (m, 2 H), 1.31 (s, 3 H), 1.19 (s, 3 H) - 
13
C NMR (75 MHz, 
CDCl3): ? = 154.7 (Cquat.), 147.4 (Cquat.), 136.4(Cquat.), 133.8 (+, CH), 130.6 (+, CH), 128.8 (+, 
CH), 127.6 (+, CH), 121.7 (+, CH), 120.5 (+, CH), 119.3 (+, CH), 118.6 (Cquat.), 115.3 (+, 
CH), 106.7 (+, CH), 105.2 (Cquat.), 83.5 (Cquat.), 75.6 (+, CH), 61.0 (-, CH2), 52.2 (Cquat.), 40.9 
(-, CH2), 31.7 (-, CH2), 25.9 (+, CH3), 21.1 (Cquat.), 20.1 (+, CH3) - IR (neat): ? [cm-1] = 3449, 
3281, 2970, 2357, 1740, 1481, 1373 - MS (ESI): m/z (%): 346.0 (100) [MH
+
] - HRMS (EI-
MS) calcd. for C23H23NO2 [M
+.
]: 345.1729, found: 345.1730 
 
 
3',3'-Dimethyl-6-ethynyl-8-methoxy-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-
propanol  
 
N O
HO
O
 
 
The compound was prepared following general procedure A and isolated as glistening 
turquoise foam. Ultrasonic irradiation time: 100 min. Yield: 75 %. Eluent for gradient flash 
chromatography: Hexane/EtOAc 3:1 to 2:1 Rf = 0.15 (Hexane/EtOAc 3:1) 
 
1
H NMR (600 MHz, CDCl3): ? = 7.17-7.03 (m, 4 H), 6.82 (t, 1 H, J = 7.3 Hz), 6.75 (d, 1 H, J 
= 10.2 Hz), 6.59 (d, 1 H, J = 7.7 Hz), 5.76 (d, 1 H, J = 10.2 Hz), 3.91 (s, 1 H), 3.68 (s, 3 H), 
3.75-3.69 (m, 2 H), 3.41-3.34 (m, 1 H), 3.29-3.24 (m, 1 H), 1.94-1.87 (m, 1 H), 1.85-1.77 (m, 
1 H), 1.29 (s, 3 H), 1.16 (s, 3 H) 
13
C NMR (150 MHz, CDCl3): ? = 147.2, 146.9, 144.4, 136.4, 
128.4, 127.5, 123.4, 121.7, 120.9, 119.2, 118.9, 116.9, 113.0, 106.5, 105.2, 83.6, 75.4, 60.8, 
56.3, 51.9, 40.5, 31.5, 25.6, 20.4 - IR (neat): ? [cm-1] = 3287, 2959, 2357, 1479, 1458 - - MS 
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(ESI): m/z (%): 376.0 [MH
+
] - HRMS (EI-MS) calcd. for C24H25NO3 [M
+.
]: 375.1834, found: 
375.1840 
 
 
3',3'-Dimethyl-6-bromo-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol  
 
N O
HO
Br
 
 
The compound was prepared following general procedure B and isolated as glistening grey-
blue foam. Ultrasonic irradiation time: 70 min. Yield: 52 %. Eluent for flash chromatography: 
Hexane/EtOAc 2:1 Rf = 0.47 
 
1
H NMR (400 MHz, CDCl3): ? = 7.20-7.14 (m, 3 H), 7.09-7.05 (d, 1 H), 6.87-6.82 (dt, 1 H), 
6.79-6.75 (d, 1 H), 6.64-6.56 (m, 2 H), 5.77-5.73 (d, 1 H), 3.72-3.67 (m, 2 H), 3.40-3.30 (m, 1 
H), 3.27-3.18 (m, 1 H), 1.97-1.89 (m, 1 H), 1.84-1.76 (m, 1 H), 1.29 (s, 3 H), 1.16 (s, 3 H) - 
13
C NMR (100 MHz, CDCl3): ? = 153.2 (Cquat.), 147.3 (Cquat.), 136.4 (Cquat.), 132.3 (+, CH), 
129.1 (+, CH), 128.3 (+, CH), 127.6 (+, CH), 121.7 (+, CH), 120.9 (+, CH), 120.4 (Cquat.), 
119.2 (+, CH), 116.9 (+, CH), 111.9 (Cquat.), 106.7 (+, CH), 105.0 (Cquat.), 60.9 (-, CH2), 52.2 
(Cquat.), 40.8 (-, CH2), 31.7 (-, CH2), 25.8 (+, CH3), 20.1 (+, CH3) - MS (ESI): m/z (%) = 401.9 
(100) [MH
+
] 
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3',3'-Dimethyl-8-methoxy-6-nitro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-
propanol  
 
N O
HO
NO2
O
 
 
The compound was prepared following general procedure A and isolated as lustrous blue 
foam. Ultrasonic irradiation time: 75 min. Yield: 83 %. Eluent for flash chromatography: 
Hexane/EtOAc 1:1 Rf = 0.49 
 
1
H NMR (600 MHz, CDCl3): ? = 7.69-7.67 (m, 1 H), 7.62 (d, 1 H, J = 2.6 Hz), 7.18-7.15 (m, 
1 H), 7.07 (d, 1 H, J = 7.3 Hz), 6.87-6.84 (m, 2 H), 6.62 (d, 1 H, J = 7.8 Hz), 5.84 (d, 1 H, J = 
10.3 Hz), 3.76 (s, 3 H), 3.71-3.68 (m, 2 H), 3.41-3.35 (m, 1 H), 3.32-3.26 (m, 1 H), 2.95-2.88 
(m, 1 H), 1.84-1.79 (m, 1 H), 1.28 (s, 3 H), 1.18 (s, 3 H) – 
13
C NMR (150 MHz, CDCl3): ? = 
149.3, 147.3, 147.0, 140.4, 136.0, 128.0, 127.6, 122.0, 121.7, 119.3, 118.3, 116.1, 115.4, 
107.9, 106.7, 60.6, 56.3, 52.5, 40.5, 31.6, 25.8, 20.1 - IR (neat): ? [cm-1] = 3016, 2970, 2359, 
1738, 1366, 1229 - MS (EI, 70 eV): m/z (%): 397.1 (100) [MH
+
] - HRMS (EI-MS) calcd. for 
C22H24N2O5 [M
+.
]: 396.1685, found: 396.1685 
 
 
3',3'-Dimethyl-6-bromo-8-methoxy-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-
propanol  
 
N O
HO
Br
O
 
 
The compound was prepared following general procedure A and isolated as pale blue-green 
foam. Ultrasonic irradiation time: 60 min. Yield: 76 %. Eluent for gradient flash 
chromatography: Hexane/EtOAc 3:1 to 1:1 Rf = 0.22 (Hexane/EtOAc 3:1) 
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1
H NMR (600 MHz, CDCl3): ? = 7.14 (t, 1 H, J = 7.6 Hz), 7.05 (dd, 1 H, J = 1.0, 7.3 Hz), 
6.84 (d, 1H, J = 2.2 Hz), 6.83-6.81 (m, 2 H), 6.71 (d, 1 H, J = 10.2 Hz), 6.58 (d, 1 H, J = 7.7 
Hz), 5.71 (d, 1 H, J = 10.2 Hz), 3.76-3.68 (m, 2 H), 3.67 (s, 3 H), 3.39-3.33 (m, 1 H), 3.28-
3.23 (m, 1 H), 1.93-1.86 (m, 1 H), 1.84-1.77 (m, 1 H), 1.29 (s, 3 H), 1.16 (s, 3 H) – 
13
C NMR 
(75 MHz, CDCl3): ? = 148.1, 147.2, 136.4, 127.9, 127.5, 121.7, 121.5, 120.6, 118.9, 116.5, 
111.4, 108.8, 106.5, 104.9, 101.2, 60.8, 56.5, 51.9, 40.6, 31.6, 25.6, 20.6 - IR (neat): ? [cm-1] 
= 2970, 2259, 1738, 1366, 1217 - HRMS (EI-MS) calcd. for C22H24BrNO3 [M
+.
]: 429.0940, 
found: 429.0930 
 
 
3',3'-Dimethyl-7-methoxy-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol  
 
N O
HO
O
 
 
The compound was prepared following general procedure A and isolated as pale pink solid. 
Ultrasonic irradiation time: 60 min. Yield: 82 %. Eluent for gradient flash chromatography: 
CH2Cl2/MeOH 20:1 to 10:1 Rf = 0.28 (CH2Cl2/MeOH 20:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 7.17 (dt, 1 H, J = 1.2, 7.6 Hz), 7.09 (dd, 1 H, J = 0.8, 7.1 
Hz), 6.94 (d, 1 H, J = 8.3 Hz), 6.85 (dt, 1 H, J = 0.9, 7.5 Hz), 6.80 (d, 1 H, J = 10.0 Hz), 6.62 
(d, 1 H, J = 7.7 Hz), 6.39 (dd, 1 H, J = 2.5, 8.3 Hz), 6.29 (d, 1 H, J = 2.5 Hz), 5.56 (d, 1 H, J = 
10.2 Hz), 3.81-3.73 (m, 1 H), 3.71 (s, 3 H), 3.69-3.62 (m, 2 H), 3.45-3.32 (m, 1 H), 3.29-3.18 
(m, 1 H), 1.98-1.88 (m, 1 H), 1.85-1.73 (m, 1 H), 1.31 (s, 3 H), 1.17 (s, 3 H) - 
13
C NMR (75 
MHz, CDCl3): ? = 161.1, 155.5, 147.6, 136.8, 129.2, 127.6, 127.5, 121.7, 119.2, 119.1, 116.3, 
111.9, 106.7, 105.1, 100.2, 61.2, 55.3, 51.8, 40.9, 31.7, 25.9, 20.1 - IR (neat): ? [cm-1] = 2970, 
2359, 1740, 1366, 1217 - MS (ESI): m/z (%) = 352.0 (100) [MH
+
] 
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General procedure C for synthesis of 3-Iodopropyl-spirobenzopyrans: 
A flask was capped with rubber septa and flushed with nitrogen for 10 minutes. The flask was 
charged with freshly prepared 1-(3-Iodopropyl)-3,3-dimethyl-2-methleneindoline and dry, 
degassed EtOH was added to obtain a 0.1 M solution. The solution was deoxygenated, 
following, salicylaldehyde (1.0 eq.) was added under nitrogen atmosphere and the mixture 
was sonicated at 35 kHz. Progress of the reaction was monitored by TLC until the starting 
materials disappeared or spot intensity of the product remained constant in successive 
controls. Following, the solvent was removed under reduced pressure, and the remaining 
residue taken up in CH2Cl2 and washed with water. The organic layer was dried over 
anhydrous MgSO4, the solvent was removed under reduced pressure and the raw product was 
dried in vacuo, followed by purification using flash chromatography on silica gel. 
 
 
1'-(3-Iodopropyl)-1',3'-dihydro-3',3'-dimethyl-6-nitro-Spiro[2H-1-benzopyran-
2,2'[2H]indole]  
 
N O
I
NO2
 
 
The compound was prepared following general procedure C and isolated as golden foam. 
Ultrasonic irradiation time: 60 min. Yield: 94 %. Eluent for flash chromatography: CH2Cl2 Rf 
= 0.83  
 
1
H NMR (400 MHz, CDCl3): ? = 8.06-8.01 (m, 2 H, H-Ar), 7.23 (dt, 1 H, J = 1.3, 7.7 Hz, H-
Ar), 7.14 (dd, 1 H, J = 0.9, 7.3 Hz, H-Ar), 6.99 (d, 1 H, J = 10.2 Hz, H-Ar), 6.93 (dt, 1 H, J = 
0.8, 7.5 Hz, H-Ar), 6.76 (d, 1 H, J = 8.5 Hz, H-Ar), 6.69 (d, 1 H, J = 7.7 Hz, H-Ar), 5.93 (d, 1 
H, J = 10.3 Hz, H-Ar), 3.41-3.17 (m, 4 H, 2 x CH2), 2.34-2.21 (m, 1 H, CH2-propyl), 2.17-
2.06 (m, 1 H, CH2-propyl), 1.34 (s, 3 H, CH3), 1.23 (s, 3 H, CH3) - 
13
C NMR (100 MHz, 
CDCl3): ? = 159.2 (Cquat.), 146.6 (Cquat.), 140.8 (Cquat.), 135.8 (Cquat.), 128.4 (+, CH), 127.6 (+, 
CH), 125.7 (+, CH), 122.6 (+, CH), 121.6 (+, CH), 121.6 (+, CH), 119.6 (+, CH), 118.3 
(Cquat.), 115.3 (+, CH), 106.6 (+, CH), 106.4 (Cquat.), 52.4 (Cquat.), 43.9 (-, CH2), 32.3 (-, CH2), 
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25.8 (+, CH3), 19.7 (+, CH3), 3.3 (-, CH2) - MS (ESI): m/z (%): 477.1 (100) [MH
+
] - HRMS 
(EI-MS) calcd. for C21H21N2O3I [M
+.
]: 476.0597, found: 476.0598 
 
 
1'-(3-Iodopropyl)-1',3'-dihydro-3',3'-dimethyl-6-chloro-Spiro[2H-1-benzopyran-2,2' 
[2H]indole]  
 
N O
I
Cl
 
 
The compound was prepared following general procedure C and isolated as orange foam. 
Ultrasonic irradiation time: 60 min. Yield: 74 %. Eluent for flash chromatography: CH2Cl2 Rf 
= 0.87  
 
1
H NMR (300 MHz, CDCl3): ? = 7.18 (dt, 1 H, J = 1.3, 7.7 Hz), 7.10-7.02 (m, 3 H), 6.86 (t, 1 
H, J = 7.4Hz), 6.80 (d, 1 H, J = 10.2 Hz), 6.62 (t, 2 H, J = 7.9 Hz), 5.74 (d, 1 H, J = 10.3 Hz), 
3.38-3.27 (m, 1 H), 3.25-3.11 (m, 3 H), 2.29-2.16 (m, 1 H), 2.14-1.99 (m, 1 H), 1.29 (s, 3 H), 
1.16 (s, 3 H) - 
13
C NMR (75 MHz, CDCl3): ? = 152.6 (Cquat.), 147.2 (Cquat.), 136.4 (Cquat.), 
129.5 (+, CH), 128.8 (+, CH), 127.6 (+, CH), 126.3 (+, CH), 124.8 (Cquat.), 121.8 (+, CH), 
120.9 (+, CH), 119.8 (Cquat.), 119.3 (+, CH), 116.4 (+, CH), 106.6 (+, CH), 104.8 (Cquat.), 52.2 
(Cquat.), 44.1 (-, CH2), 32.7 (-, CH2), 25.9 (+, CH3), 20.1 (+, CH3), 3.6 (-, CH2) - IR (neat): ? 
[cm
-1
] = 2961, 2357, 1606, 1476 - MS (ESI): m/z (%): 465.9 (100) [MH
+
] - HRMS (EI-MS) 
calcd. for C21H21ClNOI [M
+.
]: 465.0356, found: 465.0352 
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1'-(3-Iodopropyl)-1',3'-dihydro-3',3'-dimethyl-6,8-dibromo -Spiro[2H-1-benzopyran-2,2' 
[2H]indole]  
 
N O
I
Br
Br
 
 
The compound was prepared following general procedure C and isolated as turquoise foam. 
Ultrasonic irradiation time: 60 min. Yield: 83 %. Eluent for flash chromatography: CH2Cl2 Rf 
= 0.90  
 
1
H NMR (300 MHz, CDCl3): ? = 7.46 (d, 1 H, J = 2.3 Hz), 7.17 (m, 2 H), 7.08 (d, 1 H, J = 6.3 
Hz), 6.86 (t, 1 H, J = 7.4 Hz), 6.77 (d, 1 H, J = 10.2 Hz), 6.61 (d, 1 H, J = 7.7 Hz), 5.76 (d, 1 
H, J = 10.2 Hz), 3.40-3.28 (m, 1 H), 3.27-3.12 (m, 3 H), 2.31-2.15 (m, 1 H), 2.13-1.98 (m, 1 
H), 1.30 (s, 3 H), 1.17 (s, 3 H) - 
13
C NMR (75 MHz, CDCl3): ? = 149.67 (Cquat.), 146.8 
(Cquat.), 136.1 (Cquat.), 134.9 (+, CH), 128.4 (+, CH), 128.1 (+, CH), 127.6 (+, CH), 122.1 (+, 
CH), 121.8 (+, CH), 121.3 (Cquat.), 119.4 (+, CH), 111.9 (Cquat.), 110.2 (Cquat.), 106.6 (+, CH), 
106.2 (Cquat.), 52.3 (Cquat.), 44.0 (-, CH2), 32.3 (-, CH2), 25.7 (+, CH3), 20.5 (+, CH3), 3.9 (-, 
CH2) - IR (neat): ? [cm-1] = 2960, 2357, 1606, 1481, 1444, 1364 - MS (ESI): m/z (%): 587.8 
(100) [MH
+
] - HRMS (EI-MS) calcd. for C21H20Br2INO [M
+.
]: 586.8957, found: 586.8961 
 
 
1'-(3-Iodopropyl)-1',3'-dihydro-3',3'-dimethyl-6-bromo-8-methoxy-Spiro[2H-1-
benzopyran-2,2'-[2H]indole]  
 
N O
I
Br
O
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The compound was prepared following general procedure C and isolated as dark orange 
crystals. Ultrasonic irradiation time: 50 min. Yield: 80 %. Eluent for flash chromatography: 
CH2Cl2 Rf = 0.63 
 
1
H NMR (300 MHz, CDCl3): ? = 7.16 (dt, 1 H, J = 1.2, 7.6 Hz), 7.06 (dd, 1 H, J = 0.9, 7.2 
Hz), 6.87-6.80 (m, 3 H), 6.75 (d, 1 H, J = 10.2 Hz), 6.58 (d, 1 H, J = 7.7 Hz), 5.71 (d, 1 H, J = 
10.2 Hz), 3.27-3.11 (s, 3 H), 3.43-3.30 (m, 1 H), 3.27-3.11 (m, 3 H), 2.27-2.00 (m, 2 H), 1.29 
(s, 3 H), 1.15 (s, 3 H) - 
13
C NMR (75 MHz, CDCl3): ? = 148.1 (Cquat.), 147.1 (Cquat.), 142.6 
(Cquat.), 136.4 (Cquat.), 128.5 (+, CH), 127.5 (+, CH), 121.8 (+, CH), 121.5 (+, CH), 121.2 (+, 
CH), 120.5 (Cquat.), 119.0 (+, CH), 116.5 (+, CH), 111.4 (Cquat.), 106.4 (+, CH), 104.7 (Cquat.), 
56.4 (+, CH3), 52.2 (Cquat.), 44.0 (-, CH2), 32.7 (-, CH2), 26.0 (+, CH3), 20.2 (+, CH3), 3.8 (-, 
CH2) - IR (neat): ? [cm-1] = 2960, 2930, 2862, 1606, 1476, 1381 - MS (ESI): m/z (%): 539.8 
(100) [MH
+
] - HRMS (EI-MS) calcd. for C22H23BrINO2 [M
+.
]: 538.9957, found: 538.9952 
 
 
1'-(3-Iodopropyl)-1',3'-dihydro-3',3'-dimethyl-6-nitro-8-methoxy-Spiro[2H-1-
benzopyran-2,2'-[2H]indole]  
 
N O
I
NO2
O
 
 
The compound was prepared following general procedure C and isolated as turquoise-blue 
foam. Ultrasonic irradiation time: 60 min. Yield: 68 %. Eluent for flash chromatography: 
CH2Cl2 Rf = 0.75 
 
1
H NMR (300 MHz, CDCl3): ? = 7.70 (d, 1 H, J = 2.5 Hz), 7.63 (d, 1 H, J = 2.5 Hz), 7.18 (dt, 
1 H, J = 1.3, 7.7 Hz), 7.08 (dd, 1 H, J = 0.9, 7.3 Hz), 6.87 (m, 2 H), 6.61 (d, 1 H, J = 7.8 Hz), 
5.83 (d, 1 H, J = 10.3Hz), 3.79-3.74 (s, 3 H), 3.41-3.12 (m, 4 H), 2.28-2.01 (m, 2 H), 1.28 (s, 
3 H), 1.17 (s, 3 H) - 
13
C NMR (75 MHz, CDCl3): ? = 149.1 (Cquat.), 147.4 (Cquat.), 146.8 
(Cquat.), 140.5 (Cquat.), 136.0 (Cquat.), 128.5 (+, CH), 127.6 (+, CH), 121.9 (+, CH), 121.8 (+, 
CH), 119.5 (+, CH), 118.2 (Cquat.), 115.4 (+, CH), 107.9 (+, CH), 106.7 (+, CH), 106.4 (Cquat.), 
56.3 (+, CH3), 52.6 (Cquat.), 43.9 (-, CH2), 32.5 (-, CH2), 26.1 (+, CH3), 20.0 (+, CH3), 3.4 (-, 
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CH2) - IR (neat): ? [cm-1] = 2965, 1517, 1476, 1334 - MS (ESI): m/z (%): 506.9 (100) [MH+] 
- HRMS (EI-MS) calcd. for C22H23IN2O4 [M
+.
]: 506.0703, found: 506.0699 
 
 
1'-(3-Iodopropyl)-1',3'-dihydro-3',3'-dimethyl-6-ethynyl-Spiro[2H-1-benzopyran-2,2'-
[2H]indole]  
 
N O
I  
 
The compound was prepared following general procedure C and isolated as yellow-orange 
crystals. Ultrasonic irradiation time: 65 min. Yield: 58 %. Eluent for gradient flash 
chromatography: CH2Cl2 to CH2Cl2/MeOH 30:1 Rf = 0.75 (CH2Cl2) 
 
1
H NMR (300 MHz, CDCl3): ? = 7.22 (m, 3 H), 7.10 (d, 1 H, J = 6.3 Hz), 6.87 (dd, 2 H, J = 
8.8 Hz, J = 14.1 Hz), 6.64 (t, 2 H, J = 7.7 Hz), 5.74 (d, 1 H, J = 10.3 Hz), 3.40-3.30 (m, 1 H), 
3.26-3.11 (m, 3 H), 2.99 (s, 1 H), 2.31-2.17 (m, 1 H), 2.15-2.02 (m, 1 H), 1.30 (s, 3 H), 1.18 
(s, 3 H) - 
13
C NMR (75 MHz, CDCl3): ? = 154.6 (Cquat.), 147.2 (Cquat.), 136.4 (Cquat.), 133.9 (+, 
CH), 130.7 (+, CH), 129.1 (+, CH), 127.7 (+, CH), 121.8 (+, CH), 120.4 (+, CH), 119.4 (+, 
CH), 118.6 (Cquat.), 115.4 (+, CH), 113.7 (Cquat.), 106.6 (+, CH), 105.1 (Cquat.), 83.5 (Cquat.), 
75.7 (+, CH), 52.2 (Cquat.), 44.1 (-, CH2), 32.7 (-, CH2), 26.0 (+, CH3), 20.1 (+, CH3), 3.6 (-, 
CH2) - MS (ESI): m/z (%): 455.9 (100) [MH
+
] - HRMS (EI-MS) calcd. for C23H22INO [M
+.
]: 
455.0746, found: 455.0745 
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9-[[4-(dimethylamino)-2-phenolate]methylene]-7,8,9,10-tetrahydro-10,10-dimethyl-6H-
Pyrido[1,2-a]indolium 
 
7
5
6 17
13
12
15
8
18
N
N
O
10 11
14
16
19
21 23 24
25 26
 
 
A Schlenk flask was charged with dry EtOH (12 mL) and freshly prepared 1-(3-Iodopropyl)-
3,3-dimethyl-2-methleneindoline (372 mg, 1.14 mmol). The solution was deoxygenated and 
5-(diethylamino)-2-hydroxybenzaldehyde (220 mg, 1.14 mmol) was added under nitrogen 
atmosphere. The reaction mixture was sonicated at 35 kHz for 60 minutes. Following, EtOH 
was removed under reduced pressure, the residue was dissolved in CH2Cl2 and dried over 
anhydrous Na2SO4. The solution was filtered and the solvent was evaporated under reduced 
pressure. The residue was dried in vacuo to afford the crude product as glistening purple-
green crystals. Purification by gradient flash chromatography on silica gel (CH2Cl2/MeOH 
19:1 to 12:1) afforded the product as a lustrous purple-green solid (87 %). Rf = 0.30 
(CH2Cl2/MeOH 20:1) 
 
1
H NMR (600 MHz, CDCl3): ? = 8.53 (s, 1H), 7.56 (d, 1 H, J = 9.5 Hz, C8-H), 7.43-7.39 (m, 
2 H), 7.33 (t, 1 H, J = 7.1 Hz), 7.30-7.27 (m, 2 H), 4.15 (m, 2 H), 3.45 (q, 4 H, J = 7.1 Hz, 
C23/25), 2.98 (t, 2 H, J = 6.2 Hz), 2.24 (m, 2 H), 1.70 (s, 6 H, C13/14), 1.23 (t, 6 H, J = 7.1 
Hz, C24/26) - 
13
C NMR (150 MHz, CDCl3): ? = 176.6 (Cquat.), 164.0 (Cquat.), 154.8 (Cquat.), 
145.8 (CH, C16), 141.6 (Cquat.), 141.1 (Cquat.), 133.1 (CH), 128.7 (CH), 126.8 (CH), 122.3 
(CH), 113.6 (Cquat.), 111.2 (CH), 106.9 (CH), 98.3 (CH), 50.6 (Cquat.), 45.3 (CH3, C24/26), 
43.5 (C10), 28.5 (Cquat.), 24.9 CH2, C12), 20.3 (CH2, C11), 12.9 (CH2, C23/25) - MS (ESI): 
m/z (%): 375.0 (100) [MH
+
] 
 
 
1’-(3-Iodopropyl)-1’,3’-dihydro-3’.3’-dimethyl-spiro[3H]naphth[2,1-b][1,4]oxazine 
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N O
N
I  
 
A Schlenk flask was charged with freshly prepared 1-(3-Iodopropyl)-3,3-dimethyl-2-
methleneindoline (348 mg, 1.06 mmol) and dry EtOH (12 mL) under N2 atmosphere. The 
solution was degassed and 1-Nitroso-2-naphthol (203 mg, 1.17 mmol) was added under a 
slow flow of N2. The mixture was sonicated for 2 hours at 35 kHz, then the solvent was 
removed under reduced pressure, the residue was dried in vacuo and the crude product was 
purified by gradient flash chromatography on silica gel (CH2Cl2 to CH2Cl2/MeOH 200:1) to 
yield 1’-(3-Iodopropyl)-1’,3’-dihydro-3’.3’-dimethyl-spiro[3H]naphth[2,1-b][1,4]oxazine as a 
yellow powder (126 mg, 25 %). Rf = 0.60 (CH2Cl2) 
 
1
H NMR (600 MHz, CDCl3): ? = 8.55 (d, 1 H, J = 8.4 Hz, H-Ar), 7.78-7.72 (m, 2 H, H-Ar), 
7.68 (d, 1 H, J = 8.9 Hz, H-Ar), 7.58 (ddd, 1 H, J = 1.1, 6.9, 8.3 Hz, H-Ar), 7.40 (ddd, 1 H, J = 
1.2, 6.9, 8.1 Hz, H-Ar), 7.22 (dt, 1 H, J = 1.2, 7.7 Hz, H-Ar), 7.09 (dd, 1 H, J = 1.0, 7.3 Hz, H-
Ar), 7.00 (d, 1 H, J = 8.9 Hz, H-Ar), 6.90 (dt, 1 H, J = 0.7, 7.4 Hz, H-Ar), 6.67 (d, 1 H, J = 7.8 
Hz, H-Ar), 3.42-3.22 (m, 2 H, CH2-propyl), 3.20-3.09 (m, 2 H, CH2-propyl), 2.30-2.08 (m, 2 
H, CH2-propyl), 1.35 (s, 3 H, CH3), 1.34 (s, 3 H, CH3) - 
13
C NMR (150 MHz, CDCl3): ? = 
151.0 (CH), 146.7 (Cquat.), 143.7 (Cquat.), 135.6 (Cquat.), 130.8 (Cquat.), 130.4 (CH), 129.3 
(Cquat.), 128.0 (CH), 127.8 (CH), 127.2 (CH), 124.2 (CH), 122.7 (Cquat.), 121.8 (CH), 121.5 
(CH), 119.8 (CH), 116.8 (CH), 106.9 (CH), 98.9 (Cquat.), 52.1 (Cquat.), 44.9 (CH2), 32.5 (CH2), 
25.3 (CH3), 21.0 (CH3), 2.8 (CH2) - MS (ESI): m/z (%) = 482.9 (100) [MH
+
], 524.0 (16) 
[MH
+
+MeCN] 
 
 
General procedure D for synthesis of Trimethylammoniopropyl-spirobenzopyrans: 
 
A flask was charged with the corresponding 3-iodopropyl-spirobenzopyran (1.0 eq.), capped 
with rubber septum and flushed with argon. A solution of trimethylamine (66 eq., 33 wt %, in 
EtOH) was added and the reaction mixture was stirred at room temperature in the dark. 
Following, the solvent and excess trimethylamine were evaporated under reduced pressure 
and the crude product was dried in vacuo over night. 
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1’-(3’’-trimethylammoniopropyl)-3’,3’-dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2’-
indoline] iodide 
 
N O
N
NO2
I  
 
The compound was prepared following general procedure D. Reaction time: 60 hours. 
Purification by recrystallization from EtOH/Et2O (twice); pale green crystals; Yield: 79 %. 
 
1
H NMR (300 MHz, DMSO-d6): ? = 8.25 (d, 1 H, J = 2.8 Hz), 8.01 (dd, 1 H, J = 2.8, 9.0 Hz), 
7.24 (d, 1 H, J = 10.4 Hz), 7.15 (d, 2 H, J = 6.9 Hz), 6.91 (d, 1 H, J = 9.0 Hz), 6.84 (t, 1 H, J = 
7.3 Hz), 6.73 (d, 1 H, J = 7.9 Hz), 6.09 (d, 1 H, J = 10.4 Hz), 3.27-3.14 (m, 4 H), 2.14-1.86 
(m, 2 H), 1.21 (s, 3 H), 1.14 (s, 3 H) - MS (ESI): m/z (%): 408.0 (100) [M
+
] 
 
 
1’-(3’’-trimethylammoniopropyl)-3’,3’-dimethyl-6-chloro-Spiro[2H-1-benzopyran-2,2’-
indoline] iodide 
 
N O
N
Cl
I  
 
The compound was prepared following general procedure D. Reaction time: 64 hours. For 
purification CH2Cl2 was added and hexane was carefully layered on top to obtain the product; 
lustrous orange crystals; Yield: 91 %. 
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1
H NMR (300 MHz, MeOD): ? = 7.18-7.03 (m, 4 H), 6.97 (d, 1 H, J = 10.3 Hz), 6.82 (t, 1 H, 
J = 7.4 Hz), 6.67 (dd, 2 H, J = 8.2, 16.0 Hz), 5.94 (d, 1 H, J = 10.3 Hz), 3.44-3.28 (m, 4 H), 
2.26-2.10 (m, 1 H), 2.09-1.93 (m, 1 H), 1.27 (s, 3 H), 1.17 (s, 3 H) - 
13
C NMR (75 MHz, 
MeOD): ? = 154.0 (Cquat.), 148.3 (Cquat.), 137.8 (Cquat.), 130.6 (+, CH), 130.2 (+, CH), 128.8 
(+, CH), 127.7 (+, CH), 126.2 (Cquat.), 122.9 (+, CH), 122.1 (+, CH), 121.6 (Cquat.), 120.8 (+, 
CH), 117.4 (+, CH), 107.9 (+, CH), 106.4 (Cquat.), 66.1 (-, CH2), 53.8 (Cquat.), 53.4 (+, CH3), 
41.6 (-, CH2), 26.5 (+, CH3), 24.1 (-, CH2), 20.5 (+, CH3) - MS (ESI): m/z (%): 397.1 (100) 
[M
+
] 
 
 
1’-(3’’-trimethylammoniopropyl)-3’,3’-dimethyl-6,8-dibromo-Spiro[2H-1-benzopyran-
2,2’-indoline] iodide 
 
N O
N
Br
I
Br
 
 
The compound was prepared following general procedure D. Reaction time: 64 hours. For 
purification a saturated solution of product in MeOH was placed in the freezer and the pure 
product was obtained; ivory crystals; Yield: 88 %. 
 
1
H NMR (300 MHz, MeOD): ? = 7.50 (d, 1 H, J = 2.3 Hz), 7.32 (d, 1 H, J = 2.3 Hz), 7.15 (dt, 
1 H, J = 1.2, 7.7 Hz), 7.09 (d, 1 H, J = 7.3 Hz), 6.96 (d, 1 H, J = 10.3 Hz), 6.83 (t, 1 H, J = 7.4 
Hz), 6.72 (d, 1 H, J = 7.8 Hz), 5.96 (d, 1 H, J = 10.3 Hz), 3.48-3.31 (m, 4 H), 2.29-2.12 (m, 1 
H), 2.11-1.93 (m, 1 H), 1.29 (s, 3 H), 1.17 (s, 3 H) - 
13
C NMR (75 MHz, MeOD): ? = 151.0 
(Cquat.), 147.8 (Cquat.), 137.5 (Cquat.), 135.9 (Cquat.), 130.1 (+, CH), 129.6 (+, CH), 129.5 (+, 
CH), 128.9 (+, CH), 123.5 (+, CH), 123.3 (Cquat.), 122.9 (+, CH), 121.0 (+, CH), 113.3 (Cquat.), 
110.7 (Cquat.), 107.9 (+, CH), 66.0 (-, CH2), 53.8 (+, CH3), 53.6 (Cquat.), 41.5 (-, CH2), 26.3 (+, 
CH3), 23.8 (-, CH2), 20.7 (+, CH3) - MS (ESI): m/z (%): 521.1 (100) [M
+
] 
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1’-(3’’-trimethylammoniopropyl)-3’,3’-dimethyl-6-bromo-8-methoxy-Spiro[2H-1-
benzopyran-2,2’-indoline] iodide 
 
N O
N
Br
I
O
 
 
The compound was prepared following general procedure D. Reaction time: 64 hours. For 
purification CH2Cl2 was added and Et2O was carefully layered on top to obtain the product; 
ivory crystals; Yield: 85 %. 
 
1
H NMR (300 MHz, MeOD): ? = 7.13 (dt, 1 H, J = 1.2, 7.7 Hz), 7.06 (dd, 1 H, J = 0.9, 7.3 
Hz), 6.95 (dd, 2 H, J = 2.2, 12.0 Hz), 6.90 (d, 1 H, J = 10.3 Hz), 6.81 (t, 1 H, J = 7.4 Hz), 6.66 
(d, 1 H, J = 7.8 Hz), 5.86 (d, 1 H, J = 10.2 Hz), 3.70 (s, 3 H), 3.51.3.32 (m, 4 H), 2.26-1.92 
(m, 2 H), 1.27 (s, 3 H), 1.14 (s, 3 H) - 
13
C NMR (75 MHz, MeOD): ? = 149.2 (Cquat.), 148.1 
(Cquat.), 143.5 (Cquat.), 137.6 (Cquat.), 129.8 (+, CH), 128.8 (+, CH), 123.0 (+, CH), 122.9 (+, 
CH), 122.5 (+, CH), 122.3 (Cquat.), 120.6 (+, CH), 117.3 (+, CH), 112.9 (Cquat.), 107.5 (+, CH), 
106.3 (Cquat.), 66.1 (-, CH2), 56.9 (+, CH3), 53.6 (+, CH3), 53.5 (Cquat.), 41.2 (-, CH2), 26.3 (+, 
CH3), 24.1 (-, CH2), 20.5 (+, CH3) - MS (ESI): m/z (%): 473.1 (100) [M
+
] 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1  67 
1’-(3’’-trimethylammoniopropyl)-3’,3’-dimethyl-6-nitro-8-methoxy-Spiro[2H-1-
benzopyran-2,2’-indoline] iodide 
 
N O
N
NO2
I
O
 
 
The compound was prepared following general procedure D. Reaction time: 64 hours. For 
purification CH2Cl2 was added and Et2O was carefully layered on top to grow crystals. 
Following, trituration with Et2O; green crystals; Yield: 89 %. 
 
1
H NMR (300 MHz, DMSO-d6): ? = 7.93 (d, 1 H, J = 2.6 Hz), 7.67 (d, 1 H, J = 2.6 Hz), 7.23-
7.11 (m, 3 H), 6.83 (t, 1 H, J = 7.4 Hz), 6.74 (d, 1 H, J = 7.7 Hz), 6.08 (d, 1 H, J = 10.4 Hz), 
3.78 (s, 3 H), 3.40-3.31 (m, 4 H), 2.13-1.88 (m, 2 H), 1.19 (s, 3 H), 1.13 (s, 3 H) - 
13
C NMR 
(75 MHz, DMSO-d6): ? = 148.4 (Cquat.), 146.6 (Cquat.), 146.4 (Cquat.), 139.9 (Cquat.), 135.6 
(Cquat.), 128.2 (+, CH), 127.5 (+, CH), 121.8 (+, CH), 121.6 (+, CH), 119.3 (+, CH), 118.3 
(Cquat.), 115.3 (+, CH), 107.3 (+, CH), 106.7 (+, CH), 106.3 (Cquat.), 63.3 (-, CH2), 55.9 (+, 
CH3), 52.2 (+, CH3), 52.1 (Cquat.), 40.1 (-, CH2), 25.8 (+, CH3), 22.1 (-, CH2), 19.4 (+, CH3) - 
MS (ESI): m/z (%): 438.2 (100) [M
+
] 
 
 
1'-(3-Azidopropyl)-1',3'-dihydro-3',3'-dimethyl-6-nitro-Spiro[2H-1-benzopyran-
2,2'[2H]indole]  
 
N O
N3
NO2
 
 
1'-(3-Iodopropyl)-1',3'-dihydro-3',3'-dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'[2H]indole] 
(1.576 g, 3.31 mmol) was dissolved in dry N,N-Dimethylformamide (62 mL). Following, 
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NaN3 (877 mg, 13.49 mmol) was added in one portion and the reaction mixture was stirred in 
the dark at room temperature for 19 hours. The solvent was evaporated under reduced 
pressure, the residue was dried in vacuo and the crude product was purified by flash 
chromatography on silica gel (CH2Cl2) to yield 1'-(3-Azidopropyl)-1',3'-dihydro-3',3'-
dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'[2H]indole as glistening golden foam (1.076 g, 
83 %). Rf = 0.82 (CH2Cl2) 
 
1
H NMR (400 MHz, CDCl3): ? = 8.01 (m, 2 H, H-Ar), 7.20 (dt, 1 H, J = 1.3, 7.7 Hz, H-Ar), 
7.10 (dd, 1 H, J = 0.9, 7.3 Hz, H-Ar), 6.94 (d, 1 H, J = 10.3 Hz, H-Ar), 6.90 (dt, 1 H, J = 0.9, 
7.5 Hz, H-Ar), 6.75 (d, 1 H, J = 8.4 Hz, H-Ar), 6.60 (d, 1 H, J = 7.8 Hz, H-Ar), 5.86 (d, 1 H, J 
= 10.4 Hz, H-Ar), 3.39-3.18 (m, 4 H, 2 x CH2), 2.01-1.90 (m, 1 H, CH2-propyl), 1.88-1.75 (m, 
1 H, CH2-propyl), 1.29 (s, 3 H, CH3), 1.19 (s, 3 H, CH3) - 
13
C NMR (100 MHz, CDCl3): ? =  
159.4 (Cquat.), 146.8 (Cquat.), 141.1 (Cquat.), 136.0 (Cquat.), 128.4 (CH), 127.8 (CH), 125.9 (CH), 
122.8 (CH), 121.8 (CH), 121.6 (CH), 119.8 (CH), 118.4 (Cquat.), 115.5 (CH), 106.7 (CH), 
106.6 (Cquat.), 52.6 (Cquat.), 49.0 (CH2), 40.8 (CH2), 28.1 (CH2), 25.9 (CH3), 19.9 (CH3) - IR 
(neat): ? [cm-1] = 2970, 2359, 2097, 1738, 1477, 1333 - MS (ESI): m/z (%): 392.0 (100) 
[MH
+
] - HRMS (PI-EI) calcd. for C21H21N5O3 [M
+.
]: 391.1644, found: 391.1644 
 
 
1'-(3-Azidopropyl)-1',3'-dihydro-3',3'-dimethyl-6-ethynyl-Spiro[2H-1-benzopyran-2,2'-
[2H]indole]  
 
N O
N3  
 
1'-(3-Iodopropyl)-1',3'-dihydro-3',3'-dimethyl-6-ethynyl-Spiro[2H-1-benzopyran-2,2'-
[2H]indole] (264 mg, 0.58 mmol) was dissolved in dry N,N-Dimethylformamide (13 mL). 
Following, NaN3 (204 mg, 3.14 mmol) was added in one portion and the reaction mixture was 
stirred in the dark at room temperature for 48 hours. The solvent was evaporated under 
reduced pressure, the residue was dissolved in a mixture of CH2Cl2 and water. The aqueous 
layer was extracted twice with CH2Cl2, the organic layers were combined and dried over 
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anhydrous Na2SO4.The product was purified by gradient flash chromatography on silica gel 
(CH2Cl2 to CH2Cl2/MeOH 50:1) to yield 1'-(3-Azidopropyl)-1',3'-dihydro-3',3'-dimethyl-6-
ethynyl-Spiro[2H-1-benzopyran-2,2'-[2H]indole] as a pale yellow-green fluffy foam (207 mg, 
96 %). Rf = 0.86 (CH2Cl2) 
 
1
H NMR (300 MHz., CDCl3): ? = 7.30-7.19 (m, 4 H), 6.87 (dd, 2 H, J = 8.7, 15.2 Hz), 6.62 
(dd, 2 H, J = 7.9, 18.0 Hz), 5.73 (d, 1 H, J = 10.3 Hz), 3.49-3.33 (m, 4 H), 3.00 (s, 1 H), 1.98-
1.92 (m, 1 H), 1.87-1.79 (m, 1 H), 1.31 (s, 3 H), 1.19 (s, 3 H) - MS (ESI): m/z (%): 371.1 
(100) [MH
+
] 
 
 
1’-(3-Azidopropyl)-1’,3’-dihydro-3’.3’-dimethyl-spiro[3H]naphth[2,1-b][1,4]oxazine 
 
N O
N
N3  
 
1’-(3-Iodopropyl)-1’,3’-dihydro-3’.3’-dimethyl-spiro[3H]naphth[2,1-b][1,4]oxazine (119 mg, 
0.25 mmol) was dissolved in dry N,N-Dimethylformamide (3.0 mL). Following, NaN3 (64 
mg, 0.985 mmol) was added in one portion and the reaction mixture was stirred in the dark at 
room temperature for 48 hours. The solvent was evaporated under reduced pressure, the 
residue was dissolved in a mixture of CH2Cl2 (25 mL) and water (30 mL). The aqueous layer 
was extracted again with CH2Cl2 (25 mL), the organic layers were pooled and dried over 
anhydrous Na2SO4.The product was purified by gradient flash chromatography on silica gel 
(CH2Cl2 to CH2Cl2/MeOH 1000:1) to yield 1’-(3-Azidopropyl)-1’,3’-dihydro-3’.3’-dimethyl-
spiro[3H]naphth[2,1-b][1,4]oxazine as a pale yellow powder (82 mg, 84 %). Rf = 0.83 
(CH2Cl2) 
 
1
H NMR (600 MHz, CDCl3): ? = 8.56 (d, 1 H, J = 8.4 Hz, H-Ar), 7.75 (d, 1 H, J = 8.1 Hz, H-
Ar), 7.68 (d, 1 H, J = 8.9 Hz, H-Ar), 7.58 (ddd, 1 H, J = 1.1, 6.9, 8.2 Hz, H-Ar), 7.41 (ddd, 1 
H, J = 1.1, 7.0, 8.0 Hz, H-Ar) , 7.22 (dt, 1 H, J = 1.1, 7.7 Hz, H-Ar), 7.09 (dd, 1 H, J = 0.8, 7.2 
Hz, H-Ar), 7.00 (d, 1 H, J = 8.8 Hz, H-Ar), 6.91 (t, 1 H, J = 7.4 Hz, H-Ar), 6.63 (d, 1 H, J = 
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7.8 Hz, H-Ar), 3.39-3.22 (m, 4 H, 2 x CH2-propyl), 2.01-1.95 (m, 1 H, CH2-propyl), 1.89-1.83 
(m, 1 H, CH2-propyl), 1.36 (s, 3 H, CH3), 1.34 (s, 3 H, CH3) - 
13
C NMR (150 MHz, CDCl3): ? 
= 150.9 (CH), 146.7 (Cquat.), 143.8 (Cquat.), 135.6 (Cquat.), 130.8 (Cquat.), 130.4 (CH), 129.3 
(Cquat.), 128.0 (CH), 127.8 (CH), 127.2 (CH), 124.2 (CH), 121.8 (CH), 121.5 (CH), 119.8 
(CH), 116.8 (CH), 106.8 (CH), 99.0 (Cquat.), 52.1 (Cquat.), 49.1 (CH2), 41.5 (CH2), 29.7 (Cquat.), 
28.2 (CH2), 25.3 (CH3), 21.0 (CH3) - IR (neat): ? [cm-1] = 2959, 2926, 2854, 2095, 1483 - MS 
(ESI): m/z (%): 398.0 (100) [MH
+
], 439.1 (42) [MH
+
+MeCN] 
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Chapter 2: 
Synthesis of a spirobenzopyran azide and alkyne fluorescent dyes - “click”-type 
synthesis and optical properties of molecular dyads 
 
2.1. Introduction 
 
In 2002, Meldal and Sharpless independently reported the regioselective formation of 1,4-
disubstituted 1,2,3-triazoles in a Huisgen 1,3-dipolar cycloaddition of terminal acetylenes 
with azides under copper(I)-catalysis.
[1]
 Although other chemical reactions have been 
evaluated and discussed as key steps for fast and modular approaches, none of them were able 
to beset the indefeasible stardom of this reaction.
[2]
 Since the discovery of this copper(I)-
catalyzed azide/alkyne cycloaddition (CuAAC), the reaction has become very popular under 
the catchphrase “click” reaction, and the interest and applications have increased dramatically, 
with no sign of slowing down.
[3]
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Scheme 1.1. Copper(I)-catalyzed synthesis of 1,4-substituted 1,2,3-triazole
[4]
  
 
Experimentally, the click process itself is very forgiving and only requires benign reaction 
and workup conditions. However, it still can rapidly create molecular diversity through the 
use of its molecular building blocks and therefore appears to have enormous scope.  
The mechanism leading to the 1,4-regioselectivity for 1,2,3-triazole formation begins with 
addition of copper(I) to the terminal acetylene resulting in the formation of the copper(I) 
acetylide through abstraction of a proton and displacement of one ligand. For the next step it 
is proposed that the azide replaces another copper ligand and binds to the copper with the 
nitrogen proximal to the carbon atom. Following, the distal nitrogen of the azide attacks on 
the C-2 carbon of the acetylide, proceeding via a six-membered copper(III) intermediate. 
After that, ring contraction forms the triazolyl-copper intermediate from which the desired 
triazole product is released by proteolysis.
[1a, 5]
 Despite other proposed outlines for the 
dynamically changing family of different copper(I) species and mechanisms,
[6]
 the CuAAC 
entails the 1,4-regioselective formation of 1,2,3-triazole via a stepwise mechanism.  
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Scheme 1.2. Outline of a proposed catalytic cycle for CuAAC reaction
[5]
 
 
Since no systematic study of optimal conditions have been reported, particularly with respect 
to the formation of the active copper(I) species, conditions have varied widely.
[7]
 Excellent 
copper(I) sources have been found by in situ reduction of copper(II) sulphate or copper(II) 
acetate using the reductant ascorbic acid or sodium ascorbate. Among the myriad of CuAAC 
reactions, the combination of sodium ascorbate and copper(II) sulphate hydrate is the most 
utilized way to produce the active copper(I) species.
[8]
 Other sources include copper(I) salts, 
most commonly copper iodide. In addition, most click reactions also demand the use of bases 
such as triethylamine, DIPEA or 2,6-lutidine.
[7]
 Due to the general thermodynamic instability 
of copper(I), other additives and ligands bearing triazole moieties themselves have been 
shown to be capable of stabilizing the copper(I) species and therefore also increase reaction 
rates; e.g. the most commonly used polytriazole additive TBTA features three triazole 
moieties and a central tertiary nitrogen atom.  
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Scheme 1.3. TBTA, a copper(I) stabilizing ligand 
 
TBTA precludes the need for additional base and its tetradentate binding ability is believed to 
completely shield the copper(I) from interactions that would lead to destabilizing interactions 
or degradation.
[4]
 While addition of TBTA can improve certain aspects of the CuAAC 
reaction such as protecting copper(I) oxidation or disproportionation,
[9]
 it should be 
mentioned that use of TBTA also may complicate simple workup and purification steps, 
major aspects that, in the first place, drew the attention of many chemists towards click 
chemistry.  
The impressive versatility of the click reaction was already utilized in broad fields, such as 
chemical synthesis,
[10]
 labeling
[11]
 and bioconjugation techniques
[12]
 and material science.
[13]
 
The use of click chemistry and CuAAC with respect towards DNA is discussed in Chapters 3 
and 4.   
Until now, the spectrum of click chemistry has been further explored and expanded in view of 
triazole formation, e.g. by use of internal alkynes in the copper-catalyzed transformation
[14]
 
and establishing the regioselective synthesis of 1,5-disubstituted and 1,4,5-trisubstituted 1,2,3-
triazoles from azides and terminal and internal alkynes employing Ru-catalysis.
[15]
 
 
Herein, we present the Huisgen-Meldal-Sharpless click reaction as a facile methodology 
providing a new efficient avenue to construct molecular dyads,
[16]
 bearing a photochromic 
spirobenzopyran and fluorescent chromophores (pyren, perylene or nile red). Interestingly, the 
application of CuAAC has rarely been applied for spirobenzopyran conjugation, where only 
one example has been reported in the literature up to now. There, click chemistry was applied 
for the formation of supramolecular photochromic dendrimers.
[17]
 However, until now there 
has been no precedent on the click synthesis of spirobenzopyran bearing dyads.  
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2.2. Results and Discussion 
 
2.2.1. Synthesis of a spirobenzopyran azide 
In order to synthesize the desired dyads we decided to perform CuAAC with a 
spirobenzopyran azide and fluorescent chromophores bearing terminal alkyne groups. The 
spirobenzopyran 5 was chosen as the azide building block for the following click reactions. 5 
was prepared in four steps with an overall yield of 55 %, according to the synthetic protocol 
that is discussed in detail in Chapter 1.  
 
N
I
I
N
I
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45
 
 
Scheme 2.1. Synthesis of 5. Reagents and conditions: a) I(CH2)3I (3.5 eq.), MeCN, reflux, 48 
h, 77 %; b) NaOH (30 eq.), 80 °C to r.t., 1 h, 91 %; c) 2-hydroxy-5-nitro-benzaldehde (1.0 
eq.), EtOH, ))), 1 h, 94 %; d) NaN3 (4.1 eq.), DMF, r.t., 19 h, 83 % 
 
2.2.2. Synthesis of benzylazide and TBTA 
The synthesis of the copper(I) stabilizing ligand TBTA 8 was performed in two steps. A 
plethora of synthetic procedures for the approach of alkyl azides have been described. Among 
those, the nucleophilic substitution of bromide with lithium azide or sodium azide from the 
corresponding alkyl bromide is the most common procedure. Benzyl azide 7 was therefore 
synthesized by a modified procedure reported in the literature.
[18]
 A stock solution of sodium 
azide in DMSO was prepared and subsequently freshly distilled benzyl bromide 6 was added. 
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After two hours, successful transformation of the bromide to the azide was found and benzyl 
azide 7 was afforded in 96 % yield.     
 
N3Br
N
N
N
N
N
N N
NN
N
a) b)
8: TBTA6 7
 
 
Scheme 2.2. Synthesis of TBTA 8. Reagents and conditions: a) NaN3, Bz-Br (1.3 eq.), r.t., 2 
h, 96 %; b) Propargylamine (1.0 eq.), Bz-N3 (3.3 eq.), CuSO4 (16 mol-%), L-ascorbic acid (44 
mol-%), NaOH (44 mol-%), H2O, CH2Cl2, r.t., 14 h, 96 %. 
 
In the second step, TBTA was then synthesized by a modified procedure with use of 
dichloromethane as a co-solvent with water through the copper(I)-catalyzed 1,3-dipolar 
cycloaddition of propargylamine and benzyl azide 7. Although the reaction displayed 
complete conversion upon TLC control, purification was performed with use of flash 
chromatography to separate excess benzyl azide. An assimilable excellent yield of 96 % was 
obtained for TBTA (lit.:98 %)
[19]
. 
 
2.2.3. Synthesis of 1,3,6,8-Tetra-ethynyl-pyrene 
Starting from pyrene 9, 1,3,6,8-tetrabromopyrene 10 was synthesized by exhaustive 
bromination using 4.3 equivalents of bromine in nitrobenzene at 140 °C and obtained as a 
yellow solid (92 %).
[20]
 In the next step, the Sonogashira cross-coupling reaction was 
performed with little excess of ethynyltrimethylsilane, while PdCl2(PPh3)2 and copper iodide 
were used as catalysts. The corresponding tetrakis(trimethylsilylethynyl)pyrene product 11 
was achieved as lustrous orange crystals in 78 % yield and showed good solubility in common 
organic solvents such as dichloromethane, toluene, tetrahydrofuran and chloroform. 
Consequent desilylation went smoothly by using potassium carbonate in a mixture of 
methanol and tetrahydrofuran. There, the desired tetraethynylpyrene 12 precipitated and could 
be obtained in excellent yield after filtration and washing.  
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Scheme 2.3. Synthesis of 1,3,6,8-tetraethynylpyrene 12. Reagents and conditions: a) Br2 (4.3 
eq.), nitrobenzene, 4 h, 140 °C, 92 %; b) (CH3)3SiCCH (6.1 eq.), PdCl2(PPh3)2 (20.4 mol-%), 
CuI (9.9 mol-%), PPh3 (20.4 mol-%), DMF, NEt3, 70 °C, 20 h, 78 %; c) K2CO3 (8.0 eq.), 
MeOH, THF, r.t., 16 h, 95 %. 
 
2.2.4. Synthesis of 3-Ethynylperylene 
3-Ethynylperylene 16 was prepared in three steps and the synthetic approach starts from the 
route published in the literature.
[21]
 Our approach entails three synthetic steps, starting with 
commercially available perylene.  
First, bromination of perylene 13 with N-bromosuccinimide in DMF gave 3-bromoperylene 
14, according to a procedure described in the literature in 94 % yield.
[22]
 Deviant from the 
literature, 3-trimethylsilylethynylperylene 15 was prepared by a Sonogashira cross-coupling 
reaction in the presence of PdCl2(PPh3)2 and copper iodide as catalysts, in a heated DMF 
trimethylamine mixture, and gave 15 in 97 % yield as lustrous yellow-orange crystals. Final 
cleavage of the TMS protecting group of compound 15 with K2CO3 in a methanol 
tetrahydrofuran mixture was found suitable and afforded 3-ethynylperylene 16 in excellent 
yield as glistening yellow crystals.  
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Scheme 2.4. Synthesis of 3-Ethynylperylene 16. Reagents and conditions: a) NBS (1.0 eq.), 
DMF, r.t., 26 h, 94 %; b) (CH3)3SiCCH (1.7 eq.), PdCl2(PPh3)2 (10.0 mol-%), CuI (6.1 mol-
%), DMF, NEt3, 85 °C, 20 h, 97 %; c ) K2CO3 (3.8 eq.), MeOH, THF, r.t., 61 h, 97 %. 
 
2.2.5. Synthesis of Ethynyl modified nile red 
As depicted in Scheme 2.5, the 2-ethynyl derivative 22 of nile red was prepared in five steps, 
following the general outline.
[23]
 The synthesis was initiated by nitrosation of 3-
diethylaminophenol 17 with isopentylnitrite and gave 5-diethylamino-2-nitrosophenol 
hydrochloride 18 in very good yield. The 2-hydroxy derivative 19 was prepared by reaction of 
the nitrosophenol hydrochloride 18 and 1,6-dihydroxynaphthalene in boiling N,N-
dimethylformamide in 73 % yield.  
19 shows a strong red fluorescence and is therefore very easy to detect during flash 
chromatography. Gradient elution was our method of choice since it cultivates very accurate 
and narrow bands. At this point we foreclose that it was also possible to perform very fast 
separations and purifications using gradient elution for the following benzo[a]phenoxazine 
compounds 20, 21 and 22 with use of flash chromatography or dry-vacuum flash 
chromatography.
[24]
 However, in the next step, the hydroxy group was converted to the 
trifluoromethanesulfonate ester 20 with a N-triflated amide as acylating reagent in 75 % yield. 
The 2-trimethylsilyl-protected ethynyl modified nile red 21 was then synthesized by Pd-
catalyzed Sonogashira-Hagihara cross-coupling reaction of 20 and trimethylsilylethylene in 
heated DMF, where Pd(PPh3)4 was an effective catalyst. After flash chromatography, 
trituration in a tetrahydrofuran/diethyl ether mixture gave 21 as wine red crystals. Finally, 21 
was smoothly silyl deprotected with TBAF in a mixture of dichloromethane and 
tetrahydrofuran within 10 minutes to yield 22 in 94 % yield. 
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Scheme 2.5. Synthesis of 2-ethynyl nile red 22. Reagents and conditions: a) Isopentylnitrite 
(1.0 eq.), HCl (5.0 eq.), 0 °C, 2 h, 95 %; b) 1,6-dihydroxynaphthalene (1.0 eq.), DMF, reflux, 
4 h, 73 %; c ) N-phenyl-bis(trifluoromethane sulphonamide) (2.4 eq.), NEt3 (2.4 eq.), THF, 
r.t., 24 h, 75 %; d) (CH3)3SiCCH (1.6 eq.), Pd(PPh3)4 (3.5 mol-%), CuI (3.5 mol-%), DMF, 
NEt3, 80 °C, 4 h, 79 %; e) Bu4NF (2.0 eq.), CH2Cl2, THF, r.t., 10 min, 94 %. 
 
2.2.6. Click synthesis of molecular dyads  
According to our outlined strategy and in order to synthesize the dyads we chose the click 
reaction (CuAAC) as a facile methodology for conjugation of spirobenzopyran azide with the 
previously synthesized ethynyl-bearing chromophores (12, 16 and 22) and commercially 
available 1-ethynylpyrene.  
For conjugation of the azide compound 5 and 12 we attempted click reactions using various 
mixtures of common polar and apolar solvents due to the very poor solubility of 12. However, 
no reaction was observed and thus, we changed to run the click reaction in a “one-pot” 
manner that was recently reported to offer a straightforward methodology for the synthesis 
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and transformation of molecules containing terminal triple bonds.
[25]
 Using this approach we 
slowly added the K2CO3 solution in a mixture of water/methanol/tetrahydrofuran to the 
trimethylsilylacetylene pyrene 11 while maintaining click conditions, i.e. the spirobenzopyran 
azide 5, TBTA and copper(II) salt and sodium ascorbate were also present in the mixture so 
that sequential deprotection and click reaction of pyrene with the azide could occur. Although 
the deprotection of the TMS groups was performed slowly, TLC did not show formation of 
the desired triazole with the azide but precipitation of 12. However, this attempt was no avail 
and can be allocated to the very poor solubility of the deprotected pyrene compound.  
Nevertheless, the spirobenzopyran azide 5 was reacted in a click reaction with compounds 1-
ethynyl-pyrene, 16 and 22 to form the dyads 23 a, 23 b and 23 c, respectively. Evidently, the 
demand of the copper(I)-catalyzed cycloaddition for better solubility of compounds proved 
true. The click reaction was performed according to a general procedure in a water/DMF 
mixture and afforded the three dyads 23 a-c. Flash chromatography was utilized for 
purification of the dyads, with slow increase of polarity during gradient elution, and we were 
able to isolate conjugates 23a, 23 b and 23 c, bearing pyrene, perylene and nile red as 
chromophores in excellent yields.  
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R
NO2
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23 b: R =23 a: R = 23 c: R =
N O
O
NEt2  
Scheme 2.6. Synthesis of photochromic dyads 23 a - 23 c. Reagents and conditions: a) NaN3 
(4.1 eq.), DMF, r.t., 19 h, 83 %; b) HC?CR, CuSO4 (15-21 mol-%), Na ascorbate (29-40 mol-
%), TBTA (5-7.5 mol-%), DMF, H2O, r.t., 24 h, 23 a: 91 %, 23 b: 84 %, 23 c: 91 %. 
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2.2.7. Optical properties of molecular dyads  
The UV/Vis absorption of the spiropyran conjugates 23 a-c (Figure 1) after irradiation at 590 
nm display exclusively the spiropyran isomer and the additional chromophore by the 
characteristic bands at ~ 350 nm (pyrene in 23 a), ~ 425 nm (perylene in 23 b) or ~ 550 nm 
(nile red in 23 c), respectively. After irradiation with UV light, the photogenerated extended 
?-system of the merocyanine forms of all three dyads show an additional absorption in the 
visible region at ~ 560 nm. 
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Figure 2.1. UV/Vis absorption spectra of 23 a-c (20 µM in MeCN) after irradiation at 312 nm 
(solid lines, MC), and after irradiation at 590 nm (dashed lines, SP). 
 
If the dyads are excited at their characteristic wavelength (23 a: 355 nm, 23 b: 413 nm, 23 c: 
545 nm) the fluorescence (Figure 2) is quenched by the merocyanine which is even more 
obvious if the data is corrected by the optical densities at the excitation wavelength. The latter 
result indicates an energy transfer process from the chromophore to the merocyanine which 
makes these switches interesting candidates for functional ?-systems. The efficiency of this 
process increases from dyad 23 a over 23 b to 23 c due to the enhanced spectral overlap. In 23 
c, however, the nile red can not be excited selectively because the merocyanine absorbs in the 
same range. Dyad 23 a shows a small emission at ~ 650 nm probably due an exciplex. 
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Figure 2.2. Fluorescence spectra of 23 a (20 µM in MeCN) and 23 b-c (~ 1 µM in MeCN) 
after irradiation at 312 nm (solid lines, MC), and after irradiation at 590 nm (dashed lines, 
SP), ?exc = 355 nm (23 a), 413 nm (23 b), 545 nm (23 c). The dotted lines represent the 
spectra that are corrected by the differences in optical density at the excitation wavelength. 
 
 
 
Image 2.1. Visual representation of photochromic switching in dyad 23 b. After Vis 
irradiation, during UV irradiation, after UV irradiation (from left to right).  
 
A useful extension for the improvement of spectral overlap is provided by new green-emitting 
fluorophores. These fluorescent dyes are currently being developed in our group and make 
meaningful units for the construction of additional dyads where fluorescence is even more 
strongly quenched by energy transfer. Thus, incorporated into DNA, these dyads serve as 
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valuable assemblies for photoswitching and manipulation of emission intensity and optical 
signals by light and can be used for clever biomedical applications. 
 
 
2.3. Conclusion 
 
In conclusion, a spirobenzopyran azide and fluorescent dyes bearing terminal alkynes groups 
have been prepared. With use of these building blocks, three novel photoswitchable 
fluorescent dyads 23 a-c have been successfully synthesized using click chemistry as an 
elaborate and reasoned methodology. The photochromism was investigated using absorption 
and fluorescence spectroscopy. The dyads are composed of two units, integrating a 
spirobenzopyran photochrome and luminescent components (pyrene, perylene or nile red) in 
their molecular skeleton. The click reaction was used to conjugate the photochromic unit 
(azide) and the fluorophores (alkynes) by 1,4-regioselective formation of 1,2,3-triazoles.  
The spectroscopic measurements show that by UV irradiation the spirobenzopyran unit of the 
dyads switch into their corresponding merocyanine form with appearance of its characteristic 
absorption band in the visible range. Fluorescence is quenched by the photoinduced 
merocyanine form for all three dyads and indicates an energy transfer process from the 
fluorophore unit to the merocyanine. The efficiency of this process increases from dyad 23 a 
over 23 b to 23 c due to the enhanced spectral overlap. 
In commemoration, since the switching of conformations and electronic states of organic 
molecules by external stimulations and input signals is of fundamental interest in matters of 
mechanism and potential applications, thus the results provide a novel synthetic strategy for 
engineering and creating new photochromic functional ?-systems based on the concept of 
click chemistry. Meanwhile, this concept is followed up in the group of Prof. Decurtins for 
the construction of new materials and promises reasonable continuation of the project using 
photochromic spirobenzopyrans in a synergistic way with BDF chromophores.
[26]
 
 
 
2.4. Experimental Section 
 
General 
Conferrable details on reagents, solvents, reaction processing, chromatography, NMR, IR, 
UV/Vis and fluoresecence spectroscopy and MS are registered in the general section of the 
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experimental part in Chapter 1. Compound 5 was prepared according to the synthetic 
procedure reported in the experimental section in Chapter 1. 
 
Light sources 
For irradiation experiments a UV hand-held lamp (Herolab, 6 W, ? = 312 nm) and a Luxeon 
III Star high-power LED (? = 590 nm / amber) were used. 
 
 
Benzylazide 
 
N3
 
 
A stock solution of sodium azide was prepared by stirring sodium azide (4.877 g, 75.02 
mmol) in DMSO (158 mL) at room temperature for 24 hours. Following, freshly distilled 
benzylbromide (11.70 mL, 98.51 mmol) was added and the reaction mixture was stirred for 
90 minutes. Water was added, the mixture was stirred for 30 minutes and extracted with Et2O. 
The organic layer was washed with water (2 x) and brine (2 x), dried over anhydrous MgSO4, 
the solvent was removed under reduced pressure and the residue was dried in vacuo over 
night to give a colorless oil. Finally, the product was purified by distillation to afford 
benzylazide as colorless oil (9.590 g, 96 %). 
 
1
H NMR (300 MHz, CDCl3) ? = 7.47-7.27 (m, 5 H), 4.34 (s, 2 H) - 13C NMR (75 MHz, 
CDCl3) ? = 135.4 (Cquat.), 128.9 (+, CH), 128.4 (+, CH), 128.3 (+, CH), 54.8 (-, CH2)  
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Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine  
 
N
N
N
N
N
N N
NN
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A mixture of tripropargylamine (2.2 mL, 15.55 mmol) and freshly prepared benzylazide (6.45 
mL, 51.62 mmol) were added to a mixture of CH2Cl2/H2O (32 mL, 1:1). Under vigorous 
stirring, copper(II) sulphate (621 mg, 2.49 mmol), L-ascorbic acid (1.204 g, 6.84 mmol), 
water (2 mL) and an aqueous sodium hydroxide solution (6.84 mL, 6.88 mmol) were added. 
The bright yellow reaction mixture was stirred at room temperature for 14 hours. Following, 
CH2Cl2 (50 mL) and water (50 mL) were added. The aqueous layer was extracted again with 
CH2Cl2 (50 mL), the organic layers were pooled and dried over anhydrous MgSO4. The 
product was subjected to gradient flash chromatography (CH2Cl2/MeOH 100:1 to 30:1). The 
solvents were removed in vacuo, MeOH was added and Et2O was carefully layered on top to 
provide tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine as glistening white crystals (7.949 
g, 96 %). Rf = 0.19 (CH2Cl2/MeOH 100:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 7.65 (s, 3 H, CH-triazol), 7.37-7.30 (m, 9 H, H-Ar), 7.27-
7.22 (m, 6 H, H-Ar), 5.49 (s, 6 H), 3.69 (s, 6 H) - 
13
C NMR (75 MHz, CDCl3): ? = 144.3 
(Cquat.), 134.8 (Cquat.), 129.1 (+, CH), 128.7 (+, CH), 128.0 (+, CH), 123.7 (+, CH), 54.1 (-, 
CH2), 47.1 (-, CH2) - MS (ESI): m/z (%): 531.2 (100) [MH
+
] - HRMS (EI-MS) calcd. for 
C30H30N10 [M
+.
]: 530.2655, found: 530.2654 
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1,3,6,8-Tetrabromopyrene  
 
Br Br
BrBr  
 
To a solution of pyrene (7.263 g, 35.91 mmol) in nitrobenzene (170 mL), there was added 
bromine (7.82 mL, 152.62 mmol) over 15 minutes. The mixture was heated at 140 °C for 4 
hours, stirred vigorously and slowly cooled to room temperature whereas spontaneous 
formation of a precipitate was observed. Following, an aqueous solution of sodium sulfite 
(11.90 mmol, 14 mL) was added and the mixture was stirred at room temperature for 15 
minutes. The precipitate was filtered, washed with water (10 mL), methanol (40 mL) and 
dried in vacuo to yield 1,3,6,8-tetrabromopyrene as a yellow solid (17.192 g, 92 %). 
 
MS (CI, 70 eV): m/z (%): 515.8 (63) [M
+.
], 517.9 (100) [M
+.
] 
 
 
1,3,6,8-Tetrakis(2-(trimethylsilyl)ethynyl)pyrene 
 
TMS TMS
TMSTMS  
 
A Schlenk flask was charged under argon atmosphere with 1,3,6,8-tetrabromopyrene (339 
mg, 0.655 mmol), PdCl2(PPh3)2 (93.7 mg, 0.134 mmol), CuI (12.4 mg, 0.0651 mmol), 
triphenylphosphine (35 mg, 0.133 mmol), dry NEt3 (6.5 mL) and dry DMF (6.5 mL) were 
added. The mixture was degassed via freeze-pump-thaw (3 cycles) and Ethynyltrimethylsilane 
(0.56 mL, 3.963 mmol) was added under argon atmosphere. The reaction mixture was heated 
at 70 °C for 20 hours and slowly cooled to room temperature. CH2Cl2 (5 mL) and water (5 
mL) were added and the mixture was stirred for 10 minutes. Following, the mixture was 
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extracted with CH2Cl2, washed with brine and water and the aqueous layer was extracted with 
CH2Cl2. The organic layers were pooled and dried over anhydrous MgSO4, filtered and the 
solvent was evaporated under reduced pressure. The residue was dried in vacuo and the 
remaining solid was purified by flash chromatography on silica gel (Hexane) to give 1,3,6,8-
tetrakis(2-(trimethylsilyl)ethynyl)pyrene as lustrous orange crystals (300 mg, 78 %). Rf = 0.13 
(Hexane) 
 
1
H NMR (300 MHz, CDCl3): ? = 8.59 (s, 4 H), 8.31 (s, 2 H), 0.39 (s, 36 H) - 13C NMR (75 
MHz, CDCl3): ? = 134.4, 131.9, 126.9, 118.5, 102.7, 101.3, -0.1 - MS (CI, NH3): m/z (%) = 
586.3 (100) [M
+.
], 571.2 (11) [M
+
-CH3
.
] 
 
 
1,3,6,8-Tetraethynylpyrene   
 
 
 
A flask was charged with 1,3,6,8-tetrakis(2-(trimethylsilyl)ethynyl)pyrene (203 mg, 0.346 
mmol) and a mixture of THF/MeOH (1:1, 24 mL). To this blood-red suspension potassium 
carbonate (384 mg, 2.778 mmol) was added and the mixture was stirred vigorously in the dark 
at room temperature for 16 hours. The formed precipitate was filtered, washed with water 
(200 mL) and dried in vacuo. 1,3,6,8-tetraethynylpyrene was obtained as a yellow-brown 
solid (98 mg, 95 %). 
 
IR (neat): ? [cm-1] = 3277, 1599, 905 
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3-Bromoperylene  
 
Br
 
 
Perylene (518 mg, 2.05 mmol) was dissolved in dry N,N-Dimethylformamide (95 mL). After 
stirring for 15 minutes under nitrogen, a solution of N-Bromosuccinimide (365 mg, 2.05 
mmol) in dry N,N-Dimethylformamide (20.5 mL) was injected through a syringe. The 
solution was stirred at room temperature for 26 h under a slow flow of nitrogen. Water (400 
mL) was added and the solution was stirred for 1 hour at room temperature. The resulting 
precipitate was separated through suction filtration, rinsed with water, and dried under 
vacuum. The precipitate was then recrystallized from hexane to afford 3-Bromoperylene as 
yellow crystals (639 mg, 94 %). 
 
1
H NMR (300 MHz, CDCl3): ? = 8.27-8.10 (m, 4 H), 8.07 (d, 1 H, J = 8.0 Hz), 7.97 (d, 1 H, J 
= 8.0 Hz), 7.74-7.68 (m, 2 H), 7.59-7.46 (m, 3 H) - MS (EI, 70 eV): m/z (%): 330.0 (100) 
[M
+.
], 332.0 (84)  
 
 
Trimethyl(2-(perylen-4-yl)ethynyl)silane 
 
TMS
 
 
A small Schlenk tube with stirring bar was flushed with argon and charged with 3-
Bromoperylene (104 mg, 0.312 mmol) and dry N,N-Dimethylformamide (3 mL). The solution 
was degassed via freeze-pump-thaw (3 cycles), PdCl2(PPh3)2 (21.9 mg, 0.0312 mmol), CuI 
(3.6 mg, 0.0189 mmol) and NEt3 (3 mL) were added under inert atmosphere. To the orange-
yellow solution Ethynyltrimethylsilane (52.1 mg, 0.531 mmol) was added. The reaction was 
stirred at 85 °C for 20 hours, quenched with water and extracted with CH2Cl2 (3 x 20 mL). 
The combined organic phases were washed with brine, dried over anhydrous Na2SO4, the 
solution was filtered and concentrated in vacuo. Purification was done by gradient flash 
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chromatography on silica gel (Hexane/CH2Cl2 200:1 to 50:1) and Trimethyl(2-(perylen-4-
yl)ethynyl)silane was isolated as lustrous yellow-orange crystals (106 mg, 97 %). Rf = 0.18 
(Hexane/CH2Cl2 100:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 8.20 (dd, 4 H, J = 7.6, 15.2 Hz), 8.10 (d, 1 H, J = 7.9 Hz), 
7.73-7.65 (m, 3 H), 7.57 (t, 1 H, J = 7.6 Hz), 7.48 (dt, 2 H, J = 1.7, 7.9 Hz), 0.34 (s, 9 H) - MS 
(EI, 70 eV): m/z (%): 348.2 (100) [M
+.
], 349.2 (60)  
 
 
3-Ethynylperylene  
 
 
 
Trimethyl(2-(perylen-4-yl)ethynyl)silane (106 mg, 0.303 mmol) was dissolved in a mixture of 
MeOH (20 mL) and THF (15 mL) and finely grounded K2CO3 (157 mg, 1.136 mmol) was 
added. The reaction mixture was stirred at room temperature for 61 hours, then water (50 mL) 
and CH2Cl2 (50 mL) were added and the solution was stirred for 30 minutes. The mixture was 
extracted with CH2Cl2 (3 x 50 mL), washed with brine and dried over Na2SO4. The organic 
solvent was evaporated under reduced pressure and the residue was dried in vacuo to afford 
81 mg of 3-Ethynylperylene as glistening yellow crystals (0.29347 mmol, 97 %). 
 
1
H NMR (300 MHz, CDCl3): ? = 8.18-8.09 (m, 4 H), 8.02 (d, 1 H, J = 7.9 Hz), 7.67-7.62 (m, 
3 H), 7.51 (t, 1 H, J = 7.9 Hz), 7.43 (dt, 2 H, J = 2.5, 7.9 Hz), 3.53 (s, 1 H) - IR (neat): ? [cm-1] 
= 2924, 2361, 1738, 1375, 1217 - MS (EI, 70 eV): m/z (%): 276.1 (100) [M
+.
] 
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5-Diethylamino-2-nitrosophenol hydrochloride 
 
OHEt2N
NO
 
 
3-Diethylaminophenol (4.125 g, 24.97 mmol) was dissolved in a 4 M HCl solution in dioxane 
(32.5 mL, 125 mmol), cooled to 0 °C and freshly distilled isopentylnitrite (3.37 mL, 25.09 
mmol) was added dropwise at 0 °C for 75 minutes and stirred for additional 45 minutes. Cold 
Et2O (45 mL) was added to the mixture and the precipitate was filtered off, washed with 
dioxane (10 mL) and Et2O (45 mL) to afford 5-Diethylamino-2-nitrosophenol hydrochloride 
as a pale brown solid (4.627 g, 95 %). 
 
1
H NMR (300 MHz, MeOD): ? = 7.71 (d, 1 H, J = 10.4 Hz), 7.20 (d, 1 H, J = 10.4 Hz), 6.40 
(d, 1 H, J = 2.4 Hz), 3.91 (qd, 4 H, J = 7.2, 25.8 Hz), 1.39 (t, 6 H, J = 7.2 Hz) - 
13
C NMR (75 
MHz, MeOD) ? = 167.2, 164.1, 124.8, 121.0, 68.2, 23.0, 14.7, 13.1 - MS (ESI): m/z (%): 
195.0 (100) [MH
+
], 236.0 (11) [MH
+
+MeCN] 
 
 
9-(diethylamino)-2-hydroxy-5H-benzo[a]phenoxazin-5-one 
 
O
N
O
OH
Et2N  
 
To a dry flask containing 5-Diethylamino-2-nitrosophenol hydrochloride (2.892 g, 12.57 
mmol) in dry DMF (130 mL), a solution of 1,6-dihydroxynaphthalene (2.019 g, 12.61 mmol) 
in dry DMF (130 mL) was added. The reaction mixture was refluxed in the dark for 4 hours, 
slowly cooled to room temperature and DMF was removed under reduced pressure. The 
resulting dark solid was dissolved in EtOAc, washed with brine and water. The organic layers 
were pooled, concentrated to half volume and dried over anhydrous Na2SO4. The residue was 
dried in vacuo to constant weight and the remaining solid was purified by gradient flash 
chromatography on silica gel (Hexane/EtOAc 8:2 to 3:7) to give 9-(diethylamino)-2-hydroxy-
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5H-benzo[a]phenoxazin-5-one as a dark olive-green solid (3.085 g, 73 %). Rf = 0.60 
(Hexane/EtOAc 1:1) 
 
1
H NMR (300 MHz, DMSO-d6): ? = 10.43 (s, 1 H), 7.96 (d, 1 H, J = 8.6 Hz), 7.87 (d, 1 H, J = 
2.5 Hz), 7.57 (d, 1 H, J = 9.1 Hz), 7.08 (dd, 1 H, J = 2.5, 8.6 Hz), 6.79 (dd, 1 H, J = 2.7, 9.1 
Hz), 6.62 (d, 1 H, J = 2.6 Hz), 6.14 (s, 1 H), 3.48 (q, 4 H, J = 7.0 Hz), 1.15 (t, 6 H, J = 6.9 Hz) 
- MS (EI, 70 eV): m/z (%): 319.1 (100) [M
+
-CH3
.
], 334.2 (56) [M
+.
] 
 
 
9-(diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-yl trifluoromethanesulfonate 
 
O
N
O
OTf
Et2N  
 
Under nitrogen atmosphere a flask was charged with 9-(diethylamino)-2-hydroxy-5H-
benzo[a]phenoxazin-5-one (3.050 g, 9.13 mmol) and dry THF (250 mL). The solution was 
degassed and N-phenyl-bis(trifluoromethane sulphonamide) (8.114 g, 22.31 mmol) and dry 
NEt3 (3.05 mL, 21.89 mmol) were added. The mixture was stirred in the dark at room 
temperature for 24 hours, diluted with CH2Cl2, washed with water and dried over anhydrous 
MgSO4. The organic solvents were removed in vacuo and the crude product was purified by 
gradient flash chromatography on silica gel (Hexane/EtOAc 8:2 to 4:6) to give 9-
(diethylamino)-5-oxo-5H-benzo[a]phenoxazin-2-yl trifluoromethanesulfonate as lustrous dark 
red crystals (3.200 g, 75 %). Rf = 0.67 (Hexane/EtOAc 1:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 8.52 (d, 1 H, J = 2.5 Hz), 8.40 (d, 1 H, J = 8.8 Hz), 7.63 (d, 
1 H, J = 9.2 Hz), 7.48 (dd, 1 H, J = 2.5, 8.7 Hz), 6.71 (dd, 1 H, J = 2.7, 9.2 Hz), 6.47 (d, 1 H, J 
= 2.7 Hz), 6.44 (s, 1 H), 3.48 (q, 1 H, J = 7.1 Hz), 1.28 (t, 1 H, J = 7.2 Hz) - 
13
C NMR (75 
MHz, CDCl3) ? = 182.2 (Cquat.), 152.9 (Cquat.), 151.7 (Cquat.), 151.5 (Cquat.), 147.2 (Cquat.), 
137.2 (Cquat.), 134.2 (Cquat.), 131.8 (+, CH), 131.0 (Cquat.), 128.7 (+, CH), 125.5 (Cquat.), 122.2 
(+, CH), 117.7 (Cquat.), 116.4 (+, CH), 110.7 (+, CH), 105.2 (+, CH), 96.2 (+, CH), 45.3 (-, 
CH2) 12.6 (+, CH3) - MS (ESI): m/z (%): 466.9 (100) [MH
+
] 
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9-(diethylamino)-2-((trimethylsilyl)ethynyl)-5H-benzo[a]phenoxazin-5-one 
 
O
N
OEt2N
TMS
 
 
A Schlenk flask was charged under argon atmosphere with 9-(diethylamino)-5-oxo-5H-
benzo[a]phenoxazin-2-yl trifluoromethanesulfonate (3.177 g, 6.82 mmol) and dry DMF (70 
mL). Following, Pd(PPh3)4 (275.5 mg, 0.238 mmol), CuI (45.5 mg, 0.239 mmol), and dry 
NEt3 (5.0 mL) were added. The mixture was degassed via freeze-pump-thaw (3 cycles) and 
Ethynyltrimethylsilane (1.50 mL, 10.61 mmol) was added under argon atmosphere. The 
reaction mixture was heated at 80 °C for 4 hours, slowly cooled to room temperature under 
vigorous stirring, CH2Cl2 (10 mL) and water (10 mL) were added and the mixture was stirred 
for 10 minutes. The mixture was extracted with CH2Cl2 (3 x 50 mL), washed with brine and 
water and the aqueous layer was extracted with CH2Cl2 (20 mL). The organic layers were 
combined and dried over anhydrous Na2SO4, filtered and the solvent was evaporated under 
reduced pressure. The residue was dried in vacuo over night and the remaining crude product 
was subjected to gradient flash chromatography on silica gel (Hexane/EtOAc 4:1 to 1:1). The 
purified product was triturated with a THF/Et2O 1:1 mixture and 9-(diethylamino)-2-
((trimethylsilyl)ethynyl)-5H-benzo[a]phenoxazin-5-one was obtained as a wine red crystals 
(2.230 g, 79 %). Rf = 0.52 (Hexane/EtOAc 1:1) 
 
1
H NMR (300 MHz, CDCl3): ? = 8.75 (d, 1 H, J = 1.3 Hz), 8.24 (d, 1 H, J = 8.1 Hz), 7.70 (dd, 
1 H, J = 1.6, 8.2 Hz), 7.64 (d, 1 H, J = 9.1 Hz), 6.70 (dd, 1 H, J = 2.7, 9.1 Hz), 6.49 (d, 1 H, J 
= 2.7 Hz), 6.34 (s, 1 H), 3.49 (q, 4 H, J = 7.1 Hz), 1.27 (t, 6 H, J = 7.1 Hz), 0.30 (s, 9 H) - MS 
(ESI): m/z (%): 415.1 (100) [MH
+
] 
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9-(diethylamino)-2-ethynyl-5H-benzo[a]phenoxazin-5-one 
 
O
N
OEt2N  
 
To a solution of 9-(diethylamino)-2-((trimethylsilyl)ethynyl)-5H-benzo[a]phenoxazin-5-one 
(1.773 g, 4.28 mmol) in dry CH2Cl2 (24 mL), a freshly prepared solution of Bu4NF in dry 
THF (8.56 mL, 8.56 mmol) was added. The reaction mixture was stirred at room temperature 
for 10 minutes, and water (25 mL) was added. The mixture was extracted with CH2Cl2 (2 x 20 
mL) and the aqueous layer was extracted with EtOAc. The pooled organic layers were 
concentrated to half volume, dried over anhydrous Na2SO4 and the solvents were removed 
under reduced pressure. Purification was performed by gradient flash chromatography on 
silica gel (Hexane/EtOAC 2:1 to 1:1), followed by trituration with a Hexane/Et2O mixture 
over night to yield 9-(diethylamino)-2-ethynyl-5H-benzo[a]phenoxazin-5-one as beautiful 
purple red crystals (1.383 g, 94 %). Rf = 0.42 (Hexane/EtOAC 1:1) 
 
1
H NMR (400 MHz, CDCl3): ? = 8.80 (d, 1 H, J = 1.4 Hz), 8.27 (d, 1 H, J = 8.2 Hz), 7.72 (dd, 
1 H, J = 1.6, 8.1 Hz), 7.57 (dd, 1 H, J = 1.4, 2.9Hz), 6.70 (dd, 1 H, J = 2.7, 9.1 Hz), 6.49 (d, 1 
H, J = 2.7 Hz), 6.40 (s, 1 H), 3.49 (q, 1 H, J = 7.1 Hz), 3.26 (s, 1 H), 1.28 (t, 6 H, J = 7.1 Hz) - 
IR (neat): ? [cm-1] = 2970, 2359, 1738, 1366, 1217 - MS (ESI): m/z (%): 343.1 (100) [MH+] 
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1-(1’,3’-dihydro-3’3’-dimethyl-6-nitro-spiro[2H-1-benzopyran-2,2’[2H]indole]-1’-propyl 
-1H-[1,2,3]triazol-4-yl)-pyrene  
 
N O
N
NO2
N
N
 
 
To a solution of 2-(3’,3’-Dimethyl-6-nitro-3’H-spiro[chromene-2,2’-indol]-1’-yl)-1-(3-
Azidopropane) (182 mg, 0.465 mmol) in a 3:1 mixture (v/v) of DMF and water (24 mL), 1-
Ethynylpyrene (105 mg, 0.464 mmol), Copper(II) sulphate pentahydrate (17 mg, 0.068 
mmol), Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (12 mg, 0.023 mmol) and (+)-
Sodium L-ascorbate (27 mg, 0.136 mmol) were added. The mixture was stirred at room 
temperature until complete consumption of the pyrene (~ 24 hours), diluted with EtOAc and 
washed with brine and water. The aqueous phase was extracted with CH2Cl2, the organic 
layers were combined and dried over anhydrous Na2SO4. The solvents were removed under 
reduced pressure and the crude product was purified by gradient flash chromatography on 
silica gel (CH2Cl2/MeOH 200:1 to 100:1) to afford 1-(1’,3’-dihydro-3’3’-dimethyl-6-nitro-
spiro[2H-1-benzopyran-2,2’[2H]indole]-1’-propyl -1H-[1,2,3]triazol-4-yl)-pyrene as a pale 
green foam (262 mg, 91 %). Rf = 0.17 (CH2Cl2/MeOH 200:1) 
 
1
H NMR (600 MHz, CDCl3): ? = 8.64 (d, 1 H, J = 9.2 Hz, H-Ar), 8.23-8.19 (m, 3 H, H-Ar), 
8.14 (d, 1 H, J = 7.9 Hz, H-Ar), 8.10 (q, 3 H, J = 8.7 Hz, H-Ar), 8.03 (t, 1 H, J = 7.6 Hz, H-
Ar), 7.98 (dd, 1 H, J = 2.7, 9.0 Hz, H-Ar), 7.85 (d, 1 H, J = 2.7 Hz, H-Ar), 7.83 (s, 1 H, 
triazol), 7.21 (dt, 1 H, J = 1.2, 7.7 Hz, H-Ar), 7.11 (dd, 1 H, J = 0.9, 7.2 Hz, H-Ar), 6.92 (t, 1 
H, J = 7.4 Hz, H-Ar), 6.81 (d, 1 H, J = 10.3 Hz, H-Ar), 6.74 (d, 1 H, J = 9.0 Hz, H-Ar), 6.58 
(d, 1 H, J = 7.7 Hz, H-Ar), 5.83 (d, 1 H, J = 10.3 Hz, H-Ar), 4.61-4.50 (m, 2 H, CH2-propyl), 
3.43-3.36 (m, 1 H, CH2-propyl), 3.36-3.29 (m, 1 H, CH2-propyl), 2.52-2.42 (m, 1 H, CH2-
propyl), 2.41-2.30 (m, 1 H, CH2-propyl), 1.27 (s, 3 H, CH3), 1.18 (s, 3 H, CH3) - 
13
C NMR 
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(150 MHz, CDCl3): ? = 159.2 (Cquat.), 147.7 (Cquat.), 146.6 (Cquat.), 141.0 (Cquat.), 136.1 (Cquat.), 
131.4 (Cquat.), 130.8 (Cquat.), 128.5 (+, CH), 128.5 (Cquat.), 128.3 (+, CH), 127.9 (+, CH), 127.9 
(+, CH), 127.3 (+, CH), 127.0 (+, CH), 126.1 (+, CH), 125.9 (+, CH), 125.5 (+, CH, triazol), 
125.2 (+, CH), 125.1 (Cquat.), 125.0 (Cquat.), 124.9 (+, CH), 124.7 (Cquat.), 124.6 (+, CH), 122.7 
(+, CH), 122.5 (+, CH), 122.0 (+, CH), 121.5 (+, CH), 120.0 (+, CH), 118.3 (Cquat.), 115.4 (+, 
CH), 106.7 (+, CH), 106.7 (Cquat.), 53.4 (Cquat.), 52.6 (Cquat.), 48.1 (-, CH2), 40.8 (-, CH2), 29.1 
(-, CH2), 25.9 (+, CH3), 19.9 (+, CH3) - HRMS (EI-MS) calcd. for C39H31N5O3 [M
+.
]: 
617.2427, found: 617.2417 
 
 
3-(1’,3’-dihydro-3’3’-dimethyl-6-nitro-spiro[2H-1-benzopyran-2,2’[2H]indole]-1’-propyl 
-1H-[1,2,3]triazol-4-yl)-perylene  
 
N O
N
NO2
N
N
 
 
3-Ethynylperylene (56 mg, 0.203 mmol) and 2-(3’,3’-Dimethyl-6-nitro-3’H-spiro[chromene-
2,2’-indol]-1’-yl)-1-(3-Azidopropane) (76 mg, 0.208 mmol) were dissolved in a 3:1 mixture 
(v/v) of DMF and water (10 mL). (+)-Sodium L-ascorbate (14 mg, 0.071 mmol), Tris[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (7 mg, 0.013 mmol) and Copper(II) sulphate 
pentahydrate (8 mg, 0.032 mmol), were added. The mixture was stirred at room temperature 
for 24 hours, diluted with CH2Cl2, washed with brine and water. The aqueous phase was 
extracted with CH2Cl2, the organic layers were combined and dried over anhydrous Na2SO4. 
The solvent was evaporated and the remaining solid was purified by gradient flash 
chromatography on silica gel (CH2Cl2/MeOH 1000:1 to 20:1) to yield 3-(1’,3’-dihydro-3’3’-
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dimethyl-6-nitro-spiro[2H-1-benzopyran-2,2’[2H]indole]-1’-propyl -1H-[1,2,3]triazol-4-yl)-
perylene as a lustrous yellow solid (123 mg, 91 %). Rf = 0.48 (CH2Cl2) 
 
1
H NMR (600 MHz, CD2Cl2): ? = 8.30-8.25 (m, 5 H, H-Ar), 7.99 (dd, 1 H, J = 2.7, 9.0 Hz, H-
Ar), 7.91 (d, 1 H, J = 2.7 Hz, H-Ar), 7.79 (s, 1 H, triazol), 7.74 (dd, 2 H, J = 4.4, 8.0 Hz, H-
Ar), 7.64 (d, 1 H, J = 7.8 Hz, H-Ar), 7.55-7.63 (m, 3 H, H-Ar), 7.18 (dt, 1 H, J = 1.1, 7.7 Hz, 
H-Ar), 7.11 (d, 1 H, J = 7.2 Hz, H-Ar), 6.89 (dd, 2 H, J = 4.4, 8.8 Hz, H-Ar), 6.77 (d, 1 H, J = 
8.9 Hz, H-Ar), 6.57 (d, 1 H, J = 7.8 Hz, H-Ar), 5.88 (d, 1 H, J = 10.3 Hz, H-Ar), 4.58-4.48 (m, 
2 H, CH2-propyl), 3.42-3.35 (m, 1 H, CH2-propyl), 3.34-3.27 (m, 1 H, CH2-propyl), 2.48-2.40 
(m, 1 H, CH2-propyl), 2.36-2.29 (m, 1 H, CH2-propyl), 1.27 (s, 3 H, CH3), 1.18 (s, 3 H, CH3) 
- 
13
C NMR (150 MHz, CD2Cl2): ? = 159.6 (Cquat.), 147.2 (Cquat.), 147.1 (Cquat.), 141.5 (Cquat.), 
136.6 (Cquat.), 135.1 (Cquat.), 132.7 (Cquat.), 132.0 (Cquat.), 131.8 (Cquat.), 131.5 (Cquat.), 131.2 
(Cquat.), 129.5 (Cquat.), 128.9 (+, CH), 128.8 (Cquat.), 128.5 (+, CH), 128.3 (+, CH), 128.2 (+, 
CH), 128.1 (+, CH), 128.1 (Cquat.), 127.4 (+, CH), 127.1 (+, CH), 127.1 (+, CH), 126.2 (+, 
CH), 125.8 (+, CH), 123.1 (+, CH), 122.9 (+, CH, triazol), 122.3 (+, CH), 121.9 (+, CH), 
121.1 (+, CH), 121.0 (+, CH), 121.0 (+, CH), 120.3 (+, CH), 120.2 (+, CH), 119.0 (Cquat.), 
115.8 (+, CH), 107.3 (+, CH), 107.1 (Cquat.), 48.6 (-, CH2), 41.2 (-, CH2), 30.1 (Cquat.), 29.5 (-, 
CH2), 26.1 (+, CH3), 19.9 (+, CH3) - HRMS (EI-MS) calcd. for C43H33N5O3 [M
+.
]: 667.2589, 
found: 667.2589 
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2-(1’,3’-dihydro-3’3’-dimethyl-6-nitro-spiro[2H-1-benzopyran-2,2’[2H]indole]-1’-propyl 
-1H-[1,2,3]triazol-4-yl)-9-(Diethylamino)-5H-benzo[a]phenoxazin-5-one  
 
N O
N
NO2
N
N
N
O
O
N
 
 
9-(Diethylamino)-2ethynyl-5H-benzo[a]phenoxazin-5-one (18 mg, 0.053 mmol) and 2-(3’,3’-
Dimethyl-6-nitro-3’H-spiro[chromene-2,2’-indol]-1’-yl)-1-(3-Azidopropane) (27 mg, 0.069 
mmol) were dissolved in a 3:1 mixture (v/v) of DMF and water (6 mL). Copper(II) sulphate 
pentahydrate (2.6 mg, 0.011 mmol), (+)-Sodium L-ascorbate (4.2 mg, 0.021 mmol), and 
Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (2.0 mg, 0.004 mmol) were added. The 
mixture was stirred at room temperature for 24 hours, diluted with EtOAc, washed with brine 
and water (2 x). The organic layers were combined and dried over anhydrous MgSO4. The 
solvent was removed under reduced pressure and the crude product was purified by gradient 
flash chromatography on silica gel (CH2Cl2/MeOH 300:1 to 70:1) to yield 2-(1’,3’-dihydro-
3’3’-dimethyl-6-nitro-spiro[2H-1-benzopyran-2,2’[2H]indole]-1’-propyl -1H-[1,2,3]triazol-4-
yl)-9-(Diethylamino)-5H-benzo[a]phenoxazin-5-one as a pink solid (32.3 mg, 84 %) Rf = 
0.15 (CH2Cl2/MeOH 200:1) 
 
1
H NMR (600 MHz, CDCl3): ? = 8.99 (s, 1 H, triazol), 8.35 (d, 1 H, J = 8.2 Hz, H-Ar), 8.08 
(d, 1 H, J = 8.2 Hz, H-Ar), 7.99 (dd, 1 H, J = 2.7, 9.0 Hz, H-Ar), 7.94-7.89 (m, 2 H, H-Ar), 
7.62 (d, 1 H, J = 9.0 Hz, H-Ar), 7.20 (t, 1 H, J = 7.6 Hz, H-Ar), 7.10 (d, 1 H, J = 7.1 Hz, H-
Ar), 6.89 (dd, 2 H, J = 8.8, 14.6 Hz, H-Ar), 6.74 (d, 1 H, J = 8.9 Hz, H-Ar), 6.69 (dd, 1 H, J = 
2.4, 9.0 Hz, H-Ar), 6.55 (d, 1 H, J = 7.8  Hz, H-Ar), 6.48 (d, 1 H, J = 2.3 Hz, H-Ar), 6.39 (s, 1 
H, CH-C=O), 5.84 (d, 1 H, J = 10.3 Hz, H-Ar), 4.55-4.45 (m, 2 H, CH2-propyl), 3.48 (q, 4 H, 
J = 7.0 Hz, 2 x CH2-CH3), 3.40-3.26 (m, 2 H, CH2-propyl), 2.47-2.38 (m, 1 H, CH2-propyl), 
2.37-2.27 (m, 1 H, CH2-propyl), 1.29 (s, 3 H, CH3), 1.26 (d, 6 H, J = 6.3 Hz, 2 x CH2-CH3), 
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1.19 (s, 3 H, CH3) - 
13
C NMR (150 MHz, CDCl3): ? = 183.3 (Cquat.), 159.2 (Cquat.), 152.3 
(Cquat.), 150.9 (Cquat.), 147.3 (Cquat.), 146.9 (Cquat.), 146.5 (Cquat.), 141.1 (Cquat.), 139.5 (Cquat.), 
136.0 (Cquat.), 133.2 (Cquat.), 132.6 (Cquat.), 131.2 (CH), 131.2 (Cquat.), 128.5 (CH), 127.9 (CH), 
126.8 (CH), 126.6 (CH), 126.0 (CH), 125.0 (Cquat.), 122.8 (CH), 122.0 (CH), 121.5 (CH), 
120.6 (CH, triazol), 120.5 (CH), 120.1 (CH), 118.3 (Cquat.), 115.5 (CH), 109.9 (CH), 106.7 
(CH), 106.7 (Cquat.), 105.8 (CH-C=O), 96.3 (CH), 52.7 (Cquat.), 48.2 (CH2-propyl), 45.1 (CH2-
CH3), 40.8 ( CH2-propyl), 29.7 (CH2-CH3), 29.3 (CH2-propyl), 25.9 (CH3), 19.9 (CH3), 14.1 
(Cquat.), 12.6 (Cquat.) - HRMS (LSI-MS) calcd. for C43H40N7O5 [MH
+
]: 734.3091, found: 
734.3086 
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Chapter 3: 
Synthesis of spirobenzopyran building blocks for DNA synthesis and internal covalent 
modifications 
 
3.1. Introduction 
 
Among the structurally miscellaneous photochromic compounds that were prepared and 
characterized,
[1]
 diazobenzenes and spirobenzopyrans are the most prominent representatives 
for photoswitching of biopolymers.
[2]
 However, mainly diazobenzene derivatives have been 
extensively studied in peptides to switch folding and conformation,
[3]
 and as artificial and 
photoswitchable bases in nucleic acids with commercial success.
[4]
 The cis-trans 
isomerization is switched by irradiation with light and the azobenzene moieties as part of the 
nucleic acids can reversibly control the dissociation and formation of a DNA duplex, 
photomodulate the DNA polymerase reaction, and the DNA triplex formation.
[3-4, 5]
 General 
aspects about these switches are discussed in Chapter 1. However, photoregulation of 
hybridization can also be accomplished irreversibly by introduction of caging systems into the 
DNA,
[2a, 6]
 or reversibly controlled upon cis-trans photoisomerization with fluorescence 
switching readouts of other photochromic nucleosides like 
8FV
G.
[7]
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Figure 1.1. DMT-protected T, equipped with NDBF caging group
[6b]
, fluorescence switching 
nucleosides 
VPy
G
[7c]
 and 
8FV
G.
[7a]
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Though, for reversible systems like spirobenzopyrans, the ring opening of the 
spirobenzopyrans to the open merocyanine does not only involve a significant structural 
change from nonplanar to a planar structure but also a large polarity change, in contrast to 
diazobenzenes.
[8]
 This is an important option with respect to nucleic acids because it can be 
assumed that the ring-closed spirobenzopyran form of these photoswitches is not able to insert 
into the base stack whereas the open and planar merocyanine form could potentially 
intercalate. This presumption was experimentally reinforced by photochromic 
spirobenzopyrans that were designed as noncovalent DNA and RNA binders.
[9]
 The strong 
ground state interaction that was only observed between the merocyanine form and the DNA 
bases induces a significant CD signal, i.e. indicating intercalation of the open merocyanine 
form into the DNA.
[9b, 10]
 
Although, amino acids,
[11]
 peptides,
[12]
 and proteins
[13]
 have been conjugated with 
spirobenzopyrans in order to endow these biomolecules with the optical switch. However, 
there are only two reports in the literature about the covalent linking of a spirobenzopyran to 
nucleic acids.
[14]
  
 
Herein, two new alternative synthetic routes to modify oligonucleotides covalently with 
spirobenzopyrans are reported: for the first route a spirobenzopyran phosphoramidite was 
synthesized as a DNA building block; the second route applies a postsynthetic click-type 
ligation strategy. As a surrogate for the 2’-deoxyribose moiety in DNA, acyclic linker systems 
have been established over the last years,
[15]
 and it turned out to be useful to replace the 
naturally occurring 2’-deoxyribofuranoside moiety by (S)-3-amino-1,2-propanediol as an 
acyclic linker.
[15b, 16]
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Figure 1.2. Typical acyclic building blocks.
[17]
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The replacement of the labile glycosidic bond between the 2’-deoxyribofuranoside and a 
chromophore by using acyclic linker systems eludes stability issues that arise with 
glycosylamines.
[17a]
 Similar acyclic linker systems have been prepared, e.g. based on glycol 
nucleic acids (GNA)
[17c, 18]
 or twisted intercalating nucleic acids (TINA).
[17d]
 Meanwhile, 
these linker systems have been connotatively expanded and refined towards sophisticated 
bioorthogonal labeling, by endowing them with alkyne functionalities for further 
postsynthetic modifications.
[17b, 17e, 19]
 Further aspects on postsynthetic strategies are described 
in Chapter 4. 
 
 
3.2. Results and Discussion 
 
3.2.1. Synthesis of acyclic linker 
The acyclic linker that has been used contains a primary and secondary hydroxy function, to 
serve as platform for the functionalization for the DNA building block chemistry, and also an 
additional primary amino group to attach the desired modifications. Synthesis of the building 
block 4 was carried out based on the acyclic linker that was established in our group.
[15b, 16]
 
The synthesis of 4 consists of three steps (Scheme 2.1). First, the amino-group of (S)-3-
amino-1,2-propanediol 1 was reacted with an excess of methyl trifluoroacetate at room 
temperature for 24 hours to afford 2 in 90 % yield. Second, the primary hydroxy-group was 
tritylated, to serve as the 5’-position during later DNA synthesis. Since it is crucial to prevent 
hydrolysis of DMT chloride already upon start of the reaction, it should be stressed out, that 
freshly dried solvents were used for the reaction and thus, 3 was obtained in 93 % yield. The 
final step for the synthesis of 4 involved the deprotection to regain the primary amino-
function. The reaction was performed by stirring 3 in aqueous ammonia solution in a mixture 
of methanol and tetrahydrofuran and workup by extraction with dichloromethane. 4 was then 
isolated as a colorless fuzzy foam in 89 % yield. 
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Scheme 2.1. Synthesis of acyclic linker 4. Reagents and conditions: a) Methyltrifluoroacetate 
(10.0 eq.), r.t., 24 h, 90 %; b) DMTCl (1.0 eq.), NEt3, pyridine, r.t., 60 h, 93 %; c) aq. NH3 (94 
eq.), MeOH, THF, r.t., 24 h, 89 %. 
 
3.2.2. Synthesis of spiropyran iodide, tosylate and coupling to acyclic linker 
Our initial attempt for the preparation of a DNA building block that consists of the 
spirobenzopyran unit and an acyclic sugar surrogate was to use a common strategy for the 
synthesis of 6 (Scheme 2.2). According to the literature, it should be possible to attach the 
spirobenzopyran 5 to the acyclic linker 4, with addition of base in N,N-
dimethylformamide.
[15b, 20]
  
In order to synthesize the spirobenzopyran-acyclic linker conjugate 6, the iodide 5 was 
chosen. 5 was prepared in three steps with an overall yield of 66 %, according to the synthetic 
protocol that is discussed in Chapter 1. With the iodide as a good leaving group, a 
nucleophilic substitution with the primary amino-functionality of the acyclic linker system 
should occur. Thus, experiments under the described conditions were conducted,
[15b, 20]
 but 
none gave the desired product 6. 
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Scheme 2.2. Coupling of spirobenzopyrans with acyclic linker compound. Reagents and 
conditions: a) p-TsCl (1.5 eq.), pyridine (1.5 eq.), THF, 0 °C to r.t., 21 h, 9 %.  
 
As another route, the conversion of 7 into a tosylate was performed to facilitate a subsequent 
nucleophilic substitution reaction with the acyclic linker 4. Therefore, the spirobenzopyran 7 
was synthesized as described in Chapter 1. Then, the tosylation of spirobenzopyran compound 
was carried out with p-toluenesulfonyl chloride in the presence of pyridine in tetrahydrofuran. 
Although, a standard protocol was used for the tosylation, the desired compound 8 could only 
be isolated in low yield after column chromatography. Additionally, 8 could not be isolated 
by recrystallization on several attempts. Presumably the formation of pyridinium salt resulted 
in a concomitant loss of the desired tosylate.
[21]
 However, coupling procedures of the gained 
tosylate 8 with linker compound also resulted in no formation of the desired product 6.  
After all, the isolable quantities of tosylated spirobenzopyran 8 were not ample in the long 
run, and establishing steady reaction conditions to form the desired product 6 appeared very 
protracted. Thus, we decided to tackle a new route, where an elongation of the linkage 
between the spirobenzopyran and the acyclic linker was accepted. For practical reasons we 
designed our new approach particularly with regard to avoid mandatory tedious protection 
group chemistry that is associated with the acyclic linker.
[15b]
 
 
3.2.3. Synthesis of activated spirobenzopyrans and conjugation with acyclic linker 
As previous attempts failed to synthesize the spiropyran-acyclic-linker conjugate 6 starting 
from iodo-alkylated spirobenzopyran 5 or the tosylated compound 8 via nucleophilic 
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substitution chemistry to the primary amino group of the acyclic linker 4, it was important to 
embark on a new strategy. 
For this reason, to activate the hydroxyl functions of 7 for nucleophilic attack of the amino 
functionality of 4, a N-acylimidazole 9 and a mixed anhydride 10 were prepared (Scheme 
2.3). These active intermediates liberate imidazole or p-nitrophenol, respectively, upon 
reaction with the amino-group, but not the carbonyl group.
[22]
 Accordingly, a one-carbon 
spacer is introduced and a stable N-alkyl carbamate (urethane) linkage is formed.  
 
N O
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NO2N O
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DMTO
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9: R = O
N
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O
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Scheme 2.3. Synthesis of activated spirobenzopyrans 9 together with 10 and coupling to the 
acyclic linker. Reagents and conditions: a) CDI (3.7 eq.), dioxane, r.t., 64 h, 51 %; b) 4-NPC 
(3.0 eq.), DIPEA, CH2Cl2, 0 °C, 3 h, 93 %; c) 4 (1.5 eq.), 4-DMAP (1.0 eq.), CH2Cl2, DMF, 
r.t., 67 h, 46 %; d) 4 (2.0 eq.), DIPEA (6.4 eq.), DMF, 0 °C, 5 h, 97 %. 
 
The N-acylimidazole 9 was synthesized by reacting 7 with excess of 1,1’-carbonyldiimidazole 
(CDI). The reaction was carried out in dry dioxane at room temperature and 9 was obtained in 
51 % yield as a yellow solid. The formed imidazolyl carbamate could then be coupled to the 
acyclic linker with its primary amino functionality in later reactions. 
The mixed anhydride 10 was synthesized by reaction of 7 with 4-nitrophenylchloroformate 
(4-NPC), a popular reagent for the activation of alcohols towards the formation of carbamates 
and carbonates.
[23]
 According to assimilable procedures reported in the literature,
[24]
 an excess 
of 4-NPC was reacted with spirobenzopyran 7 at 0 °C in dry dichloromethane and addition of 
diisopropylethylamine for 3 hours. The resulting 4-NP carbonate was purified by flash 
chromatography and afforded 10 in 93 % yield. 
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Interestingly, equimolar amounts of activation agents and 7 did not show complete conversion 
to 9 or 10, respectively. Both activation reactions worked smoothly with an excess of the 
activating agent. Accordingly, the in situ substitution of the 4-nitrophenyl moiety by addition 
of the amine was not possible at this step due to the excess of activation agent. Remarkably, 
the CDI-activated spirobenzopyran compound 9 appeared to be prone to hydrolysis, and 
decomposition was observed during chromatography where the original spirobenzopyran 
compound 7 reformed, explaining the lower yield (51 %). The observation of decomposition 
of CDI-activated labels has also been reported in the literature.
[22]
 However, the mixed 
anhydride compound 10 was stable during chromatography and did not show decomposition, 
and thus it was obtained in excellent yield (93 %). 
Although, the conjugation reaction of 9 with the acyclic linker 4 was carried out in dry 
solvents to prevent hydrolysis, TLC displayed slow reaction and gave 11 in 46 % yield. On 
the other hand, the reaction of 10 with the acyclic linker 4 showed complete conversion 
within 5 hours and 11 was obtained in 97 % yield. Interestingly, in the meantime the 
preparation of CDI- or 4-NP-activated molecules has been adopted routinely by other 
members of our group and the strategy was used for successful conjugation reactions of 
different chromophores with the acyclic linker.
[25]
  
 
3.2.4. Synthesis of spirobenzopyran phosphoramidite and DNA  
The final stage in the synthesis of the spirobenzopyran modified acyclic linker derivative is 
accomplished by addition of the phosphoramidite group. The appropriate 
cyanoethylphosphoramidite 12 was prepared by an optimized reaction of 11 with excess of 
commercially available 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite 21 in 
dichloromethane with triethylamine at room temperature for 11 hours. The progress of the 
reaction was monitored with TLC, indicating complete conversion into the desired product 
12. However, it was important to purify the compound otherwise the incorporation during 
DNA synthesis functioned poorly. Thus, the phosphoramidite was carefully purified by flash 
chromatography on silica gel using hexanes-ethylacetate as an eluent that contains 
triethylamine as base to prevent cleavage of the trityl group. After chromatography both 
methods, lyophilization of 12 from benzene and solidification by precipitation, gave 12 in 
consistent and excellent yield. 
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Scheme 2.4. Phosphitylation of spirobenzopyran acyclic linker. Reagents and conditions: a) 
21 (2.0 eq.), CH2Cl2, NEt3, r.t., 11 h, 95 %. 
 
Following, the detritylated oligonucleotides DNA 1a-1c were synthesized automatically on 
the 1 µmol scale using building block 12 in acetonitrile and a coupling time of 6.3 minutes. 
With respect to the expected chemical lability of the spirobenzopyran, the DNA was 
deprotected under very mild conditions at room temperature for 18 hours.  
 
N
O
O
NO2
OHN
O
X
O
DNA 1a: 5'-GCA-GTC-TTX-TTC-ACT-GA-3'
DNA 1b: 5'-GCA-GTC-TAX-ATC-ACT-GA-3'
DNA 1c: 5'-GCA-GTC-TCX-CTC-ACT-GA-3'
to 5'
to 3'
 
 
The crude products were analyzed by HPLC, and, in fact, both isomers (spirobenzopyran and 
merocyanine) of the modified oligonucleotides were detectable by HPLC and could be 
identified by ESI mass spectrometry. However, the oligonucleotides were prone to 
decompose especially during the basic conditions for deprotection and cleavage. Due to the 
latter observation in combination with the low yield we decided to apply an alternative 
synthetic approach which is a so-called postsynthetic methodology. Alternatively, the use of 
different deprotection and cleavage systems might be considered for further experiments 
when the building block 12 is used for incorporation into DNA. E.g., ultrafast deprotection 
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and cleavage with AMA can be used as a reasonable alternative to ammonium hydroxide, but 
requires the substitution of Bz-dC with Ac-dC during DNA synthesis.
[26]
 
 
3.2.5. Synthesis of click dU and DNA 
If labels or probes in DNA, like the spirobenzopyran modification or viologens,
[27]
 are 
chemically incompatible with the conditions under which DNA synthesis, deprotection or 
cleavage occur, postsynthetic modifications of presynthesized oligonucleotides can overcome 
these limitations and give access to the desired modification.
[28]
 Then, bioorthogonal ligation 
reactions are required where both, the functional group of the oligonucleotides and the 
functional group of the modifier should not be present in typical biomolecules and should 
react selectively with each other.
[29]
 The CuAAC click reaction matches the requirements 
since neither terminal alkyne nor azide functional groups are generally present in natural 
systems.
[30]
 Therefore, it has become the most important bioorthogonal labeling strategy and 
is introduced and discussed in Chapter 2.  
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Figure 2.1. DNA building block with terminal alkyne functionality  
 
As alkyne component for the click reaction we chose a 2’-O-propargyl-modified uridine 19 as 
phosphoramidite building block.
[31]
 Starting with commercially available uridine 13, the 5’- 
and 3’-OH positions were first simultaneously protected with the bifunctional 
tetraisopropyldisiloxane (TIPDS) protection group (“Markiewicz group”) under dry reaction 
conditions to afford 14 in 80 % yield. In the next step, the base-labile pivaloyloxymethyl 
(POM) protection group was introduced at the N
3
-position of the uracil base with TBAHS as a 
phase-transfer catalyst to yield 15 as glistening foam in 70 % yield. 15 was then reacted with 
30 % excess of propargyl bromide and BEMP to give the 2’-O-propargyl-modified protected 
uridine 16. Desilylation of the Markiewicz 3’,5’-O-silyl protection group was carried out 
using NEt3
.
3HF in THF and gave the desired nucleoside product 17 in 69 % yield.  
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Scheme 2.5. Synthesis of N
3
-POM-2’-alkynyl nucleoside 17. Reagents and conditions: a) PG 
(1.1 eq.), pyridine, r.t., 6 h, 80 %; b) pivaloyloxymethyl chloride (10.0 eq.), TBAHS (25.1 
mol-%), aq. Na2CO3 (10.2 eq.), CH2Cl2, r.t., 48 h, 70 %; c) Propargylbromide (1.3 eq.), 
BEMP (1.3 eq.), MeCN, 0 °C to r.t., 2 h, 30 %; d) NEt3
.
3HF (4.0 eq.), THF, r.t., 16 h, 69 %. 
 
To obtain the building block for DNA solid-phase synthesis, the 5’-OH group of 17 was 
protected with the acid-labile DMT protection group under addition of triethylamine to afford 
18 in 92 % yield. Finally, the dimethoxytritylated compound was converted into the 2’-O-
propargyluridine building block 19 by phosphitylation with 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite 21 and triethylamine in dichloromethane. Purification by 
flash chromatography on a short column and precipitation with hexane in ethyl acetate gave 
19 as colorless crystals in 93 % yield. 
 
 
 
 
Chapter 3  113 
O
HO N
N
O
O
O
O
HO O
a)
O
DMTO N
N
O
O
O
O
HO O
b)
O
DMTO N
N
O
O
O
O
O OPO
N
NC
17 18 19
 
 
Scheme 2.6. Synthesis of 2’-alkynyl-phosphoramidite building block 19. Reagents and 
conditions: a) DMTCl (1.2 eq.), NEt3 (3.2 eq.), pyridine, r.t., 16 h, 92 %; b) 21 (3.2 eq.), NEt3 
(12.5 eq.), CH2Cl2, r.t., 5 h, 93 %. 
 
In order to synthesize the spirobenzopyran-conjugated DNA we performed CuAAC with a 
spirobenzopyran azide and presynthesized DNA bearing terminal alkyne groups. The 
spirobenzopyran 20 was chosen as the azide component for the following click reactions, and 
it was synthesized in four steps with an overall yield of 55 %, according to the synthetic 
protocol that is discussed in detail in Chapter 1.  
 
N O
N3
NO2
20
 
Figure 2.2. Spirobenzopyran azide for DNA click reactions 
 
For the preparation of the oligonucleotides, we increased the concentration of 
phosphoramidite 19 to 0.1 M and the coupling time was extended to 6.3 minutes. After 
preparation, the trityl-off oligonucleotides were cleaved from the solid phase and deprotected 
by treatment with conc. NH4OH at room temperature for 24 hours. For the click ligations the 
cleaved oligonucleotides were treated with spirobenzopyran azide 20 in the presence of Cu(I), 
TBTA and sodium ascorbate in a solvent mixture (DMSO/
t
BuOH/H2O) at room temperature 
for 22 hours. At last, the oligonucleotides were desalted and purified.
[17b, 17e]
 The modified 
oligonucleotides could be identified by ESI mass spectrometry and finally hybridized with 1.2 
eq. of the corresponding unmodified counterstrands to the spirobenzopyran-modified DNA 
duplexes DNA 2-5. 
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The melting temperatures (Tm) of the spirobenzopyran-modified duplexes were measured 
(Table 2.1). As expected for a twisted structure like the spirobenzopyrans the duplexes show a 
significant destabilization when compared with the melting temperatures (Tm’) of their 
corresponding unmodified duplex (X
2
 = T).  
 
Duplex Tm (°C) Tm’ (°C) ?Tm 
DNA 2 47.9 66.0 -18.1 
DNA 3 50.0 62.5
[17e]
 -12.5 
DNA 4 48.0 61.0 -13.0 
DNA 5 47.8 68.0
[17e]
 -20.2 
 
Table 2.1. Melting temperatures (Tm) of duplexes DNA 2 - DNA 5 in comparison to the 
unmodified duplexes. Duplex (2.5 µM) in Na-Pi buffer (10 mM), NaCl (250 mM) 
 
The UV/Vis absorption spectra of the duplexes (Figure 2.3) clearly revealed the presence of 
the spirobenzopyran modification by the broad absorption band between 300 nm and 420 nm. 
DNA5 shows the strongest extinction which may be due to stacking with guanine. The very 
weak absorption of DNA 2 - DNA 5 between 500 and 600 nm seems to represent a small 
amount of the merocyanine form which may result of a preset equilibrium between the 
spirobenzopyran and open merocyanine form during the synthetic and preparative procedures.  
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Figure 2.3. UV/Vis absorption spectra of DNA 2 - DNA 5 
(2.5 µM) in Na-Pi buffer (10 mM), NaCl (250 mM) 
 
It was unexpected, however, that irradiation with UV light at ? = 312 and 366 nm did not 
initiate the ring opening of the spirobenzopyran-modified DNA duplexes to the corresponding 
merocyanine-modified ones. It is important to point out that the irradiation conditions were 
sufficient to switch the spirobenzopyran derivatives without DNA. Obviously, the presence of 
DNA in the neighborhood of the spirobenzopyran moiety inhibits the photoopening process to 
the merocyanine. According to the literature,
[32]
 the presence of the nitro group at the 6-
position of the benzopyran moiety should shift the equilibrium towards the open merocyanine 
form by enhancing the quantum yield of intersystem crossing and thereby favoring a triplet 
pathway for photocoloration. On the other hand, it was found that polar solvents decrease the 
quantum yield for the triplet pathway of photocoloration significantly.  
Under the assumption that the polarity of the DNA base stack is not extremely high, it seems 
to be very likely that the DNA bases quench the triplet state of the spirobenzopyran by energy 
or electron transfer processes thereby inhibiting the photoswitching process. Further work by 
time-resolved laser spectroscopy could be used to elucidate these processes. Nevertheless, it 
evinced that the spirobenzopyran chromophore cannot be simply applied as such for 
switching DNA hybridization but must be further developed and tuned by chromophore 
substituents to achieve this goal. 
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3.3. Conclusion 
 
In conclusion, the photochromic spirobenzopyran was incorporated as an internal 
modification into oligonucleotides by two different synthetic strategies: For the first route the 
spirobenzopyran phosphoramidite was synthesized as a DNA building block phosphoramidite 
from scratch. Therefore, an acyclic linker system was prepared and the CDI- or 4-NP-
activated spirobenzopyran was linked as a N-alkyl carbamate. The presented prolongation of 
the acyclic linker has turned out to be a very expedient synthetic method. Decomposition 
during deprotection of the modified oligonucleotides led to a second route where the 
postsynthetic click-type ligation was successfully applied. There, melting temperature 
measurements of the spirobenzopyran-modified duplexes displayed significant destabilization 
compared to unmodified DNA. However, photoinduced ring opening of the chromophore 
could not be achieved in duplex DNA. Further tuning of the chromophore substituents and 
time-resolved spectroscopy or testing of other photoswitchable compounds could help to find 
molecules that might be better suited for photoswitchable DNA hybridization. Alternative 
deprotection and cleavage conditions (e.g., AMA) as well as purification of the synthesized 
oligonucleotides by gel electrophoresis can develop investigations of spirobenzopyran-
modified DNA further. 
 
 
3.4. Experimental Section 
 
General 
Assignable details on reagents, solvents, reaction processing, chromatography, NMR and MS 
are specified in the general section of the experimental part in Chapter 1. Compounds 5, 7 and 
20 were prepared according to the synthetic procedures reported in the experimental section in 
Chapter 1. 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite 21 was obtained from 
commercial suppliers. Purified water with a resistivity ? 18 M? cm-1 was used for preparation 
of buffer solvents, a MARTIN CHRIST Alpha 2-4 freeze dryer was used for lyophilization 
and oligonucleotides were desalted with use of prepacked illustra NAP-5 columns from GE 
Healthcare and NH4OAc buffer (5 mM). Unmodified oligonucleotides were purchased from 
Metabion. 
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RP-HPLC 
RP-HPLC was performed with use of a Shimadzu instrument (Autosampler SIL-10AD, Pump 
module LC-10AT, Control unit SCL-10A, Mulit-diodearray detector SPD-M10A). For 
oligonucleotide analysis, a Supelcosil LC-318 column (250 mm x 4.6 mm), for semi-
preparative purifications a Supelcosil LC-318 column (250 mm x 10 mm, ID, 5 µm) were 
used. Solvents used: A) NH4OAc buffer (50 mM), pH 6.8; B) acetonitrile. Analytical 
separations were performed with a flow rate of 1.0 mL/min, semi-preparative separations 
were performed with a flow rate of 2.5 mL/min. Unless mentioned otherwise, 
oligonucleotides were detected by their absorption at 260 nm. 
 
DNA solid support synthesis 
Oligonucleotides were prepared on an Expedite 8909 Synthesizer from Applied Biosystems 
(ABI) using standard phosphoramidite chemistry on a 1 µmol scale. Reagents and controlled 
pore glass (CPG) were purchased from ABI and Glen Research. The concentration of the 
modified DNA building blocks was increased to 0.1 M (in MeCN) and the coupling time was 
extended to 6.3 min. Further details are given in the appendix. DNA 1a-c were cleaved from 
the resin and deprotected by treatment with concentrated NH4OH at r.t. for 18 h.  
 
Synthesis of oligonucleotides: Off bead coupling protocol and purification 
The 2’-modified uridine 19 was introduced into DNA by using standard coupling conditions, 
extended coupling time (6.3 min) and increased concentration of 0.1 M (in MeCN).The 
oligonucleotides were cleaved from the resin and deprotected by treatment with concentrated 
NH4OH solution at r.t. for 24 h. Compound 20 (1.5 mL, 10 mM), CuI (223.6 µL, 100 mM), 
TBTA (447 µL, 100 mM), each in DMSO/tBuOH (3:1), and sodium ascorbate (125 µL, 400 
mM) in H2O were added to the oligonucleotide (1µmol). The vial was vortexted, shaken for 
22 h at r.t., and then evaporated to dryness using a SpeedVac. NaOAc (100 µL, 0.15 mmol) 
was added, and the mixture was stored for 1 h at r.t. After EtOH precipitation, the 
oligonucleotides were dissolved in H2O (500 µL), desalted, dried and purified by RP-HPLC 
using the following conditions: A) NH4OAc buffer (50 mM), pH 6.8; B) acetonitrile; gradient 
0-15 % B over 45 min, flow rate 2.5 mL/min and lyophilized. The oligonucleotides were 
quantified in 10 mM sodium phosphate buffer by their absorbance at 260 nm using ?260nm = 
11000 M
-1
 cm
-1
 for X
2
, ?260nm = 13800 M-1 cm-1 for A, ?260nm = 10500 M-1 cm-1 for G, ?260nm = 
8000 M
-1
 cm
-1
 for T, ?260nm = 6500 M-1 cm-1 for C. ?260nm of the respective DNA strand: the 
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number of individual bases was multiplied with their respective extinction coefficients and 
added together. 
 
UV/Vis spectroscopy and melting temperature measurements of DNA 
Unless otherwise specified, spectroscopic measurements were performed at 20 °C and quartz 
glass cuvettes (Starna, 10 mm) were used. UV/Vis spectra were recorded with a Cary BIO 
100 UV/Vis/NIR spectrometer (Varian) with temperature-controlled 6x6 cuvette holder.  
 
Hybridization and melting temperatures 
Duplexes were formed by heating of the modified oligonucleotides (2.5 µM) in 10 mM 
sodium phosphate buffer (pH 7) and 250 mM NaCl in the presence of 1.2 eq. unmodified 
complementary strand to 90 °C (10 min), followed by slow cooling to r.t. Melting 
temperatures of the duplexes (20-90 °C, 0.7 °C/min, step width 0.5 °C) were recorded on a 
Varian Cary 100 spectrometer equipped with a temperature-controlled 6×6 cell changer unit. 
 
Light sources 
For irradiation experiments a UV hand-held lamp (Herolab, 6 W, ? = 312 nm), a UV hand-
held lamp (Faust, 2 x 4 W, ? = 366 nm), a mercury-vapor lamp (500 W) with interference 
filter (? = 367.55 nm, HW = 12.9 nm) and a Luxeon III Star high-power LED (? = 590 nm / 
amber) were used. 
 
Table 4.1. ESI-MS of modified oligonucleotide single strands (ss). 
ss DNA Sequence calcd. found 
DNA 1a 5’-GCA-GTC-TTX-TTC-ACT-GA-3’ 5390.0 1346.8 [M-4H
+
]
4-
, 
1796.1 [M-3H
+
]
3-
 
DNA 1b 5’-GCA-GTC-TAX-ATC-ACT-GA-3’ 5408.0 1351.3 [M-4H
+
]
4-
, 
1802.1 [M-3H
+
]
3-
 
DNA 1c 5’-GCA-GTC-TCX-CTC-ACT-GA-3’ 5360.0 1339.4 [M-4H
+
]
4-
, 
1786.2 [M-3H
+
]
3-
 
DNA 2 5’-GCA-GTC-TCX
2
-CTC-ACT-GA-3’ 5550.0 1387.4 [M-4H
+
]
4-
, 
1850.5 [M-3H
+
]
3-
 
DNA 3 5’-GCA-GTC-TTX
2
-TTC-ACT-GA-3’ 5580.0 1395.0 [M-4H
+
]
4-
, 
1860.1 [M-3H
+
]
3-
 
DNA 4 5’-GCA-GTC-TAX
2
-ATC-ACT-GA-3’ 5598.1 1399.3 [M-4H
+
]
4-
, 
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1866.5 [M-3H
+
]
3-
 
DNA 5 5’-GCA-GTC-TGX
2
-GTC-ACT-GA-3’ 5630.1 1407.5 [M-4H
+
]
4-
, 
1876.7 [M-3H
+
]
3-
 
 
 
2,2,2-trifluoro-N-((S)-2,3-dihydroxypropyl)acetamide 
 
N
H
OH
OH
O
F3C
 
 
A mixture of (S)-3-amino-1,2-propanediol (1.00 g, 10.98 mmol) and methyl trifluoroacetate 
(11.0 mL, 109.36 mmol) was stirred at room temperature for 24 hours. Following, the 
reaction mixture is concentrated in vacuo and residual solvent was coevaporated using 
toluene. 2,2,2-trifluoro-N-((S)-2,3-dihydroxypropyl)acetamide was obtained as gooey pale 
yellow oil (1.845 g, 90 %).  
 
The analytical data was consistent with the literature.
[15b, 16]
  
 
 
N-((S)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-hydroxypropyl)-2,2,2-
trifluoroacetamide 
 
N
H
ODMT
OH
O
F3C
 
 
A flask was charged with 2,2,2-trifluoro-N-((S)-2,3-dihydroxypropyl)acetamide (2.264 g, 
12.10 mmol), dry pyridine (36 mL) and 4,4’-dimethoxytriphenylmethyl chloride (4.093 g, 
12.08 mmol). The solution was degassed, dry NEt3 (2.0 mL) was added under nitrogen 
atmosphere and the reaction mixture was stirred in the dark at room temperature for 60 hours. 
Following, the solvents were removed under reduced pressure, EtOAc (150 mL) and an 
aqueous saturated NaHCO3 solution (150 ml) were added. The aqueous layer was extracted 
again with EtOAc, the organic layers were pooled and dried over anhydrous Na2SO4. The 
solvent was removed under reduced pressure and the crude product was purified by gradient 
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flash chromatography on silica gel (CH2Cl2 + 1 % NEt3 to CH2Cl2/MeOH 50:1 + 1 % NEt3) to 
afford the title compound as glistening pale yellow foam (5.515 g, 93 %). Rf = 0.10 (CH2Cl2 + 
1 % NEt3) 
 
1
H NMR (300 MHz, CDCl3): ? = 7.44-7.37 (m, 2 H, arom.), 7.32-7.26 (m, 7 H, arom.), 6.86-
6.82 (m, 4 H, arom.), 3.98-3.97 (m, 1 H), 3.79 (s, 6 H, 2 x OCH3), 3.67-3.56 (m, 1 H), 3.36-
3.21 (m, 2 H), 3.18-3.10 (m, 1H) - 
13
C NMR (75 MHz, CDCl3): ? = 158.7, 157.2, 149.7, 
136.1, 130.0, 129.2, 128.0, 127.1, 123.8, 113.3 (+, CH), 86.6, 68.9 (+, CH), 64.8 (-, CH2), 
55.2 (+, CH3, 2 x OCH3), 46.1 (-, CH2) 
 
 
(S)-1-amino-3-(bis(4-methoxyphenyl)(phenyl)methoxy)propan-2-ol 
 
H2N ODMT
OH  
 
A flask was charged with N-((S)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-
hydroxypropyl)-2,2,2-trifluoroacetamide (3.525 g, 7.21 mmol), MeOH (50 mL), THF (23 
mL) and capped with rubber septum. A solution of ammonia (50 mL, 25 wt %, in water) was 
added and the reaction mixture was stirred at room temperature in the dark for 24 hours. 
Following, the volatile solvents were evaporated under reduced pressure and afforded the 
mucous crude product. CH2Cl2 (60 mL) and water (40 mL) were added, the aqueous layer 
was extracted with CH2Cl2 (2 x 50 mL), the organic layers were pooled, and concentrated to a 
total volume of 50 mL. The organic layer was washed with brine (2 x 50 mL) and dried over 
anhydrous Na2SO4. The solvent was removed under reduced pressure to yield (S)-1-amino-3-
(bis(4-methoxyphenyl)(phenyl)methoxy)propan-2-ol as colorless fuzzy foam (2.530 g, 89 %). 
 
The analytical data was consistent with the literature.
[15b, 16]
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3',3'-Dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-3-propyl-4-
methylbenzenesulfonate 
 
N O
O
NO2
SO
O
 
 
3',3'-Dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol (532 mg, 
1.45 mmol) was dissolved in dry THF (8.0 mL) and dry pyridine (230 µL, 2.17 mmol) was 
added. The mixture was cooled to 0 °C and p-toluenesulfonyl chloride (414 mg, 2.17 mmol) 
was added in portions over 1 hour. The mixture was allowed to slowly warm up to ambient 
temperature and after 20 hours the solvents were evaporated under reduced pressure to give 
the crude product as yellow-brown oil. Purification by gradient flash chromatography on 
silica gel (Hexane/EtOAc 10:2 to 10:4) afforded 3',3'-Dimethyl-6-nitro-Spiro[2H-1-
benzopyran-2,2'-[2H]indole]-1'(3'H)-3-propyl-4-methylbenzenesulfonate as pale pink solid 
(68 mg, 9 %). Rf = 0.37 (Hexane/EtOAc 10:2) 
 
13
C NMR (150 MHz, CDCl3): ? = 150.8, 147.7, 146.4, 146.3, 138.7, 133.4, 132.4, 132.2, 
130.3, 128.3, 127.5, 126.6, 123.9, 123.6, 122.4, 122.0, 119.6, 108.8, 100.6, 62.7, 49.7, 40.2, 
27.2, 22.0, 21.7, 18.5 - MS (ESI): m/z (%): 521.2 (100) [MH
+
] 
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4-Nitrophenyl-2-(3’,3’-dimethyl-6-nitro-3’H-spiro[chromene-2,2’-indole]-1’-
yl)propylcarbonate 
 
N O
O
NO2
O
O
NO2  
 
A solution of 3',3'-Dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-
propanol (1.060 g, 2.89 mmol) in dry CH2Cl2 (22 mL) was cooled to 0 °C and dry DIPEA 
(2.2 mL, 12.94 mmol) was added under argon atmosphere. 4-Nitrophenylchloroformate 
(1.765 g, 8.76 mmol) was dissolved in dry dichloromethane (16.5 mL) and added in small 
portions over 3 hours. The reaction was slowly warmed up to ambient temperature, the 
solvent was evaporated and the crude product was dried over night under vacuum. The crude 
material was purified by flash chromatography on silica gel (Petrolether/EtOAc 2:1). 
Evaporation of the solvent afforded a pale pink solid that was repeatedly purified by flash 
chromatography on silica gel (Toluene). 4-Nitrophenyl-2-(3’,3’-dimethyl-6-nitro-3’H-
spiro[chromene-2,2’-indole]-1’-yl)propylcarbonate was triturated with Et2O and obtained as a 
pale yellow solid (1.436 g, 93 %). 
 
1
H NMR (400 MHz, CDCl3): ? = 8.28 (d, 2 H, J = 9.3 Hz, H-Ar), 8.05-7.98 (m, 2 H, H-Ar), 
7.34 (d, 2 H, J = 9.3 Hz, H-Ar), 7.20 (dt, 1 H, J = 1.3, 7.7 Hz, H-Ar), 7.11 (dd, 1 H, J = 0.9, 
7.3 Hz, H-Ar), 6.91 (t, 2 H, J = 8.6 Hz, H-Ar), 6.77 (d, 1 H, J = 8.8 Hz, H-Ar), 6.61 (d, 1 H, J 
= 7.7 Hz, H-Ar), 5.88 (d, 1 H, J = 10.3 Hz, H-Ar), 4.34 (dt, 2 H, J = 1.7, 5.9 Hz, CH2-propyl), 
3.44-3.28 (m, 2 H, CH2-propyl), 2.19-1.98 (m, 2 H, CH2-propyl), 1.30 (s, 3 H, CH3), 1.20 (s, 
3 H, CH3) - 
13
C NMR (100 MHz, CD2Cl2): ? = 162.0 (Cquat.), 159.9 (Cquat.), 156.0 (Cquat.), 
152.9 (Cquat.), 147.3 (Cquat.), 145.9 (Cquat.), 141.5 (Cquat.), 136.6 (Cquat.), 128.9 (+, CH), 128.2 
(+, CH), 126.5 (+, CH), 126.3 (+, CH), 125.7 (+, CH), 123.2 (+, CH), 122.3 (+, CH), 122.3 
(+, CH), 122.0 (+, CH), 120.2 (+, CH), 119.1 (Cquat.), 116.1 (+, CH), 115.9 (+, CH), 107.3 
(Cquat.), 107.0 (+, CH), 67.6 (-, CH2), 40.5 (-, CH2), 28.3 (-, CH2), 26.1 (+, CH3), 20.0 (+, 
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CH3) - IR (neat): ? [cm-1] = 2970, 2359, 1740, 1217 - MS (ESI): m/z (%): 532.3 (100) [MH+] 
- HRMS (PI-EI) calcd. for C28H25N3O8 [M
+.
]: 531.1642, found: 531.1639 
 
 
2-(3’,3’-dimethyl-6-nitro-3’H-spiro[chromene-2,2’-indole]-1’-yl)propyl-1H-imidazole-1-
carboxylate 
 
N O
O
NO2
O
N
N  
 
3',3'-Dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)-propanol (366 mg, 
1.00 mmol) was dissolved in dry dioxane (40 mL) and the purple solution was stirred for 1 
hour at room temperature in the dark. Following, 1,1’-carbonyldiimidazole (172 mg, 1.06 
mmol) was added and the mixture was stirred vigorously for 24 hours. Reaction control using 
TLC showed non-complete consumption of the starting material, 1,1’-carbonyldiimidazole 
(431 mg, 2.66 mmol) was additionally added. After 64 hours the solvent was evaporated, the 
crude product was dried and purified by gradient flash chromatography on silica gel 
(Hexane/EtOAc 2:1 to 1:1). 2-(3’,3’-dimethyl-6-nitro-3’H-spiro[chromene-2,2’-indole]-1’-
yl)propyl-1H-imidazole-1-carboxylate was triturated with Et2O and obtained as yellow solid 
(235 mg, 51 %). Rf = 0.29 (Hexane/EtOAc 1:1) 
 
1
H NMR (600 MHz, CDCl3): ? = 8.07 (dd, 1 H, J = 0.9, 1.3 Hz, imidazol, N=CH-N), 8.00 
(dd, 1 H, J = 2.7, 9.0 Hz, C7-H), 7.93 (dd, 1 H, J = 0.5, 2.7 Hz, C5-H), 7.33 (dd, 1 H, J = 1.3, 
1.7 Hz, imidazol, CH=CH-N), 7.19 (ddd, 1 H, J = 1.3, 7.6, 7.7 Hz, C7’-H), 7.10 (ddd, 1 H, J = 
0.4, 1.3, 7.7 Hz, C5’-H), 7.07 (dd, 1 H, J = 0.9, 1.7 Hz, imidazol, CH=CH-N), 6.90 (ddd, 1 H, 
J = 1.0, 7.3, 7.6 Hz, C6-H), 6.82 (d, 1 H, J = 10.3 Hz, C4-H), 6.74 (dd, 1 H, J = 0.5, 9.0 Hz, 
C8-H), 6.58 (ddd, 1 H, J = 0.5, 1.0, 7.7 Hz, C8’-H), 5.83 (d, 1 H, J = 10.3 Hz, C3-H), 4.51-
4.45 (m, 2 H, O-CH2-propyl), 3.45-3.36 (m, 1 H, -CH2-CH2-CH2-), 3.34-3.28 (m, 1 H, , -CH2-
CH2-CH2-), 2.25-2.16 (m, 1 H, N-CH2-propyl), 2.14-2.07 (m, 1 H, N-CH2-propyl), 1.30 (s, 3 
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H, CH3), 1.20 (s, 3 H, CH3) -
 13
C NMR (150 MHz, CDCl3): ? = 159.2 (Cquat., C6-NO2), 148.5 
(Cquat., imidazol-N-(C=O)-O), 146.5 (Cquat.), 141.1 (Cquat.), 136.9 (imidazol, N=CH-N), 136.0 
(Cquat.), 130.7 (imidazol, CH=CH-N), 128.3 (CH, C4-H), 127.8 (CH, C7’-H), 125.9 (CH, C7-
H), 122.7 (CH, C5-H), 121.9 (CH, C5’-H), 121.4 (CH, C3-H), 120.0 (CH, C6’-H), 118.2 
(Cquat.), 116.9 (imidazol, CH=CH-N), 115.5 (CH, C8-H), 106.5 (Cquat.), 106.5 (CH, C8’-H), 
65.9 (O-CH2-propyl), 52.6 (Cquat.), 40.1 (-CH2-CH2-CH2-), 27.7 (N-CH2-propyl), 25.9 (+, 
CH3), 19.9 (+, CH3) - IR (neat): ? [cm-1] = 2970, 2365, 1744, 1366 - MS (ESI): m/z (%): 
461.2 (100) [MH
+
] - HRMS (PI-EI) calcd. for C25H24N4O5 [M
+.
]: 460.1747, found: 460.1746 
 
 
[3',3'-Dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)]propyl-(S)-3-
(bis(4-methoxyphenyl)(phenyl)methoxy)-2-hydroxypropylcarbamate 
 
N O
O
NO2
O
HN
HO
ODMT  
 
Route 1: 
A solution of 4-Nitrophenyl-2-(3’,3’-dimethyl-6-nitro-3’H-spiro[chromene-2,2’-indole]-19-
yl)propylcarbonate (25 mg, 0.047 mmol) in dry DMF (5 mL) was cooled to 0 °C. Dry DIPEA 
(50 µL, 0.3025 mmol) was added under nitrogen and stirred for 5 minutes. (S)-1-Amino-3-
[bis-(4-methoxy-phenyl)-phenylmethoxy]-propan-2-ol (37 mg, 0.0941 mmol) was added 
under nitrogen and the reaction mixtures was stirred at 0 °C over 5 hours. The reaction was 
slowly warmed to room temperature. The reaction mixture was concentrated in vacuo and 
purified by gradient flash chromatography on silica gel (Petrolether/EtOAc 2:1 + 0.1 % 
DIPEA to 1:1 + 0.1 % DIPEA). The title compound was obtained as a pale pink solid (36 mg, 
97 %). Rf = 0.49 (Hexane/EtOAc 2:1 + 0.1 % DIPEA) 
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To a solution of 2-(3’,3’-dimethyl-6-nitro-3’H-spiro[chromene-2,2’-indole]-1’-yl)propyl-1H-
imidazole-1-carboxylate (132 mg, 0.287 mmol) in a 1:2 mixture of dry CH2Cl2/DMF (24 
mL), (S)-1-amino-3-[bis-(4-methoxy-phenyl)-phenylmethoxy]-propan-2-ol (169 mg, 0.430 
mmol) and 4-DMAP (36 mg, 0.295 mmol) were added under argon atmosphere. The reaction 
mixture was stirred at room temperature for 67 hours. Following, the reaction mixture was 
concentrated in vacuo and purified by preparative thin layer chromatography on silica gel 
(Hexane/EtOAc 2:1 + 0.1 % NEt3) to afford the title compound as pink foam (104 mg, 46 %).   
 
1
H NMR (400 MHz, CDCl3): ? = 8.05-7.93 (m, 2 H), 7.41 (d, 2 H, J = 7.3 Hz), 7.33-7.27 (m, 
6 H), 7.24-7.15 (m, 2 H), 7.09 (dd, 1 H, J = 0.8, 7.2 Hz), 6.90-6.81 (m, 6 H), 6.74 (d, 1 H, J = 
8.9 Hz), 6.57 (d, 1 H, J = 7.7 Hz), 5.84 (d, 1 H, J = 10.4 Hz), 4.96 (s, 1 H, OH), 4.15-4.01 (m, 
3 H), 3.90-3.83 (m, 1 H, CH-OH), 3.78 (s, 6 H, 2 x OCH3), 3.39 (s, 1 H, NH), 3.32-3.25 (m, 1 
H), 3.25-3.12 (m, 4 H), 2.01-1.92 (m, 1H), 1.90-1.83 (m, 1 H), 1.28 (s, 3 H), 1.18 (s, 3 H) - 
13
C NMR (100 MHz, CDCl3): ? = 159.5, 158.6, 146.9, 144.5, 141.0, 136.0, 135.7, 130.0, 
128.2, 128.0 (CH), 128.0, 127.8, 126.9, 125.9 (CH), 122.7 (CH), 121.7, 119.6 (CH), 118.5, 
115.5 (CH), 113.2 (CH), 106.7 (CH), 106.7 (CH), 86.3, 70.3, 70.3, 65.0, 64.9, 62.5, 60.4, 55.2 
(OCH3), 52.6, 44.1, 40.3, 31.5, 28.2, 28.2, 25.9 (CH3), 25.5, 21.0, 19.8 (CH3), 14.2 - MS 
(ESI): m/z (%): 786.4 (100) [MH
+
] - HRMS (PI-MS) calcd. for C46H47N3O9 [M
+.
]: 785.3312, 
found: 785.3325 
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[3',3'-Dimethyl-6-nitro-Spiro[2H-1-benzopyran-2,2'-[2H]indole]-1'(3'H)]propyl-(S)-3-
(bis(4-methoxyphenyl)(phenyl)methoxy)-2-O-(2-cyanoethyl-N,N 
diisopropylphosphoramidite)-propylcarbamate 
 
N O
O
NO2
O
HN
O
ODMT
P
O
NC
N
 
 
Compound (100 mg, 0.127 mmol) was dissolved in dry CH2Cl2 (5 mL). NEt3 (250 µL, 1.794 
mmol) and 2-cyanoethyl-N,N-Diisopropylchlorophosphoramidite (56.8 µL, 0.255 mmol) 
were added and the solution stirred for 11 h at room temperature. The solvents were 
evaporated in vacuo, CH2Cl2 was added, the solution was poured into aqueous saturated 
NaHCO3 solution and extracted with CH2Cl2 (2 x). The combined organic layers were dried 
over anhydrous Na2SO4, the solvent was evaporated and the remaining solid was purified by 
flash chromatography on silica gel (Petrolether/EtOAc 2:1 + 1 % NEt3). Following, the 
product was dissolved in benzene (3 mL) and lyophilized to yield the title compound (119 
mg, 95 %) as pale purple foam, which was dissolved in dry MeCN and applied directly for 
oligonucleotide synthesis. Instead of lyophilization, precipitation of the product from a 
solution in EtOAc by addition of hexane under vigorous stirring at -50 °C gave consistent 
results. Rf = 0.76 (Hexane/EtOAc 1:1 + 1 % NEt3) 
 
31
P NMR (121 MHz, CDCl3): ? = 149.9, 149.8 - MS (ESI, DCM/MeOH + 10 mmol/L 
NH4Ac): m/z (%) = 986.5 (62) [MH
+
], 303.2 (100) [DMT
+
]  
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5’-O-(tetraisopropyldisiloxane-1,3-diyl)-uridine 
 
O
O N
NH
O
O
O OH
Si
Si
O
 
 
A flask was charged with dry pyridine (75.0 mL) and uridine (3.629 g, 14.86 mmol). 1,3-
dichloro-1,1,3,3-tetraisopropyldisiloxane (5.23 mL, 16.35 mmol ) was added under nitrogen 
atmosphere and the reaction mixture was stirred at room temperature for 6 hours, followed by 
addition of EtOAc and aqueous saturated NaHCO3 solution. After stirring for 30 minutes, the 
mixture was poured into EtOAc, separated and the aqueous layer was extracted with EtOAc. 
The organic layers were pooled and dried over anhydrous MgSO4. The solvent was removed 
under reduced pressure and the crude product was purified by gradient flash chromatography 
on silica gel (CH2Cl2/acteone 6:1 to 3:1) to yield 5’-O-(tetraisopropyldisiloxane-1,3-diyl)-
uridine as a colorless foam (5.778 g, 80 %). 
 
The analytical data was consistent with the literature.
[31]
  
 
 
3’,5’-O-(tetraisopropyldisiloxane-1,3-diyl)-N
3
-pivaloyloxymethyl-uridine 
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To a solution of 5’-O-(tetraisopropyldisiloxane-1,3-diyl)-uridine (5.726 g, 11.78 mmol) in 
CH2Cl2 (250 mL), a solution of Na2CO3 (250 mL, 120 mmol) and tetrabutylammonium 
hydrogensulfate (1.004 g, 2.96 mmol) were added. The mixture was vigorously stirred at 
room temperature for 10 minutes, and pivaloyl chloride (14.51 mL, 117.81 mmol) was added 
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in one portion. The reaction mixture was stirred at room temperature for 48 hours, and was 
extracted with CH2Cl2 (2 x 200 mL). The aqueous layer was extracted with Et2O (2 x 100 
mL), the organic layers were pooled and concentrated to half volume, dried over anhydrous 
Na2SO4 and the solvents were removed under reduced pressure. Purification was performed 
by gradient flash chromatography on silica gel (CH2Cl2/MeOH 80:1 to 20:1), followed by 
trituration with a Et2O/CH2Cl2 mixture over night to yield 3’,5’-O-(tetraisopropyldisiloxane-
1,3-diyl)-N
3
-pivaloyloxymethyl-uridine as glistening colorless foam (4.949 g, 70 %).  
 
The analytical data was consistent with the literature.
[31]
  
 
 
3’,5’-O-(tetraisopropyldisiloxane-1,3-diyl)-N
3
-pivaloyloxymethyl-2’-O-propargyluridine 
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A solution of 3’,5’-O-(tetraisopropyldisiloxane-1,3-diyl)-N
3
-pivaloyloxymethyl-uridine 
(4.890 g, 8.15 mmol) in dry MeCN (50 mL) was cooled to 0 °C. Propargyl bromide (945 µL, 
10.60 mmol) and 2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-
diazaphosphorine (2.95 mL, 10.19 mmol) were added under nitrogen atmosphere and the 
reaction mixture was stirred at 0 °C for 30 minutes. Following, it was stirred at ambient 
temperature for 90 minutes, the solvent was evaporated under reduced pressure and dried over 
night in vacuo. The raw product was purified by gradient flash chromatography on silica gel 
(CH2Cl2/MeOH 200:1 to 100:1). Evaporation of the solvent yielded 3’,5’-O-
(tetraisopropyldisiloxane-1,3-diyl)-N
3
-pivaloyloxymethyl-2’-O-propargyl-uridine as colorless 
foam (1.560 g, 30 %). 
 
The analytical data was consistent with the literature.
[31]
  
 
 
 
Chapter 3  129 
N
3
-pivaloyloxymethyl-2’-O-propargyluridine 
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To a solution of 3’,5’-O-(tetraisopropyldisiloxane-1,3-diyl)-N
3
-pivaloyloxymethyl-2’-O-
propargyluridine (1.499 g, 2.35 mmol) in dry THF (25 mL), there was added NEt3
.
3HF (1.53 
mL, 9.39 mmol). This mixture was stirred at ambient temperature for 16 hours. Following, the 
mixture was poured into brine/CH2Cl2 (80 mL, v/v 1:1), separated and the aqueous layer was 
extracted with EtOAc (2 x 40 mL). The organic layers were pooled and dried over anhydrous 
Na2SO4. The solvents were removed under reduced pressure and the residue was purified by 
flash chromatography on silica gel (CH2Cl2/MeOH 8:1) to afford N
3
-pivaloyloxymethyl-2’-O-
propargyluridine as a colorless foam (642 mg, 69 %). 
 
The analytical data was consistent with the literature.
[31]
  
 
 
5’-O-dimethoxytrityl-N
3
-pivaloyloxymethyl-2’-O-propargyluridine 
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To a well stirred solution of N
3
-pivaloyloxymethyl-2’-O-propargyluridine (537 mg, 1.36 
mmol) in dry pyridine (18.0 mL) there was added 4,4’-dimethoxytriphenylmethyl chloride 
(551 mg, 1.63 mmol), followed by dry NEt3 (596 µL, 4.28 mmol) under nitrogen atmosphere. 
The reaction mixture was stirred for 16 hours at room temperature in the dark. The reaction 
mixture was evaporated to dryness to afford mucous orange oil. Following, the crude product 
was dissolved in a mixture of CH2Cl2 and brine. After separation, the aqueous layer was 
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extracted with EtOAc and the combined organic layers were dried over anhydrous Na2SO4. 
The solvents were evaporated under reduced pressure and purification by gradient flash 
chromatography on silica gel (Hexane/EtOAc 3:1 + 1 % NEt3 to 2:1 + 1 % NEt3) gave 5’-O-
dimethoxytrityl-N
3
-pivaloyloxymethyl-2’-O-propargyluridine as glistening white foam (873 
mg, 92 %). Rf = 0.15 (Hexane/EtOAc 3:1 + 1 % NEt3) 
 
The analytical data was consistent with the literature.
[31]
  
 
 
5’-O-dimethoxytrityl-N
3
-pivaloyloxymethyl-2’-O-propargyluridine-3’-O-(2-cyanoethyl-
N,N-diisopropylphosphoramidite) 
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5’-O-dimethoxytrityl-N
3
-pivaloyloxymethyl-2’-O-propargyluridine (200 mg, 0.287 mmol) 
was co-evaporated with anhydrous acetonitrile (2 x) and dry CH2Cl2 (8.0 mL) was added. 
Anhydrous NEt3 (250 µL, 1.794 mmol) was added and the solution was degassed. Following, 
2-cyanoethyl-N,N-Diisopropylchlorophosphoramidite (141 µL, 0.632 mmol) was added under 
argon atmosphere and the solution stirred for 4 h at room temperature. Since TLC did not 
show complete reaction, additional NEt3 (250 µL, 1.794 mmol) and 2-cyanoethyl-N,N-
Diisopropylchlorophosphoramidite (1.0 eq.) were added. The reaction mixture was stirred at 
ambient temperature for 1 hour. Next, the solvents were evaporated under reduced pressure, 
CH2Cl2 was added to the residue and the solution was poured into aqueous saturated NaHCO3 
solution. The organic layer was dried over anhydrous Na2SO4, the solvent was evaporated and 
the remaining solid was purified by flash chromatography on silica gel (Petrolether/EtOAc 
3:2 + 1 % NEt3). The pure fractions were concentrated under reduced pressure, then dissolved 
in EtOAc and hexane was added under vigorous stirring at -50 °C to precipitate the title 
compound as colorless crystals (240 mg, 93 %). Rf = 0.32 (Hexane/EtOAc 3:2 + 1 % NEt3) 
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The analytical data was consistent with the literature.
[31]
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Chapter 4:  
An alternative postsynthetic methodology for DNA labeling and new compositions of 
versatile building blocks for oligonucleotide chemistry 
 
4.1. Introduction  
 
4.1.1. DNA labeling 
Three generic synthetic approaches serve for the directed covalent modification of 
oligonucleotides. First of all, the triphosphates of appropriate compounds can be synthesized 
and then incorporated with use of polymerases into DNA.[1] Second, the desired DNA 
modifications can be prepared separately with use of phosphoramidite chemistry and 
incorporated into DNA on solid support as subset building blocks using a DNA synthesizer 
(Scheme 1.1, Route a).[2] However, if by any means the phosphoramidite of the desired label 
or probe is hardly accessible due to synthetic challenges that may arise from its instability in 
terms of DNA synthesis conditions, a third method can be selected (Scheme 1.1, Route b).  
 
 
Figure 1.1. Schematic illustration for directed synthesis of modified oligonucleotides using 
phosphoramidite and postsynthetic pathways 
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4.1.2. Postsynthetic methods 
This method can generally be described as a postsynthetic approach,[3] although it fans out to 
different techniques. A subdivision can be made with respect towards the time when the 
modification is introduced into the DNA; either if the synthesized oligonucleotide is still 
attached to the CPG (“On bead labeling”) or if the label is linked after deprotection and 
cleavage of the oligonucleotide to the latter (“Off bead labeling”).   
These subdivisions can be further discriminated, particularly by taking temporal aspects into 
account, e.g., successive introduction of several labels using the phosphoramidite method has 
been described,[4] as well as blending with sequential on bead Pd-catalyzed Sonogashira 
cross-coupling reactions with ethynylpyrene.[5] On and off bead labeling was expanded by use 
of specific deprotection steps that can be used to label oligonucleotides via modular 
protocols.[6] Although, it is not illustrated in particular in Figure 1.1, it should also be 
mentioned that utilization of the temporal final detritylation step can offer further advances, 
especially with regard to purification and sample workup.[2c, 7]  
 
4.1.3. CuAAC for DNA labeling 
However, the postsynthetic modification of oligonucleotides allows the covalent linkage of 
molecules in a bioorthogonal fashion. Since alkyne and azide  groups typically are not present 
in oligonucleotides and react regioselectively under Cu(I) catalysis by regioselective 
formation of 1,4-substituted 1,2,3-triazoles,[8] the click reaction (CuAAC) matches the 
requirements for bioorthogonality.[9] Further details on CuAAC are introduced and discussed 
in Chapter 2.  
 
DNA
N N N R
N
N
N
DNA
R
"Cu(I)"
 
Scheme 1.1. CuAAC of DNA and azide compound 
 
Especially for labeling and modification of DNA, click chemistry depends on an azide group 
of the modifier that reacts with a presynthesized oligonucleotide carrying terminal alkyne 
groups.[6, 10]  With this approach the time consuming synthesis of phosphoramidites as DNA 
building blocks can be avoided. Interestingly, off bead click chemistry has been used for 
efficient and rapid interstrand cross-linking,[11] intrastrand circularization and catenation[12] as 
well as directed formation of either duplex or triplex DNA.[13] Also, 5’-functionalizations of 
oligonucleotides on solid support into azides[14] as well as microwave-assisted Cu(I)-catalyzed 
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cycloadditions using postsynthetic off bead labeling have been reported.[15] The merging of 
5’-azidation and CuAAC assisted by microwaves has culminated in new strategies for the 
synthesis of oligonucleotides incorporating alkyne-groups and galactosyl azide derivatives[16] 
as well as cyclic and bicyclic oligonucleotides.[17] 
 
 
 
Scheme 1.2. DNA-directed CuAAC reactions. DNA circularization and catenation[12] (left) 
and control of duplex and triplex DNA (right).[13] 
 
However, the published click-type modifications of oligonucleotides with functional ?-
systems are limited to reactions between azide groups as part of the modifying molecule and 
acetylene groups as part of the oligonucleotide.[10, 18] Remarkably, this methodology has been 
successfully commercialized by baseclick GmbH, and Invitrogen Corporation within the 
framework of Click-iT® detection assays using EdU and fluorescent azides.[19]  
 
O
HO N
NH
O
O
HO
 
 
Figure 1.2. EdU (top), and fluorescence microscopy images (bottom) of NIH3T3 cells 
labeled with EdU and successively reacted with Alexa488 and Alexa594-azide.[19]  
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Based on the aforementioned methodologies for DNA modification, we present three different 
approaches. Foremost, first examples of a new, alternative postsynthetic method are 
expounded: this on bead labeling system allows the click reaction of ethynyl-modified labels 
with an azide group in the 5-position of 2’-deoxyuridine that was formed in situ from a 
presynthesized oligonucleotide in one step. We also present the synthesis of a quinolinol 
derivative as potential metallobase nucleic acid modification and preliminary results after 
successful click conjugation to DNA by using off bead labeling. In the last section, the 
synthesis and optical properties of a new photoswitchable spirobenzopyran nucleoside that 
can be used for the triphosphate approach are showcased. 
 
 
4.2. Results and Discussion  
 
4.2.1. An alternative postsynthetic route for DNA labeling 
Since the demand for labeled oligonucleotides is rapidly growing, we wanted to develop a 
new alternative method for labeling DNA that would expand the use of the bioorthogonal 
click strategy. Therefore, it seemed to be reasonable to upturn the existing methods that have 
been described before. This complementary access would then complete the postsynthetic 
repertoire of labeling techniques involving CuAAC. In our opinion, a very good and 
reasonable way to parlay this method was to use a postsynthetic approach involving on bead 
labeling due to the advances solid-phase synthesis entails (e.g., excess of reagents, easy 
washing, unified manipulation of small quantities) and to circumvent chemical stability issues 
of the azides during DNA synthesis and workup.[20]  
 
4.2.1.1. Synthesis of nile red and 3-Ethynylperylene 
To test the functionalization of oligonucleotides with our reverted click approach, we chose 2-
Ethynyl nile red 1 and 3-Ethynylperylene 2 as chromophores (Figure 2.1). They were 
prepared in five and three steps with an overall yield of 39 %, and 88 % respectively. The 
synthetic steps are discussed in detail in Chapter 2. 
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Figure 2.1. 2-Ethynyl nile red and 3-Ethynylperylene 
 
4.2.1.2. In situ azide formation and click reaction 
At the beginning the procedure starts with the synthesis of the oligonucleotide for DNA UI, 
bearing 5-iodo-2’deoxyuridine (IdU) in the middle of the sequence. Although, the respective 
phosphoramidite of IdU is commercially available, it can be synthesized in two synthetic 
steps, starting from IdU 3. Protection at the 5’-OH position with use of a standard protocol 
afforded the tritylated compound 4 in 94 % yield. In the next step, phosphitylation of 4 with 
2-cyanoethyl-N,N-diisopropylchlorophosphoramidite gave compound 5 as the desired 
phosphoramidite building block. 
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Scheme 2.1. Synthesis of 5-IdU-Phosphoramidite 5. Reagents and conditions: a) DMTCl (1.2 
eq.), NEt3 (3.1 eq.), pyridine, r.t., 24 h, 94 %; b) 23 (3.3 eq.), NEt3 (14.1 eq.), CH2Cl2, r.t., 1 h, 
92 %. 
 
However, 5 was introduced into DNA by using standard coupling conditions (Scheme 2.2, 
DNA U
I). Subsequently, the oligonucleotide (1 µmol) was treated on solid support with an 
excess of sodium azide (200 µmol) in DMSO to yield in situ the 5-azidooligonucleotide 
which has been described as photoaffinity label.[20a, 21] After the nucleophilic displacement of 
the iodine group by azide, a washing step was performed, and the azido-oligonucleotide was 
coupled with the ethynyl nile red compound 1, or perylene derivative 2 respectively, in the 
presence of Cu(I).  
138  Chapter 4 
G C A G T C A A X A A C A C T G A5' 3'
O
O N
HN
O
O
X =
DNA UI (single strand)
O
I
O
O N
HN
O
O
X =
O
N
N
O
O
NEt2
1. NaN3
G C A G T C A A X A A C A C T G A5' 3'
2. Cu(I), TBTA
     Ascorbate
       1 or 2   
    DMSO/tBuOH 3:1
      r.t., 10 h
N
N
DNA 1
DNA 1Per
55 °C, 1 h
 
 
Scheme 2.2. Postsynthetic protocol for the preparation of the nile red modified DNA 1 and 
Perylene modified DNA 1Per 
 
At this point the boon of our alternative approach is evident: an additional and outstanding 
benefit of click chemistry on solid phase is that conjugates can be prepared on the synthesis 
columns (or Eppendorf cups and assimilable devices) so that excess of expensive acetylene 
tags can be readily recovered prior to oligonucleotide deprotection. Finally, the 
oligonucleotides were cleaved from the solid support and deprotected under very mild 
conditions (NH4OH, r.t., 18 h), desalted and analyzed by HPLC and mass spectrometry. 
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Image 2.1. Visual representation of Sephadex gel filtration of DNA 1 (left) and DNA 1Per 
(right). 
 
Interestingly, the overall yield for the postsynthetic ligation to DNA 1 is 10 % compared to 
the phosphoramidite building block approach that was used for DNA 2 in comparison,[4a, 22] 
whereas the amount of purified perylene labeled DNA 1Per was sufficient enough for 
detection with HPLC-DAD (Figure 2.2) where two distinctive absorption bands of the 
conjugated perylene moiety are observable (?abs = 431 and 457 nm). Regardless, the 
successful conjugation of nile red 1 and perylene 2 to the oligonucleotides was also verified 
by ESI mass spectrometry. 
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Figure 2.2. Normalized UV/Vis absorption spectrum of DNA 1Per (absorbance during HPLC 
25.29-26.26 min). 
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4.2.1.3. Optical properties of nile red labeled DNA 
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Scheme 2.3. Comparsion of duplexes DNA 1A and DNA 2A. 
 
Both, the single stranded DNA 1 and the duplex DNA 1A show clearly the presence of the 
covalently attached nile red chromophore by a peak at ca. 610 nm. By excitation at 610 nm 
the steady state fluorescence exhibits a broad signal with a maximum at 658 nm and a 
quantum yield of 29 % in the single strand and 31 % in the duplex. It is interesting to observe 
that the optical properties of DNA 1A are very similar in comparison with DNA 2A[4a] 
bearing the nile red dye attached via an ethynyl linker to 2’deoxyuridine (Table 2.1). 
Remarkably, the quantum yield of DNA 1A is significantly higher than that of DNA 2A.  
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Figure 2.3. UV/Vis absorption spectra (left) and fluorescence spectra (right) of the single-
stranded DNA 1 and the corresponding double-stranded DNA 1A, each 2.5 µM in NaPi buffer 
(10 mM), NaCl (250 mM), ?exc = 610 nm. 
 
The melting temperature of DNA 1A is 58.1 °C, whereas the thermal stability for DNA 2A is 
slightly lower (57.1 °C). Compared to the unmodified duplex (X = T), the Nile Red modified 
duplex DNA 1A including the triazolyl liker destabilizes the duplex by 2.1 °C, whereas DNA 
2A destabilizes the duplex by 3.6 °C. This indicates that the aromatic triazolyl bridge of the 
nile red conjugation in DNA 1A is able to regain more of the lost thermal stability by 
aromatic interactions with the adjacent base pairs.  
 
 DNA 1A DNA 2A[4a] 
?max (Absorption)/nm 612 (ss) 615 (ss) 
 608 (ds) 615 (ss) 
?/104 M-1cm-1 2.0 (ss) 2.6 (ss) 
 2.8 (ds) 2.5 (ds) 
?max (Emission)/nm 658 (ss) 658 (ss) 
 659 (ds) 665 (ds) 
?Fa 0.29 (ss) 0.20 (ss) 
 0.30 (ds) 0.10 (ds) 
Tm
b
/°C (?Tm/°C)c 58.1 (-2.6) 57.1 (-3.6) 
Table 2.1. Comparison of the optical data of DNA 1A and DNA 2A. a Determined with cresyl 
violet as the standard, ?F = 0.54; b Tm measured at 260 nm; c In comparison to unmodified 
reference duplex (X = T), Tm = 60.7 °C. 
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Moreover, we carried out calculations of the LUMOs of both nile red modified nucleosides. 
For geometry optimization, calculations using MMFF were performed that minimize 
distortion from parameterized ideal bond distances and angles. MMFF also was used to 
optimize geometry with respect to Coulombic and non-bonded van der Waals interactions. 
After full geometry optimization, the LUMOs were then calculated with use of the semi-
empirical AM1 method. Interestingly, since the linkage of the fluorophore to the 
oligonucletide is a critical issue for the resulting optical properties, the results of the 
calculations indicate that both bridges lead to largely delocalized orbitals and to exciplex-like 
states that show unstructured, solvent-dependet fluorescent bands. 
 
 
 
Figure 2.4. Calculated LUMOs for the isolated nile red modified 2’-deoxyuridine of DNA 1A 
(left) and DNA 2A (right). 
 
Further investigations with respect towards improved azidification yields and cleavage 
conditions are performed at present. Nevertheless, the method showcased herein can be 
further expanded as illustrated in Scheme 2.4. There, an oligonucleotide is equipped with 
building blocks bearing acetylene and iodo groups. The oligonucleotide is then subjected 
under typical click conditions with the desired labeling molecule bearing an azide group, 
followed by straightforward in situ azide formation (Step a). In the next step the azide is 
subjected with an acetylene modified label, again under click conditions on solid support 
(Step b). Final deprotection then affords the sequentially labeled oligonucleotide (Step c).  
 
 
Scheme 2.4. Illustration of sequential click labeling 
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4.2.2. Enhancements for the synthesis of metal-containing DNA by postsynthetic off 
bead labeling with quinolinol  
Since the incorporation of metal complexes into oligonucleotides is a key design target for the 
functionalization of DNA creating new binding motifs in duplex DNA,[23] our approach 
focused on the incorporation of a bidentate quinolinol moiety. These metallobases are 
expected to be used for the control of distinct properties in DNA through the addition or 
removal of selected metal ions, e.g. two 8-hydroxyquinolinne ligands can coordinate a central 
Cu2+ ion in a square planar fashion.[24] Specifically, our approach involves the synthesis of 
quinolinol derivatives bearing azido-groups, followed up by CuAAC with an alkyne-bearing 
oligonucleotide using off bead labeling.   
 
4.2.2.1. Synthesis of Azido-Quinolinol 
Being an exceptionally strong bidentate ligand for various transition metal ions and due to its 
extended hydrophobic aromatic surface,[24] quinolinol was chosen as a promising candidate 
for prospective metal-mediated interstrand binding studies. E.g., charge transfer processes 
have been described with 8-hydroxyquinoline and its derivatives, chelating Cu(II), Ni(II) and 
Zn(II)[25] and are therefore also of interest for oligonucleotide chemistry.   
5-nitroquinolinol can be prepared by direct nitration of 8-hydroxyquinoline 6 using nitrating 
mixture, but the reaction results in a mixture of the desired product, its 7-nitro isomer and the 
5,7-dinitro derivative.[26] Thus, a two step method for the synthesis of the nitro compound was 
chosen. Therefore, nitrosation of compound 6 using sodium nitrite in dilute sulphuric acid 
afforded 7 in excellent yield.[27] Subsequently, oxidation of 7 gave the nitro compound 8 in 
good yield (81 %) as a brown-yellow solid.[28] The aromatic amine 9 was then synthesized by 
hydrogenation of the nitro group. Therefore, 8 was reduced in a mixture of ethyl acetate and 
methanol using palladium on activated charcoal under H2 atmosphere. Addition of Celite and 
use of EDTA as a competing ligand then helped to efficiently remove the catalyst from the 
reaction mixture, and compound 9 was obtained in 95 % yield. Diazotization of 9 followed by 
reaction with sodium azide in situ gave compound 10 after simple extraction with diethyl 
ether in 30 % yield, similar to the literature (32 %).[29] To prevent complexation of copper 
ions during click synthesis we additionally protected 5-azido-quinolinol 10 in the last step as 
TBDMS ether by treatment with 1.2 eq. TBDMSCl in the presence of 1.4 eq. imidazole, 
leading to compound 11 in 87 % yield.  
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Scheme 2.5. Synthesis of Azido-Quinolinol. Reagents and conditions: a) NaNO2 (1.1 eq.), 
H2O, H2SO4, 95 %; b) NaOH (1.3 eq.), H2O2 (1.5 eq.), 70 °C, 1 h, 81 %; c) H2, Pd/C, 
MeOH/EtOAc, 95 %; d) NaNO2 (1.9 eq.), H2O, HCl, NaN3 (2.4 eq.), 3 h, 3 °C to r.t., 18 h, 30 
%; e) TBDMSCl (1.2 eq.), imidazole (1.4 eq.), CH2Cl2, r.t., 69 h, 87 %. 
 
4.2.2.2. Click reaction of Azido-quinolines with alkyne-modified oligonucleotides 
In order to prepare the quinolinol-conjugated oligonucleotides we performed CuAAC with 
both quinolinol azides 10 and 11 and presynthesized DNA bearing the terminal alkyne group. 
The alkyne component in the DNA was inserted by using the 2’-propargyl modified building 
block 12 that was prepared and incorporated into DNA as described in Chapter 3. For 
effective incorporation of the phosphoramidite 12, the concentration was increased (0.1 M) 
and the coupling time was extended (6.3 min). After preparation, the oligonucleotide was 
cleaved from the resin and deprotected by treatment with conc. NH4OH at room temperature 
for 22 hours. 
 
O
DMTO N
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O
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Figure 2.5. Building block for DNA click reactions. 
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For the click ligations the presynthesized oligonucleotides were treated with azide 10 or 11 in 
the presence of Cu(I), TBTA and sodium ascorbate in a solvent mixture (DMSO/tBuOH/H2O) 
at room temperature for 16 hours. Finally, the oligonucleotides were desalted, analyzed by 
HPLC and identified by ESI mass spectrometry. Remarkably, the click reaction with azide 11 
did not give the desired product. There, the unmodified oligonucleotide strand bearing the 
alkyne group remained unreacted, which may be due to the steric hindrance by the bulky 
TBDMS group. On the other hand, the unprotected quinolinol azide 10 gave DNA 3 and was 
identified by ESI mass spectrometry as [M+3H++Na+]4+. Notably, we also observed the 
oligonucleotide mass with addition of copper as in [M+2H++Na++Cu+]4+. However, it is a 
relevant finding that the click reaction worked well with the quinolinol azide 10. Though, our 
observations obtained by mass spectrometry indicate the complexation of a copper ion that is 
supposed to result from the previous copper catalyzed click reaction. However, to obtain the 
copper-free oligonucleotide with the alkyne-modified uridine moiety further investigations 
can be carried out with ion depletion by addition of EDTA.  
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Scheme 2.6. DNA 3, bearing a quinolinol modification. 
 
Our preliminary study of the optical properties with the modified oligonucleotide DNA 3 was 
carried out with use of HPLC-DAD. There, the purified DNA 3 displays strong absorption 
that is predominated by the DNA heterocycles, however, the absorption band at ?abs = 383 nm 
also clearly reveals the presence of the covalently linked quinolinol modification. 
Interestingly, a significant bathochromic shift is observed when compared with the azido-
quinolinol 10 (?abs = 339 nm) as displayed in Figure 2.6, which may be attributed to charge-
transfer processes upon copper chelation in DNA 3. 
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Figure 2.6. Normalized UV/Vis absorption spectra of 10 and purified DNA 3. 10 (red): in 
MeOH (10 µM); DNA 3 (black): absorbance of DNA 3 during HPLC (25.03-25.88 min). 
 
Hence, based on these results quinolinol can be used for prospective studies with 
complementary oligonucleotide strands, entailing investigations on definite metal 
complexation in the interior of duplexes as well as metal-mediated triplex formation by 
conjugation of quinolinol to alkyne-modified DNA bases like EdU. This method will allow a 
structurally defined arrangement of metal ions along the DNA periphery without interruption 
of Watson-Crick base pairing through hydrogen bonding.  
 
 
4.2.3. A new photoswitchable nucleoside bearing a spirobenzopyran 
In the following section an efficient and straight-forward synthesis of the photoswitchable 
nucleoside 22 is presented (Figure 2.7). To avoid long alkyl linkers and to maintain canonical 
base pairing of 2’deoxyuridine for further applications,[1b, 22] the spirobenzopyran 
modification was attached via a rigid acetylene linker at the C-5 position. Hence, Sonogashira 
reactions were investigated for the coupling between the alkyne functionalized 
spirobenzopyran and the halogenated nucleobase or vice versa.   
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Figure 2.7. Spirobenzopyran nucleoside 22 
 
4.2.3.1. Synthesis of spirobenzopyran nucleoside  
During the previously described investigation on the synthesis of spirobenzopyrans it was 
found that under ultrasonic conditions good yields were obtained, accompanied with a 
significant decrease of the reaction time compared to standard reaction conditions (see 
Chapter 1). With a reasonable amount of 5-ethynyl-salicylaldehyde 14 in hand, 15 was 
prepared. The reaction of freshly distilled Fischer base 13 with 14 (1.0 eq) under ultrasonic 
irradiation conditions in EtOH for 1 hour gave the corresponding N-methyl-spirobenzopyran 
15, which was isolated in 76 % yield as pale blue foam. The 6-bromo compound 18 was 
prepared from the indolium iodide 16 and 17 with addition of excess triethylamine under 
ultrasonic conditions in EtOH and obtained as a pale pink solid in assimilable yield (77 %). 
The synthesis for EdU 21 started from 5-iodo-uridine compound 19 with a Sonogashira cross-
coupling reaction with excess of ethynyltrimethylsilane, while Pd(PPh3)4 and copper iodide 
were used as catalysts. The TMS-protected product 20 was obtained in good yield and 
consequent desilylation went smoothly by using a solution of Bu4NF in MeOH to provide 21 
as colorless foam (82 %). 
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Scheme 2.7. Synthesis of 15, 18 and EdU. Reagents and conditions: a) EtOH, US, 53 min, 76 
%; b) NEt3 (1.3 eq.), EtOH, US, 2 h, 77 %; c) (CH3)3SiCCH (9.0 eq.), Pd(PPh3)4 (10.5 mol-
%), CuI (20.7 mol-%), DMF, NEt3, r.t., 4 h, 85 %; d) Bu4NF (9.7 eq.), MeOH, r.t., 2 d, 82 %. 
 
With a quantity of the spirobenzopyrans 15 and 18 in hand, the Sonogashira cross-coupling 
was performed subsequently in various ways. First, 5-iodo-2’-deoxyuridine 19 and 
spirobenzopyran 15 were heated at 55 °C for 3 hours in triethylamine in the presence of 
Pd(PPh3)2Cl2 (3 mol-%) and CuI (5 mol-%) as catalysts to provide nucleoside 22 in a yield of 
27 %. However, the reaction of EdU 21 with the spirobenzopyran 18 under similar reaction 
conditions gave product 22 in 24 %. Interestingly, a better cross-coupling efficiency was 
observed with increased amounts of catalysts, 15 and 5-iodo-2’-deoxyuridine 19 were 
dissolved in a mixture of DMF and triethylamine with a relatively high amount of 
Pd(dppf)Cl2 (17 mol-%) and CuI (22 mol-%), and the reaction was carried out at room 
temperature for 26 hours. Thus, the desired nucleoside compound 22 was isolated after 
column chromatography in 67 % yield.  
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Scheme 2.8. Synthesis of spirobenzopyran nucleoside 22. Reagents and conditions: a) 15 (1.2 
eq.), Pd(dppf)Cl2 (17 mol -%), CuI (22 mol-%), DMF, NEt3, r.t., 26 h, 67 %; b) 18 (1.2 eq.), 
Pd(PPh3)2Cl2 (4 mol-%), CuI (5 mol-%), 60 °C., 3 h, 24 %. 
 
4.2.3.2. Optical properties of spirobenzopyran nucleoside  
The synthesized spirobenzopyran nucleoside 22 was investigated with respect to its 
photoswitchable properties using UV/Vis spectroscopy. As shown in Figure 2.8, 22 displays 
photochromic switching properties. After irradiation of the sample with visible light using an 
amber high-power output LED for 2 minutes, only little absorption in the visible range is 
detectable. Upon irradiation with UV light (? = 312 nm) for 2 minutes an increase in the 
visible range is observed. 
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Figure 2.8. UV/Vis absorption spectra of SP- and MC-form interconversion of 22 in MeOH 
(100 µM) at r.t.; black: irradiated with Vis, blue: after 2 min irradiation with 312 nm, red: 
after 3 min irradiation with 312 nm. 
 
The significant formation of the MC-form is also observable by eye, since the former 
colorless solution turns magenta-red upon UV irradiation. Further irradiation of the sample 
for 1 minute only leads to little increase, then the absorption maximum (?abs = 589 nm) does 
not show any further increase, when the irradiation with the UV source is continued. This can 
be explained as a result of the experimental setup itself, since under the employed irradiation 
conditions a constant equilibrium between the SP- and the MC-isomers is reached. When this 
state is established it can be retained by UV irradiation. When the irradiation is abandoned 
thermal formation of the SP-form is observed. 
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Figure 2.9. UV/Vis absorption spectra of MC- and SP-form thermal interconversion of 22 in 
MeOH (100 µM) at r.t.; black: after 30 sec irradiation with 312 nm, others: decline followed 
each 2 sec.  
 
Figure 2.9 displays the thermal interconversion of the nucleoside compound 22. First, the 
sample was irradiated with UV light (? = 312 nm) for 30 seconds and the UV/Vis spectrum 
was measured (black spectrum, ?abs = 589 nm). The sample was left in the spectrometer and 
after 2 seconds the next spectrum was recorded (red line). The insert shows the decrease at 
?abs = 589 nm, which relates to the degeneration of the MC-form and back-formation of the 
SP-form. Interconversion of the MC-form to the SP-form is even faster when using the Vis 
high-power output LED, respectively. For further insight of the photoswitching properties of 
22, time-resolved absorption spectroscopy and fluorescence measurements at the 
photostationary state can be considered. 
 
 
4.3. Conclusion 
 
In conclusion, the in situ azide formation and click conjugation of fluorescent labels (nile red 
and perylene) with DNA as an alternative postsynthetic method was described. Using 
CuAAC, the ethynyl-modified chromophores were conjugated with an azido group that is 
formed in situ by treatment of presynthesized oligonucleotides incorporating 5-iodo-2’-
deoxyuridine with sodium azide on solid support. The method benefits from the advances of 
solid support synthesis using postsynthetic on bead labeling and completes the repertoire of 
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click reactions for the modification of DNA by providing a complementary access. In case of 
the nile red modified oligonucleotide, comparison of optical properties of the triazolyl and 
rigid acetylene conjugated DNA revealed remarkably similar optical properties, avoiding 
decoupling of the chromophore from the DNA base. Additionally, the method can be very 
useful for nucleic acid chemists since a lot of interesting labels are typically provided with 
ethynyl groups, with intended use for functional ?-systems, and due to commercial 
accessibility of halogenated precursors as DNA building blocks.     
In the present chapter a convenient synthesis of an oligonucleotide containing a quinolinol 
moiety at a modified uridine was also presented. Therefore, azido-quinolinol derivatives were 
prepared and incorporated into DNA using off bead labeling by click chemistry. With use of 
the bioorthogonal click reaction, 5-azido-8-hydroxy-quinolin was successfully conjugated to 
the oligonucleotide. For further applications, the quinolinol modification can be used for 
metal-mediated interstrand binding, catalysis and complex, self-assembled supramolecular 
arrangements of DNA.  
Furthermore, an efficient method has been developed for the synthesis of a spirobenzopyran 
nucleoside, as photoswitchable 2’-deoxyuridine derivative. The method features build up of 
the spirobenzopyran unit with use of ultrasonic irradiation, followed by Sonogashira cross-
coupling reaction with 5-iodo-deoxyuridine to form the new spirobenzopyran nucleoside, 
respectively. For the employed cross-coupling conditions, the Pd(dppf)Cl2 catalyst was found 
superior to the more commonly used Pd(PPh3)2Cl2. The synthesized nucleoside displays 
reversible switching between its SP- and MC-form by irradiation with UV or Vis light, 
respectively. The switching process from the MC- to SP-form is also accompanied by thermal 
interconversion. These optical properties of the nucleoside are of interest for new approaches, 
e.g. by using reversible photo-modulation on a molecular level in primer extension 
experiments.  
 
 
4.4. Experimental Section 
 
General 
Conferrable details on reagents, solvents, reaction processing, chromatography, NMR, IR, MS 
and RP-HPLC are specified in the general section of the experimental part in Chapter 1 and 
Chapter 3. Compounds 13, 14 and 16 were prepared according to the synthetic procedures 
reported in the experimental section in Chapter 1. Compounds 1, 2 and TBTA were prepared 
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according to the synthetic procedures reported in the experimental section in Chapter 2. 
Compound 12 was prepared according to the synthetic procedure reported in the experimental 
section in Chapter 3.  2-cyanoethyl-N,N-diisopropylchlorophosphoramidite 23 was obtained 
from commercial suppliers. Data on the duplex DNA 2A and its respective modified single 
strand has been published in the literature.[4a] Unmodified oligonucleotides were purchased 
from Metabion. Purified water with a resistivity ? 18 M? cm-1 was used for preparation of 
buffer solvents, a MARTIN CHRIST Alpha 2-4 freeze dryer was used for lyophilization. 
Further details on DNA solid support synthesis are listed in Chapter 3 and in the appendix. 
Synthetic steps involving azides were performed in the dark. Reagents and controlled pore 
glass (CPG) were purchased from ABI and Glen Research. Mass spectra of the purified 
oligonucleotides were recorded at the University of Regensburg, Zentrale Analytik 
Massenspektrometrie, with a ThermoQuest Finnigan TSQ 7000 in negative and positive 
ionization mode. 
 
UV/Vis and fluorescence spectroscopy 
Unless otherwise specified, spectroscopic measurements were performed at 20 °C and quartz 
glass cuvettes (Starna, 10 mm) were used. UV/Vis spectra were recorded with a Cary BIO 50 
and Cary BIO 100 UV/Vis/NIR spectrometer (Varian).  
 
Synthesis of oligonucleotides: On bead coupling protocol and purification 
Oligonucleotides were prepared on an Expedite 8909 Synthesizer from Applied Biosystems 
(ABI) using standard phosphoramidite chemistry on a 1 µmol scale. 5-Iodo-modified uridine 
was introduced into DNA by using standard coupling conditions. 5-Iodo-modified DNA on 
CPG was dried under high vacuum after DNA synthesis. 1.0 mL sodium azide (200 mM) 
solution in DMSO was added to the CPG and heated at 55°C for 1 h, then cooled to r.t. The 
vial was centrifuged and the supernatant was removed. The CPG was successively washed 
with DMSO (4 mL) and MeCN (4 mL). The respective ethynyl-modified dyes 1 (or 2) (300 
µL, 50 mM), TBTA (600 µL, 100 mM), [Cu(CH3CN)4]PF6 (300 µL, 100 mM) (each in 
DMSO/tBuOH 3:1) and (+)-sodium L- ascorbate (300 µL, 400 mM in H2O) were added to the 
CPG and the mixture was gently shaken for 10 h at r.t. The mixture was centrifuged and the 
supernatant removed. The CPG was successively washed with DMSO, EtOH and H2O (each 
2 mL) and dried under high vacuum. The oligomers were deprotected and cleaved off the 
CPG by concentrated NH4OH solution at r.t. for 18 h. After deprotection and cleavage from 
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the CPG the oligonucleotides were desalted with use of a prepacked NAP-5 column (GE 
Healthcare).  
The modified oligonucleotides were purified by HPLC on a semipreparative RP-C18 column 
(300 Å, Supelco) using the following conditions: A) NH4OAc buffer (50 mM), pH 6.8; B) 
acetonitrile; gradient 0-30% B over 45 min, flow rate 2.5 mL/min, UV/Vis detection at 260 
and 600 nm for DNA 1; 260 nm and 450 nm for DNA 1Per. The purified DNA 1 and the 
purified DNA 1Per were identified by ESI-MS. 
 
Optical spectroscopy of oligonucleotides 
The oligonucleotides were lyophilized and quantified by their absorbance in 10 mM sodium 
phosphate buffer at 260 nm on a Varian Cary 100 spectrometer. The oligonucleotides were 
quantified in 10 mM sodium phosphate buffer by their absorbance at 260 nm using ?260nm = 
28000 M-1 cm-1 for nile red-dU, ?260nm = 13800 M-1 cm-1 for A, ?260nm = 10500 M-1 cm-1 for G, 
?260nm = 8000 M-1 cm-1 for T, ?260nm = 6500 M-1 cm-1 for C. ?260nm of the respective DNA 
strand: the number of individual bases was multiplied with their respective coefficients and 
added together. Fluorescence spectra were measured on a Jobin-Yvon Fluoromax 3 
fluorimeter with a stepwidth of 1 nm and an integration time of 0.2 s. All spectra were 
recorded with an excitation and emission bandpass of 5 nm and are corrected for Raman 
emission from the buffer solution. 
 
Hybridization and melting temperatures 
Duplexes were formed by heating of the modified oligonucleotides (2.5 µM) in 10 mM 
sodium phosphate buffer (pH 7) and 250 mM NaCl in the presence of 1.2 eq. unmodified 
complementary strand to 90 °C (10 min), followed by slow cooling to r.t. Absorption spectra 
and melting temperature (2.5 µM DNA, 20-90 °C, 0.7 °C/min, step width 0.5 °C) were 
recorded on a Varian Cary 100 spectrometer equipped with a 6×6 cell changer unit.  
 
Synthesis of oligonucleotides: Off bead coupling protocol and purification 
The 2’-modified uridine 12 was introduced into DNA by using standard coupling conditions, 
extended coupling time (6.3 min) and increased concentration of 0.1 M (in MeCN). The 
oligonucleotides were cleaved from the resin and deprotected by treatment with concentrated 
NH4OH solution at r.t. for 22 h. The respective azido-modified quinoline compound 10 (or 
11) (300 µL, 50 mM), CuI (300 µL, 100 mM), TBTA (600 µL, 100 mM), each in 
DMSO/tBuOH (3:1), and sodium ascorbate (300 µL, 400 mM) in H2O were added to the 
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oligonucleotide (1µmol). The vial was vortexted, shaken 16 h at r.t., and then evaporated to 
dryness using a SpeedVac. NaOAc (100 µL, 0.15 mmol) was added, and the mixture was 
stored for 1 h at r.t. After EtOH precipitation, the oligonucleotides were dissolved in H2O 
(500 µL), desalted, lyophilized and analyzed by RP-HPLC using the following conditions: A ) 
NH4OAc buffer (50 mM), pH 6.8; B ) acetonitrile; gradient 0-30 % B over 45 min, flow rate 
1.0 mL/min. DNA 3 was purified by HPLC on a semipreparative RP-C18 column (300 Å, 
Supelco) using the following conditions: A) NH4OAc buffer (50 mM), pH 6.8; B) 
acetonitrile; gradient 0-30% B over 45 min, flow rate 2.5 mL/min, UV/Vis detection at 260 
and 381 nm. The purified DNA 3 was identified by ESI-MS. 
 
Table 4.1. ESI-MS of modified oligonucleotide single strands (ss). 
ss DNA Sequence calcd. found 
DNA 1 5’-GCA-GTC-AAX-AAC-ACT-GA-3’ 5554.0 1386.6 [M-4H+]4-, 1849.4 
[M-3H+]3-, 1388.6 
[M+4H+]4+, 1851.6 
[M+3H+]3+ 
DNA 1Per 5’-GCA-GTC-AAX-AAC-ACT-GA-3’ 5488.0 1378.7 [M+3H++Na+]4+, 
1838.2 [M+2H++Na+]3+ 
DNA 3 5’-GCA-GTC-TTX-TTC-ACT-GA-3’ 5374.9 1350.0 [M+3H++Na+]4+, 
1799.7 [M+2H++Na+]3+, 
1365.4 
[M+2H++Na++Cu+]4+, 
1820.2 
[M+H++Na++Cu+]3+ 
 
LUMO calculations 
Calculations were performed with Spartan ’06 software. Equilibrium geometry calculations 
were performed using the MMFF for the isolated Nile Red modified 2’-deoxyuridines, then 
the LUMOs were calculated with the semi-empirical AM1 method and are displayed with 
IsoValue 0.01.  
 
Fluorescence quantum yields 
The fluorescence quantum yields (?Fl) were determined by the standard method, taking into 
account the refractive indices (n) of the solvents:  
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The subscripts “S” and “R” refer to the sample and the reference dye, respectively. A is the 
extinction of the sample solution at the excitation wavelength; F is the emission integral over 
the area of interest. The fluorescence quantum yields were determined by the standard method 
with Cresyl Violet perchlorate in MeOH as reference (?Fl = 0.54).[30]  
 
Light sources and UV/Vis of spirobenzopyran nucleoside compound 22 
For irradiation experiments a UV hand-held lamp (Herolab, 6 W, ? = 312 nm) and a Luxeon 
III Star high-power LED (? = 590 nm / amber) were used. UV/Vis spectra of 22 were 
recorded at r.t. with a Cary BIO 50 UV/Vis/NIR spectrometer (Varian) with scanning speed 
of 4800 nm/min. 
 
 
5-nitrosoquinolin-8-ol 
 
N
OH
ON  
 
A mixture of 8-quinolinol (10.244 g, 70.57 mmol) in water (93 mL) was cooled in an external 
ice bath, followed by cautious addition of concentrated H2SO4 (4.2 mL). The resulting bright 
yellow solution was vigorously stirred for 2 hours at room temperature, and an aqueous 
sodium nitrite solution (10 mL, 74.32 mmol) were added. The viscous yellow reaction 
mixture was stirred at room temperature for 4 hours. Concentrated sodium hydroxide solution 
was added periodically to keep the pH of the mixture between 10 and 11 as determined by 
external damp of universal pH paper. The resulting blood-red solution was then acidified by 
addition of glacial acetic acid to pH 5 and the precipitate was filtered and dried in vacuo to 
afford 5-nitrosoquinolin-8-ol as a yellow soild (11.676 g, 95 %) 
 
MS (ESI): m/z (%): 175.0 (97) [MH+], 216.0 (21) [MH++MeCN], 276.1 (100) [MH++NEt3] 
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5-Nitroquinolin-8-ol 
 
N
OH
O2N  
 
To a solution of 5-nitrosoquinolin-8-ol (960 mg, 5.51 mmol) in water (10 mL) there was 
added finely ground sodium hydroxide (276 mg, 6.90 mmol), followed by hydrogen peroxide 
(600 µL, 6.12 mmol). The mixture was stirred at room temperature for 10 minutes, then the 
temperature was raised to 70 °C for 1 hour, slowly cooled to ambient temperature and stirred 
for 1 hour. Additionally, hydrogen peroxide (200 µL, 2.04 mmol) was added to complete the 
conversion. The sodium salt precipitate was removed by filtration and washed with additional 
water (15 mL). Addition of dilute sulfuric acid afforded 5-nitroquinolin-8-ol as a pale yellow-
brown solid (845 mg, 81 %) 
 
1H NMR (300 MHz, DMSO-d6): ? = 12.97 (s, 1 H), 10.66 (s, broad, 1 H), 8.86 (d, 1 H, J = 
4.3 Hz), 8.56 (dd, 1 H, J = 1.3, 8.1 Hz), 7.71 (dd, 1 H, J = 4.4, 8.2 Hz), 7.14 (s, 1 H) - MS 
(ESI): m/z (%): 191.0 (100) [MH+], 232.0 (53) [MH++MeCN] 
 
 
5-aminoquinolin-8-ol hydrochloride   
 
N
OH
H2N
HCl
 
 
A suspension of 5-nitroquinolin-8-ol (838 mg, 4.41 mmol) in a mixture of MeOH/EtOAc 
(2.5:1, 35 mL) containing concentrated HCl (1.2 mL) and palladium on activated charcoal (84 
mg, 10 % m/m), was stirred under an atmosphere of hydrogen (7 bar) for 26 h. Celite and 
EDTA were added to the reaction mixture, stirred at room temperature for 1 hour and the 
solution was filtered to afford an orange brown solid. The residue was recrystallized from 
EtOH/Et2O and dried in a desiccator to yield 5-aminoquinolin-8-ol hydrochloride as orange 
crystals (980 mg, 95 %). 
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1H NMR (300 MHz, MeOD): ? = 9.46-8.93 (m, 2 H), 8.05 (s, 1 H), 7.73-7.26 (m, 2 H) - MS 
(ESI): m/z (%): 161.1 (100) [MH+], 202.0 (13) [MH++MeCN]  
 
 
5-azidoquinolin-8-ol 
 
N
OH
N3  
 
To a solution of 5-aminoquinolin-8-ol hydrochloride (974 mg, 4.09 mmol) in water (5 mL) 
was added concentrated HCl (0.4 mL) under vigorous stirring. The blood-red solution was 
cooled to 0 °C and an aqueous solution of sodium nitrite (6.0 mL, 7.74 mmol) was added 
slowly over 30 minutes. The solution was stirred for 20 minutes at 3 °C, then an aqueous 
solution of sodium azide (40 mL, 9.71 mmol) was added slowly over 45 minutes. This was 
stirred for 2 hours at 3 °C, then allowed to slowly warm up to room temperature. After 18 
hours the reaction mixture was extracted with Et2O (4 x 50 mL). The pooled organic layers 
were washed with water, dried over anhydrous Na2SO4 and the solvent was evaporated under 
reduced pressure to yield 5-azidoquinolin-8-ol as a pale brown solid (228 mg, 30 %). 
 
1H NMR (300 MHz, CDCl3): ? = 8.82 (dd, 1 H, J = 1.5, 4.2 Hz), 8.40 (dd, 1 H, J = 1.5, 8.5 
Hz), 7.47 (dd, 1 H, J = 4.2, 8.5 Hz), 7.21 (q, 2 H, J = 8.2 Hz) - IR (neat): ? [cm-1] = 3298, 
2131, 2112, 1474, 1277 - MS (ESI): m/z (%): 187.1 (100) [MH+], 228.1 (18) [MH++MeCN]  
 
 
8-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-azidoquinoline 
 
N
O
N3
Si
 
 
8-quinolionol (80 mg, 0.430 mmol) and imidazole (40 mg, 0.588 mmol) were dissolved in dry 
CH2Cl2 (2.4 mL). Under vigorous stirring, tert-butyldimethylsilyl chloride (80 mg, 0.531 
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mmol) was added in one portion under argon atmosphere. The solution was stirred in the dark 
for 69 hours and the solvent was evaporated in vacuo. The remaining solid was purified by 
gradient flash chromatography on silica gel (Hexane/EtOAc 15:1 to 10:1) to afford 8-[[(1,1-
dimethylethyl)dimethylsilyl]oxy]-5-azidoquinoline as a mucous yellow-orange oil (112 mg, 
87 %). Rf = 0.66 (Hexane/EtOAc 10:1) 
 
1H NMR (400 MHz, CDCl3): ? = 8.89 (dd, 1 H, J = 1.7, 4.1 Hz, C2), 8.35 (dd, 1 H, J = 1.7, 
8.5 Hz, C4), 7.38 (dd, 1 H, J = 4.1, 8.5 Hz, C3), 7.19 (d, 1 H, J = 8.21, C7), 7.16 (d, 1 H, J = 
8.2, C6), 1.07 (s, 9 H, 3 x C-CH3), 0.26 (s, 6 H, 2 x Si-CH3) - 
13C NMR (100 MHz, CDCl3): ? 
= 150.0 (Cquat., C8), 149.4 (CH, C2), 142.2 (Cquat., C8a), 130.9 (CH, C4), 128.7 (Cquat., C5), 
122.7 (Cquat., C4a), 121.1 (CH, C3), 117.4 (CH, C6), 114.7 (CH, C7) , 25.9 (3 x C-CH3), 18.8 
(Cquat.), -4.0 (2 x Si-CH3) - MS (ESI): m/z (%): 301.0 (100)[MH
+] 
 
 
1',3'-dihydro-1',3',3'-trimethyl-6-bromo-spiro[2H-1-benzopyran-2,2'-[2H]indole] 
 
N O Br
 
 
A dry flask was charged with 1,2,3,3-tetramethyl-3H-indolium iodide (335 mg, 1.11 mmol), 
freshly distilled EtOH (10 mL) and dry NEt3 (200 µL, 1.43 mmol). 5-bromosalicylaldehyde 
(220 mg, 1.09 mmol) was added under argon atmosphere and the reaction mixture was 
sonicated at 35 kHz. The progress of the reaction was monitored by TLC until spot intensity 
of the product remained constant in successive controls. After 2 hours the solvent was 
removed under reduced pressure, the residue was dissolved in CH2Cl2 and dried over 
anhydrous Na2SO4. The solution was filtered and the solvent was evaporated under reduced 
pressure. The residue was dried in vacuo, purified by gradient flash chromatography on silica 
gel (Hexane/EtOAc 30:1 to 15:1) to yield 1',3'-dihydro-1',3',3'-trimethyl-6-bromo-spiro[2H-1-
benzopyran-2,2'-[2H]indole] as pale pink solid (300 mg, 77 %). Rf = 0.49 (Hexane/EtOAc 
19:1) 
 
1H NMR (300 MHz, CDCl3) ? = 7.27-7.15 (m, 3 H, H-Ar), 7.09 (d, 1 H, J = 7.2 Hz, H-Ar), 
6.87 (t, 1 H, J = 7.4 Hz, H-Ar), 6.80 (d, 1 H, J = 10.3 Hz, H-Ar), 6.61 (d, 1 H, J = 9.2 Hz, H-
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Ar), 6.55 (d, 1 H, J = 7.7 Hz, H-Ar), 5.74 (d, 1 H, J = 10.2 Hz, H-Ar), 2.74 (s, 3 H, NCH3), 
1.32 (s, 3 H, 3-CH3), 1.18 (s, 3 H, 3-CH3) - 
13C NMR (75 MHz, CDCl3) ? = 153.6 (Cquat.), 
148.0 (Cquat.), 136.5 (Cquat.), 132.2 (+, CH), 129.1 (+, CH), 128.4 (+, CH), 127.7 (+, CH), 
121.5 (+, CH), 120.7 (+, CH), 120.6 (Cquat.), 119.3 (+, CH), 116.9 (+, CH), 111.8 (Cquat.), 
106.9 (+, CH), 104.5 (Cquat.), 51.9 (Cquat.), 28.9 (+, CH3), 25.9 (+, CH3), 20.1 (+, CH3) - MS 
(EI, 70 eV): m/z (%): 357.0 (100) [M+.], 339.9 (47) [M+-CH3
.] - HRMS (EI-MS) calcd. for 
C19H18BrNO [M
+.]: 355.0572, found: 355.0570 
 
 
1',3'-dihydro-1',3',3'-trimethyl-6-ethynyl-spiro[2H-1-benzopyran-2,2'-[2H]indole] 
 
N O
 
 
A flask was charged with 5-Ethynyl-2-hydroxybenzaldehyde (490 mg, 3.35 mmol) and dry 
EtOH (50 mL) and placed in a ultrasonic bath. Freshly distilled 1,3,3-trimethyl-2-
methyleneindoline (0.59 mL, 3.33 mmol) was added in one portion under argon atmosphere. 
The reaction mixture was sonicated at 35 kHz and the progress of the reaction was monitored 
by TLC until spot intensity of the product remained constant in successive controls. After 53 
minutes ultrasonic irradiation was stopped, the solvent was removed under reduced pressure 
to afford the crude product as blue-green fluffy foam. Purification by gradient flash 
chromatography on silica gel (Hexane/THF 70:1 to 50:1) afforded 1',3'-dihydro-1',3',3'-
trimethyl-6-ethynyl-spiro[2H-1-benzopyran-2,2'-[2H]indole] as pale blue foam (762 mg, 76 
%). Rf = 0.36 (Hexane/THF 50:1) 
 
1H NMR (600 MHz, CDCl3) ? = 7.27-7.15 (m, 2 H, H-Ar), 7.20 (dt, 1 H, J = 1.2, 7.7 Hz, H-
Ar), 7.09 (d, 1 H, J = 7.2 Hz, H-Ar), 6.87 (t, 1 H, J = 7.4 Hz, H-Ar), 6.83 (d, 1 H, J = 10.3 Hz, 
H-Ar), 6.67 (d, 1 H, J = 8.3 Hz, H-Ar), 6.55 (d, 1 H, J = 7.7 Hz, H-Ar), 5.74 (d, 1 H, J = 10.2 
Hz, H-Ar), 2.98 (s, 1 H, C?CH), 2.74 (s, 3 H, NCH3), 1.31 (s, 3 H, CH3), 1.18 (s, 3 H, CH3) - 
13C NMR (150 MHz, CDCl3) ? = 155.0, 148.1, 136.6, 133.7, 130.5, 128.8, 127.6, 121.5, 
120.3, 119.3, 118.8, 115.2, 113.5, 106.9, 104.8, 83.6, 75.5, 51.9, 28.9, 25.9, 20.1 - MS (CI, 
NH3): m/z (%): 302.1 (100) [MH
+] - HRMS (EI-MS) calcd. for C21H19NO [M
+.]: 301.1467, 
found: 301.1465 
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5-Trimethylsilylethynyl-2’-deoxyuridine 
 
O
HO N
NH
O
O
HO
TMS
 
 
To a mixture of 5-Iodo-2’-deoxyuridine (512 mg, 1.446 mmol) and dry DMF (10.0 mL) there 
was added Pd(PPh3)4 (176 mg, 0.152 mmol), CuI (57 mg, 0.299 mmol) and dry NEt3 (600 µL, 
4.304 mmol). The mixture was degassed via freeze-pump-thaw (3 cycles) and 
Ethynyltrimethylsilane (1.80 mL, 12.99 mmol) was added under nitrogen atmosphere. The 
reaction mixture was stirred at room temperature for 4 days. The solvent was removed under 
reduced pressure and the crude was dried in vacuo. Purification by gradient flash 
chromatography on silica gel (CH2Cl2/MeOH 200:1 to 10:1) yielded 5-Trimethylsilylethynyl-
2’-deoxyuridine as a colorless foam (398 mg, 85 %). Rf = 0.33 (CH2Cl2/MeOH 20:1) 
 
1H NMR (300 MHz, MeOD): ? = 8.33 (s, 1 H, H-6), 6.23 (t, 1 H, J = 6.5 Hz, H-1’), 4.40 (td, 1 
H, J = 3.7, 6.2 Hz, H-3’), 3.93 (q, 1 H, J = 3.3 Hz, H-4’), 3.78 (dq, 2 H, J = 3.2, 12.0, H-5’), 
2.37-2.16 (m, 2 H, H-2’), 0.20 (s, 9 H, SiMe3) - 
13C NMR (75 MHz, CDCl3): ? = 164.3 (C-4), 
151.2 (C-2), 146.0 (C-6), 100.6 (C-5), 99.1 (Cquat.), 97.4 (Cquat.), 89.2 (C-4’), 87.1 (C-1’), 72.0 
(C-3’), 62.6 (C-5’), 41.8 (C-2’), -0.0 (SiMe3) - MS (ESI): m/z (%): 323.1 (100) [M-H
+]- 
 
 
5-ethynyl-2’-deoxyuridine 
 
O
HO N
NH
O
O
HO  
 
To a solution of 5-Trimethylsilylethynyl-2’-deoxyuridine (168 mg, 0.519 mmol) in dry 
MeOH (3 mL) there was slowly added a solution of Bu4NF (1.588 g, 5.033 mmol) in MeOH 
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(14 mL) over 32 hours. The mixture was stirred for additional 16 hours at room temperature 
and the solvent was removed under reduced pressure. Purification by gradient flash 
chromatography on silica gel (CH2Cl2/MeOH 20:1 to 10:1) afforded 5-ethynyl-2’-
deoxyuridine as a colorless foam (107 mg, 82 %). Rf = 0.15 (CH2Cl2/MeOH 20:1) 
 
1H NMR (300 MHz, MeOD): ? = 8.40 (s, 1 H, H-6), 6.24 (t, 1 H, J = 6.6 Hz, H-1’), 4.40 (m, 1 
H, H-3’), 3.94 (q, 1 H, J = 3.2 Hz, H-4’), 3.77 (dq, 2 H, J = 3.2, 12.0 Hz, H-5’), 2.99 (s, 1 H, 
C?CH), 2.36-2.17 (m, 2 H, H-2’) - MS (ESI): m/z (%): 250.9 (100) [M-H+]- 
 
 
5-[1',3'-dihydro-1',3',3'-trimethyl-spiro[2H-1-benzopyran-2,2'-[2H]indole] 6-ethynyl]-2’-
deoxyuridine 
 
O
HO N
NH
O
O
HO
O
N
 
 
A dry flask was charged under nitrogen atmosphere with 1',3'-dihydro-1',3',3'-trimethyl-6-
ethynyl-spiro[2H-1-benzopyran-2,2'-[2H]indole] (53 mg, 0.176 mmol), 5-Iodo-2’-
deoxyuridine (50 mg, 0.141 mmol), CuI (6 mg, 0.0315 mmol) and [1,1?-
Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (20 mg, 0.0245 mmol). Dry DMF 
(2.0 mL) and dry NEt3 (100 µL, 0.717 mmol) were added, the mixture was degassed and 
stirred at ambient temperature for 26 h. Then all was poured into an EtOAc/water mixture (20 
mL, v/v 1:1) and the phases separated. The aqueous phase was extracted with CH2Cl2, the 
pooled organic layers were dried over anhydrous Na2SO4 and the solvents were stripped off 
under reduced pressure. The residue was dried in vacuo and purified by gradient flash 
chromatography on silica gel (CH2Cl2/MeOH 10:1 to 5.1) to yield 5-[1',3'-dihydro-1',3',3'-
trimethyl-spiro[2H-1-benzopyran-2,2'-[2H]indole] 6-ethynyl]-2’-deoxyuridine as glistening 
green crystals (50 mg, 67 %). Rf = 0.29 (CH2Cl2/MeOH 10:1) 
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1H NMR (600 MHz, MeOD): ? = 8.36 (s, 1 H, H-6), 7.27 (d, 1 H, J = 2.0 Hz), 7.23 (dd, 1 H, J 
= 8.4 Hz), 7.10 (dt, 1 H, J = 7.6 Hz), 7.03 (d, 1 H, J = 7.2 Hz), 6.92 (d, 1 H, J = 10.3 Hz), 6.78 
(t, 1 H, J = 7.1 Hz), 6.61 (d, 1 H, J = 8.4 Hz), 6.52 (d, 1 H, J = 7.8 Hz), 6.26 (t, 1 H, J = 6.6 
Hz, H-1’), 5.80 (d, 1 H, J = 10.3 Hz), 4.43-4.40 (m, 1 H, H-3’), 3.94 (q, 1 H, J = 3.3 Hz, H-
4’), 3.83 (dd, 1 H, J = 3.0, 12.0 Hz, H-5’), 3.75 (dd, 1 H, J = 3.4, 12.0 Hz, H-5’), 2.70 (s, 3 H, 
N-CH3), 2.34-2.29 (m, 1 H, H-2’), 2.28-2.22 (m, 1 H, H-2’), 1.26 (s, 3 H, CH3), 1.14 (s, 3 H, 
CH3) - 
13C NMR (150 MHz, MeOD): ? = 164.4, 156.2, 151.2, 149.5, 144.5 (C6), 137.8, 
134.2, 131.1, 130.0, 128.6, 122.4, 121.4, 120.5, 120.4, 116.0, 107.9, 106.3, 100.9, 93.9, 89.1 
(C-4’), 87.0 (C-1’), 80.1, 72.0 (C-3’), 62.6 (C-5’), 52.9, 41.8 (C-2’), 29.2 (NCH3), 26.3 (CH3), 
20.4 (CH3), 9.3 - MS (ESI): m/z (%): 528.2 (100) [MH
+] 
 
 
5-Iodo-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine 
 
O
DMTO N
NH
O
O
HO
I
 
 
5-Iodo-2’-deoxyuridine (1.08 g, 3.05 mmol) was dried by co-evaporation from dry pyridine (2 
x 30 mL), then dry pyridine (40 mL), 4,4’-dimethoxytriphenylmethyl chloride (1.249 g, 3.69 
mmol) and dry NEt3 (1.3 mL, 9.33 mmol) were added. The reaction mixture was stirred for 24 
hours at room temperature in the dark and MeOH (8 mL) were added. Following, the mixture 
was evaporated to dryness and repeated co-evaporation with toluene removed final traces of 
pyridine to yield yellow foam. The crude product was dissolved in CH2Cl2 and washed with 
aqueous NaHCO3 and dried over anhydrous MgSO4. The solvent was evaporated under 
reduced pressure, the residue was dried in vacuo and the crude product was purified by 
gradient flash chromatography on silica gel (CH2Cl2/MeOH 100:0 + 1 % NEt3 to 15:1 + 1 % 
NEt3) to yield 5-Iodo-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine as glistening white foam 
(1.885 g, 94 %). Rf = 0.41 (CH2Cl2/MeOH 20:1 + 1 % NEt3) 
 
1H NMR (300 MHz, CDCl3): ? = 8.13 (s, 1 H, H-6), 7.44-7.37 (m, 2 H, DMT), 7.35-7.18 (m, 
7 H, DMT), 6.83 (d, 4 H, J = 8.8 Hz, DMT), 6.32 (dd, 1 H, J = 5.7, 7.9 Hz, H-1’), 4.57 (m, 1 
H, H-3’), 4.12 (d, 1 H, J = 2.5 Hz, H-4’), 3.77 (s, 6 H, 2 x OCH3), 3.35 (d, 2 H, J = 3.0 Hz, H-
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5’), 2.51 (ddd, 1 H, J = 2.3, 5.6, 13.4 Hz, H-2’), 2.26 (ddd, 1 H, J = 5.9, 7.9, 13.6 Hz, H-2’) - 
13C NMR (100 MHz, CDCl3): ? = 162.0, 158.6, 151.4, 144.0, 135.6, 135.5, 130.1, 130.1, 
128.1, 128.0, 127.0, 113.4, 86.9, 86.3, 85.4, 72.1, 69.6, 63.7, 55.3, 41.5 - MS (ESI): m/z (%): 
655.2 (100) [M-H+]- 
 
 
5-Iodo-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine-3’-(2-cyanoethyl-N,N 
diisopropylphosphoramidite) 
 
O
DMTO N
NH
O
O
O
I
P O
N
CN
 
 
A dry flask was purged with argon, charged with 5-Iodo-5’-O-(4,4’-dimethoxytrityl)-2’-
deoxyuridine (217 mg, 0.331 mmol) and dry CH2Cl2 (13.0 mL), and degassed. The mixture 
was cooled on ice, anhydrous NEt3 (650 µL, 4.664 mmol) and 2-cyanoethyl-N,N-
Diisopropylchlorophosphoramidite (240 µL, 1.076 mmol) were added under argon 
atmosphere and the solution was stirred at room temperature for 1 hour. Following, the 
reaction mixture was poured into aqueous saturated NaHCO3 solution (30 mL), additional 
CH2Cl2 (20 mL) was added and the layers separated. The organic layer was washed with 
brine, dried over anhydrous Na2SO4 and the solvent was evaporated under reduced pressure. 
The remaining ivory solid was purified by flash chromatography on silica gel (CH2Cl2/MeOH 
100:1 + 1 % DIPEA to 50:1 + 1 % DIPEA). After lyophilisation from MeCN, 5-Iodo-5’-O-
(4,4’-dimethoxytrityl)-2’-deoxyuridine-3’-(2-cyanoethyl-N,N diisopropylphosphoramidite) 
was obtained as white solid (260 mg, 92 %). Rf = 0.34 (CH2Cl2/MeOH 100:1 + 1 % DIPEA) 
 
Analytical data is reported in the literature.[31]  
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5-Trimethylsilylethynyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine 
 
O
DMTO N
NH
O
O
HO
TMS
 
 
5-Iodo-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine (1.022 g, 1.557 mmol) was dissolved in 
dry tetrahydrofuran (8.5 mL). Under nitrogen atmosphere, [1,1?-Bis(diphenylphosphino)-
ferrocene]dichloropalladium(II) (161 mg, 0.197 mmol), CuI (35 mg, 0.184 mmol) and dry 
piperidine (2.5 mL) were added and the solution was degassed. Under a flow of nitrogen, 
Ethynyltrimethylsilane (440 µL, 3.176 mmol) was added and the reaction mixture was stirred 
at room temperature for 19 hours. A saturated aqueous NH4Cl solution (15 mL) was added 
and the mixture was extracted with EtOAc (2 x 25 mL). The organic layers were pooled and 
dried over anhydrous Na2SO4. The solvent was evaporated and the remaining crude product 
was purified by gradient flash chromatography on silica gel (CH2Cl2/MeOH 20:1 + 1 % NEt3 
to 5:1 + 1 % NEt3) to yield 5-Trimethylsilylethynyl-5’-O-(4,4’-dimethoxytrityl)-2’-
deoxyuridine as ivory foam (773 mg, 79 %). Rf = 0.05 (CH2Cl2/MeOH 20:1 + 1 % NEt3) 
 
1H NMR (400 MHz, CDCl3): ? = 7.99 (s, 1 H, H-6), 7.46-7.41 (m, 2 H, DMT), 7.37-7.17 (m, 
7 H, DMT), 6.88-6.80 (m, 4 H, DMT), 6.27 (dd, 1 H, J = 5.8, 7.6 Hz, H-1’), 4.44 (m, 1 H, H-
3’), 4.07 (dd, 1 H, J = 3.3, 6.2 Hz, H-4’), 3.78 (s, 6 H, 2 x OCH3), 3.41 (dd, 1 H, J = 3.5, 10.6 
Hz, H-5’), 3.31 (dd, 1 H, J = 3.8, 10.6 Hz, H-5’), 2.47 (ddd, 1 H, J = 2.5, 5.6, 13.5 Hz, H-2’), 
2.20 (ddd, 1 H, J = 6.5, 7.6, 13.6 Hz, H-2’), 0.01 (s, 9 H, 3 x CH3) - 
13C NMR (100 MHz, 
CDCl3): ? = 161.4 (Cquat.), 158.6 (Cquat.), 149.3 (Cquat.), 144.4 (Cquat.), 142.6 (CH, C-6), 135.6 
(Cquat.), 130.0 (CH), 128.0 (CH), 127.9 (CH), 126.9 (CH), 113.3 (CH), 100.5 (Cquat.), 99.6 
(Cquat.), 94.9 (Cquat.), 86.4 (CH, C-4’), 85.7 (CH, C-1’), 72.3 (CH, C-3’), 63.5 (CH2, C-5’), 
55.2 (OCH3), 41.4 (CH2, C-2’), -0.4 (CH3, SiMe3) - MS (ESI): m/z (%): 625.3 (100) [M-H
+]- 
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5-Ethynyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine 
O
DMTO N
NH
O
O
HO  
 
Route A: 
To a solution of 5-Trimethylsilylethynyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine (551 
mg, 0.88 mmol) in dry THF (11 mL), Bu4NF (596 mg, 1.89 mmol) was added. The reaction 
mixture was stirred at room temperature for 24 hours. Water was added and the mixture was 
extracted with CH2Cl2 (2 x 80 mL). The pooled organic layers were concentrated in vacuo, 
EtOAc and brine were added. Further extraction with EtOAc gave a colorless layer. Drying 
over anhydrous Na2SO4 and evaportation of the solvent under reduced pressure gave 5-
ethynyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine as colorless foam (473 mg, 97 %). 
 
Route B: 
A flask was charged with 5-ethynyl-2’-deoxyuridine (158 mg, 0.63 mmol), dry pyridine (7.0 
mL), dry NEt3 (100 µL, 0.717 mmol) and 4-DMAP (8 mg, 0.0655 mmol). The mixture was 
degassed, 4,4’-dimethoxytriphenylmethyl chloride (247 mg, 0.729 mmol)  was added in one 
portion and the reaction mixture was stirred at room temperature for 20 hours. Following, the 
solvent was removed under reduced pressure and the crude product was purified by gradient 
flash chromatography on silica gel (CH2Cl2/MeOH 30:1 + 1 % NEt3 to 10:1 + 1 % NEt3) to 
afford 5-ethynyl-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine as a colorless foam (320 mg, 92 
%). Rf = 0.28 (CH2Cl2/MeOH 50:1 + 1 % NEt3) 
 
1H NMR (600 MHz, CDCl3): ? = 8.09 (s, 1 H, H-6), 7.40 (d, 2 H, J = 7.4 Hz, DMT), 7.31 (dd, 
4 H, J = 8.8 Hz, DMT), 7.27-7.24 (m, 2 H, DMT), 7.17 (t, 1 H, J = 7.3 Hz, DMT), 6.81 (dd, 4 
H, J = 9.0 Hz), 6.29 (dd, 1 H, J = 5.9, 7.5 Hz, H-1’), 4.61 (td, 1 H, J = 2.6, 5.5 Hz, H-3’), 4.15 
(dd, 1 H, J = 3.0, 5.9 Hz, H-4’), 3.76 (s, 6 H, 2 x OCH3), 3.38 (dd, 1 H, J = 3.7, 10.7 Hz, H-
5’), 3.29-3.26 (m, 1 H, H-5’), 2.83 (s, 1 H, C?CH), 2.57 (ddd, 1 H, J = 2.7, 5.8, 13.4 Hz, H-
2’), 2.25 (ddd, 1 H, J = 5.9, 7.5, 13.5 Hz, H-2’) - 13C NMR (150 MHz, CDCl3): ? = 161.5, 
158.5, 158.5, 155.2, 149.2, 146.0, 144.5, 143.9 (CH, C6), 135.6, 135.4, 130.0, 130.0, 128.0, 
127.9, 126.8, 113.2, 113.2, 98.9, 86.9, 86.6 (C-4’), 85.8 (C-1’), 81.6 (C?CH), 71.8 (C-3’) 55.2 
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(2 x OCH3), 41.6 (C-2’), 39.3, 24.0, 19.7, 13.6, 8.8 - MS (ESI): m/z (%): 302.9 (100) [DMT
+], 
572.1 (25) [M+NH4
+] 
 
 
2-(trimethylsilyl)ethyl-(S)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-
hydroxypropylcarbamate 
 
N
H
ODMT
OH
O
O
Si
 
 
To a solution of (S)-1-amino-3-(bis(4-methoxyphenyl)(phenyl)methoxy)propan-2-ol (993 mg, 
2.09 mmol) in dry CH2Cl2 (107 mL), dry N,N-diisopropylethylamine (4.4 mL, 25.77 mmol) 
and 4-nitrophenyl-2-(trimethylsilyl)ethyl carbonate (1.836 g, 6.48 mmol) were added. The 
solution was stirred at room temperature in the dark fro 75 hours. The solvents were removed 
under reduced pressure to yield the crude product as viscous yellow oil that was purified by 
gradient flash chromatography on silica gel (Hexane/EtOAc 4:1 + 1 % DIPEA to 1:1 + 1 % 
DIPEA) to give 2-(trimethylsilyl)ethyl-(S)-3-(bis(4-methoxyphenyl)-(phenyl)methoxy)-2-
hydroxypropylcarbamate as a glistening pale yellow foam (2.076 g, 60 %). Rf = 0.32 
(Hexane/EtOAc 2:1 + 1 % DIPEA) 
 
1H NMR (300 MHz, CDCl3)  7.43-7.33 (m, 2 H, arom.), 7.30-7.22 (m, 7 H, arom.), 6.84-6.77 
(m, 4 H, arom.), 4.15-4.06 (m, 2 H), 3.90-3.80 (m, 1 H), 3.76 (s, 6 H, 2 x OCH3), 3.58-3.23 
(m, 2 H), 3.18-3.11 (m, 2 H), 0.99-0.90 (m, 2 H), 0.00 (s, 9 H, Si(CH3)3) - 
13C NMR (100 
MHz, MeOD) 160.1, 159.3, 146.5, 137.42, 137.40, 131.3, 129.4, 128.7, 127.7, 114.0, 87.4, 
71.1, 66.9, 63.9, 55.7 (+, CH3, 2 x OCH3), 45.3, 18.7, 14.5, -1.4 (+, CH3, Si(CH3)3) - MS (ESI, 
CH2Cl2/MeOH + 10 mM NH4OAc): m/z (%): 303.0 (100) [DMT
+], 555.3 (36) [M+NH4
+] 
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8-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-quinoline  
 
N
O
Si
 
 
To a solution of 8-quinolinol (656 mg, 4.52 mmol) in dry CH2Cl2 (9 mL), imidazole (334 mg, 
4.91 mmol) and tert-butyldimethylsilyl chloride (770 mg, 5.11 mmol) were added. The 
reaction was stirred at room temperature for 24 hours. Following, the reaction mixture was 
filtered and the solvent was removed under reduced pressure. Purification by flash 
chromatography on silica gel (Hexane/EtOAc 95:5) afforded 8-[[(1,1-
dimethylethyl)dimethylsilyl]oxy]-quinoline as colorless oil (983 mg, 84 %).  Rf = 0.33 
 
1H NMR (600 MHz, CDCl3): ? = 8.88 (dd, 1 H, J = 1.7, 4.1 Hz, C2), 8.11 (dd, 1 H, J = 1.7 
Hz, J = 8.3 Hz, C4), 7.44-7.41 (m, 2 H, C5/7), 7.37 (dd, 1 H, J = 4.1, 8.3 Hz, C3), 7.21 (dd, 1 
H, J = 3.8, 5.0 Hz, C6), 1.11 (s, 9 H, 3 x C-CH3), 0.31 (s, 6 H, 2 x Si-CH3) - 
13C NMR (150 
MHz, CDCl3): ? = 152.9 (Cquat., C8), 148.6 (CH, C2), 142.2 (Cquat., C4a), 135.7 (CH, C4), 
129.7 Cquat., C8a), 126.9 (CH, C7), 121.2 (CH, C3), 120.4 (CH, C5), 117.9 (CH, C6), 26.0 (3 
x C-CH3), 18.9 (Cquat.), -3.9(2 x Si-CH3) - MS (CI, NH3): m/z (%): 260.1 (100) [MH
+] 
 
 
8-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-bromoquinoline 
 
N
O
Br
Si
 
 
8-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-quinoline (102 mg, 0.394 mmol)  was dissolved in 
dry CH2Cl2 (2 mL) and cooled to -15 °C. Under vigorous stirring, 2,4,4,6-tetrabromo-2,5-
cyclohexadienone (161 mg, 0.393 mmol) was added in small portions over 1 hour. The 
solution was allowed to slowly warm to ambient temperature and stirred for 3 hours. The 
solvent was removed under reduced pressure to yield the crude product as an orange-brown 
oil. After purification by flash chromatography on silica gel (toluene) 8-[[(1,1-
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dimethylethyl)dimethylsilyl]oxy]-5-bromoquinoline was obtained as lustrous orange crystals 
(95 mg, 72 %).  Rf = 0.58 
 
 
1H NMR (600 MHz, CDCl3): ? = 8.87 (dd, 1 H, J = 1.6, 4.1 Hz, C2), 8.45 (dd, 1 H, J = 1.6, 
8.6 Hz, C4), 7.68 (d, 1 H, J = 8.2 Hz, C6), 7.47 (dd, 1 H, J = 4.1, 8.6 Hz, C3), 7.07 (d, 1 H, J = 
8.2 Hz, C7), 1.09 (s, 9 H, 3x C-CH3), 0.29 (s, 6 H, 2 x Si-CH3) - 
13C NMR (150 MHz, 
CDCl3): ? = 152.9 (Cquat., C8), 149.0 (CH, C2), 142.9 (Cquat., C8a), 135.3 (CH, C4), 130.5 
(CH, C6), 128.5 (Cquat., C4a), 122.3 (CH, C3), 118.3 (CH, C7), 112.3 (Cquat., C5), 25.9 (3 x C-
CH3), 18.9 (Cquat.), -3.9 (2 x Si-CH3) - MS (CI, NH3): m/z (%): 338.0 (100) [MH
+] 
 
 
8-[[triisopropylsilyl]oxy]-quinoline  
 
N
O
Si
 
 
To a solution of 8-quinolinol (355 mg, 2.45 mmol) in dry DMF (7 mL), imidazole (183 mg, 
2.69 mmol) and triisopropylsilyl chloride (570 µL, 2.69 mmol) were added. The pale yellow 
reaction mixture was stirred at room temperature for 20 hours. The solvent was removed 
under reduced pressure and the yellow mucous residue was purified by flash chromatography 
on silica gel (Hexane/EtOAc 95:5) to yield 8-[[triisopropylsilyl]oxy]-quinoline as colorless oil 
(602 mg, 82 %).  Rf = 0.22 
 
1H NMR (300 MHz, CDCl3): ? = 8.85 (dd, 1 H, J = 1.7, 4.1 Hz), 8.09 (dd, 1 H, J = 1.8, 8.3 
Hz), 7.40-7.33 (m, 3 H), 7.18 (dd, 1 H, J = 3.6, 5.3 Hz), 1.43 (td, 1 H, J = 7.5, 14.9 Hz), 1.13 
(d, 1 H, J = 7.4 Hz) 
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3-bromo-8-nitroquinoline 
 
N
NO2
Br
 
 
A solution of 8-nitroquinolin (305 mg, 1.75 mmol) in glacial acetic acid (4 mL) was heated at 
110 °C. Following, N-bromosuccinimide (343 mg, 1.93 mmol) was added over one hour, the 
reaction mixture heated at 125 °C for 5 minutes and then allowed to cool to room temperature 
over 2 hours. After cooling, water (45 mL) was added. This was extracted with CH2Cl2 (2 x 
40 mL), and the pooled extracts stripped off solvent under reduced pressure. The resulting 
pale yellow solid was purified by flash chromatography on silica gel (Hexane/EtOAc 5:1) to 
afford 3-bromo-8-nitroquinoline as an ivory-white solid (326 mg, 74 %).  Rf = 0.32 
 
1H NMR (600 MHz, CDCl3): ? = 9.01 (d, 1 H, J = 2.3 Hz, C2), 8.39 (dd, 1 H, J = 0.4, 2.3 Hz, 
C4), 8.02 (dd, 1 H, J = 1.4, 7.6 Hz, C7), 7.93 (ddd, 1 H, J = 0.4, 1.4, 8.3 Hz, C5), 7.62 (dd, 1 
H, J = 7.5, 8.3 Hz, C6) - 13C NMR (150 MHz, CDCl3): ? = 153.7 (CH, C2), 148.4 (Cquat., C8), 
137.6 (Cquat., C8a), 137.3 (CH, C4), 131.0 (CH, C5), 129.8 (Cquat., C4a), 126.7 (CH, C6), 
124.0 (CH, C7), 119.3 (Cquat., C3) - MS (EI, 70 eV): m/z (%): 127.2 (100) [M
+.-NO2-Br], 
252.0 (59) [M+.] 
 
 
5-Iodo-5’-O-(tetraisopropyldisiloxane-1,3-diyl)-2’-deoxyuridine 
 
O
O N
NH
O
O
O
Si
Si
O
I
 
 
To a dry flask containing 5-iodo-2’-deoxyuridine (998 mg, 2.82 mmol) in dry pyridine (20 
mL) and 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (980 µL, 3.14 mmol) were added. The 
reaction mixture was stirred in the dark at room temperature for 7 hours. Pyridine was 
removed under reduced pressure and the residue was dried in vacuo to constant weight. The 
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remaining solid was purified by gradient flash chromatography on silica gel (CH2Cl2/MeOH 
50:1 to 10:1) to afford 5-Iodo-5’-O-(tetraisopropyldisiloxane-1,3-diyl)-2’-deoxyuridine as a 
colorless foam (1.620 g, 96 %). Rf = 0.68 (CH2Cl2/MeOH 10:1) 
 
1H NMR (600 MHz, CDCl3): ? = 9.57 (s, 1 H, NH), 8.01 (s, 1 H, H-6), 6.00 (dd, 1 H, J = 1.9, 
7.2 Hz, H-1’), 4.45 (ddd, 1 H, J = 7.3, 8.1, 10.1 Hz, H-3’), 4.13 (dd, 1 H, J = 2.4, 13.2 Hz, H-
5’), 4.01 (dd, 1 H, J = 3.0, 13.2 Hz, H-5’), 3.77 (ddd, 1 H, J = 2.4, 3.0, 8.1 Hz, H-4’), 2.50 
(ddd, 1 H, J = 7.2, 10.1, 13.6 Hz, H-2’), 2.27 (ddd, 1 H, J = 1.9, 7.3, 13.6 Hz, H-2’), 1.11 (m, 
28 H, 4 x iPr) - 13C NMR (150 MHz, CDCl3): ? = 160.2, 149.4, 144.0, 85.3, 84.6, 68.1, 67.1, 
59.9, 39.9, 17.7-16.8 (8 x iPr, CH3), 13.5-12.4 (4 x 
iPr, CH) - MS (ESI): m/z (%): 597.1 (100) 
[MH+], 614.1 (24) [M+NH4
+], 1193.4 (11) [2MH+], 1210.4 (19) [2M+NH4
+],  
 
 
5-Bromo-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine 
 
O
DMTO N
NH
O
O
HO
Br
 
 
To a solution of 5-bromo-2’-deoxyuridine (368 mg, 1.198 mmol) in dry pyridine (16 mL), 
4,4’-dimethoxytriphenylmethyl chloride (493 mg, 1.455 mmol) and dry NEt3 (550 µL, 3.946 
mmol) were added. The reaction mixture was stirred for 21 hours at room temperature. The 
reaction mixture was evaporated to dryness and repeated co-evaporation with toluene 
removed final traces of pyridine to afford orange oil. Following, the crude product was 
dissolved in a mixture of CH2Cl2 and water. The aqueous layer was extracted with CH2Cl2 (2 
x) and the pooled organic layers were dried over anhydrous MgSO4. The solvent was 
evaporated under reduced pressure and the crude product was purified by gradient flash 
chromatography on silica gel (CH2Cl2/MeOH 100:0 + 1 % NEt3 to 15:1 + 1 % NEt3) to yield 
5-Bromo-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyuridine as glistening white foam (664 mg, 91 
%). Rf = 0.20 (CH2Cl2/MeOH 20:1 + 1 % NEt3) 
 
1H NMR (300 MHz, CDCl3): ? = 8.04 (s, 1 H, H-6), 7.40 (d, 2 H, J = 7.3 Hz, DMT), 7.35-
7.17 (m, 7 H, DMT), 6.83 (d, 4 H, J = 8.6 Hz, DMT), 6.33 (dd, 1 H, J = 5.8, 7.6 Hz, H-1’), 
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4.57 (m, 1 H, H-3’), 4.10 (d, 1 H, J = 2.7 Hz, H-4’), 3.78 (s, 6 H, 2 x OCH3), 3.37 (m, 2 H, H-
5’), 2.51 (ddd, 1 H, J = 2.6, 5.7, 13.5 Hz, H-2’), 2.27 (ddd, 1 H, J = 6.0, 7.6, 13.6 Hz, H-2’) 
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5. Summary 
 
The first part of this dissertation (Chapter 1) describes the improved synthesis of 
photochromic spirobenzopyrans with use of ultrasonic irradiation. The successful preparation 
granted access to photoswitches that were equipped with hydroxyl, iodo, ethynyl and azido 
groups. The functional groups were then devised and differentiated during further progress to 
serve for the construction of functional ?-systems and conjugation to biopolymers. The 
reversibility of the photoswitching was demonstrated for representative compounds, the 
absorption spectra of the corresponding merocyanines formed by photo-induced ring opening 
was discussed with respect to different substituents at the benzopyran moiety, and the 
solvatochromism of a spirobenzopyran that was equipped with a strong electron-withdrawing 
group was studied. 
 
In the second part of this work (Chapter 2) the synthesis and optical properties of new 
photochromic dyads were described. The fluorescent building blocks (pyrene, perylene, nile 
red), bearing an alkyne-functionality, and a spirobenzopyran with an azido group were 
successfully prepared. CuAAC was used as a facile methodology for the assembly of the 
molecular dyads through 1,4-regioselective formation of 1,2,3-triazoles. Spectroscopic 
measurements revealed that by UV irradiation the spirobenzopyran unit of the dyads switch 
into their corresponding merocyanine form with appearance of its characteristic absorption 
band in the visible range. The fluorescence quenching was modulated by the formation of the 
photo-induced merocyanine form and was observed for all three dyads, indicating an energy 
transfer process from the fluorophore unit to the merocyanine. The efficiency of energy 
transfer increased from pyrene over perylene to nile red due to the enhanced spectral overlap. 
 
Furthermore, the third part of this work (Chapter 3) reported on the synthesis and 
incorporation of a spirobenzopyran as an internal modification into oligonucleotides by two 
different strategies. A new spirobenzopyran building block for oligonucleotide synthesis has 
been effectually prepared. A useful synthetic prolongation and activation of the 
spirobenzopyran was introduced and conjugated with an acyclic linker system. The second 
strategy for incorporation of the spirobenzopyran modification was successfully performed 
with use of postsynthetic off-bead click ligation. Melting temperature measurements of the 
modified duplexes displayed significant destabilization compared to unmodified duplexes, 
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albeit photoinduced switching of the chromophore was not observed. Further investigations 
by time-resolved spectroscopy could bring about clarification on the photoprocesses.  
 
The last part (Chapter 4) reported a novel and dexterous method for in situ azide formation 
and click conjugation of DNA with fluorescent labels. This approach completes the click 
repertoire by a complementary access and constitutes an alternative postsynthetic method for 
the covalent labeling of oligonucleotides on solid support. With use of CuAAC the ethynyl-
modified chromophores (perylene, nile red) were conjugated with an azido group that was 
formed in situ by treatment of presynthesized oligonucleotides incorporating IdU with sodium 
azide on solid support. Methodically benefits are based on advantages of solid support 
synthesis and multifaceted implementations of functional ?-systems. The characteristic 
properties of the nile red labeled DNA bearing a triazolyl bridge were studied and compared 
with a nile red labeled oligonucleotide with an ethynyl bridge. The results clearly display the 
great potential for the extensive use of this completive approach. Furthermore, in the last 
chapter the synthesis for new compositions of oligonucleotide building blocks was shown, 
specifically the synthesis and introduction of a quinolinol moiety into DNA for further 
purposeful metal-mediated applications as well as the synthesis and optical properties of a 
photoswitchable nucleoside. 
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6. Zusammenfassung 
 
Der erste Teil der Dissertation (Kapitel 1) beschreibt die verbesserte Synthese von 
photochromen Spirobenzopyranen mittels Ultraschallbestrahlung. Die Methode wurde an 
Photoschaltern, die mit Hydroxyl-, Iodo-, Ethinyl- und Azid-Gruppen ausgestattet waren, 
erprobt. Diese zusätzlichen funktionellen Gruppen wurden im Verlauf weiterentwickelt und 
differenziert für den Aufbau funktioneller ?-Systeme sowie für die Konjugation an 
Biopolymere verwendet. Die reversible Photoschaltung wurde für repräsentative 
Verbindungen nachgewiesen. Die Absorptionsspektren der durch licht-induzierten 
Ringöffnung gebildeten Merocyanine wurden in Hinblick auf die unterschiedlichen 
Substituenten am Benzopyran-Teil untersucht. Die Solvatochromie eines Spirobenzopyrans, 
das eine stark elektronenziehende Gruppe besitzt, wurde ebenfalls untersucht. 
 
Im zweiten Teil dieser Arbeit (Kapitel 2) wurden die Synthese und die optischen 
Eigenschaften von neuen photochromen Dyaden beschrieben. Dafür wurde ein 
Spirobenzopyran mit einer Azid-Gruppe und die fluoreszierenden Bausteine (Pyren, Perylen, 
Nilrot), die mit Alkin-Funktionalitäten ausgestattet waren, erfolgreich synthetisiert. 
Anschließend wurde die Kupfer(I)-katalysierte Azid-Alkin-Cycloaddition (CuAAC) zur 1,4-
regioselektiven Bildung von 1,2,3-Triazolen für den Aufbau der Dyaden verwendet. Die 
spektroskopischen Messungen zeigten anhand des Auftretens der charakteristischen 
Absorptionsbande im sichtbaren Bereich, dass durch UV-Bestrahlung die Spirobenzopyran-
Einheiten der Dyaden in ihre entsprechende Merocyanin-Form umschalten. Die 
Fluoreszenzlöschung wurde durch die Bildung der photoinduzierten Merocyanin-Form 
moduliert und wurde bei allen drei Dyaden beobachtet, was auf Energie-Transfer-Prozesse 
von der Fluorophor-Einheit zum Merocyanin hinweist. Dabei stieg die Effizienz der 
Energieübertragung mit verbesserter spektraler Überlagerung an. 
 
Im dritten Teil dieser Arbeit (Kapitel 3) wird über die Synthese und den Einbau eines 
Spirobenzopyrans als interne Modifikation in Oligonukleotide mittels zweier verschiedener 
Strategien berichtet. Dabei wurde ein neuer Spirobenzopyran-Baustein für die 
Oligonukleotid-Synthese erfolgreich synthetisiert. Eine nützliche synthetische Verlängerung 
und Aktivierung des Spirobenzopyrans wurde eingeführt und mit dem azyklischen 
Linkersystem konjugiert. Die zweite Strategie zum Einbau der Spirobenzopyran-Modifikation 
wurde erfolgreich unter Verwendung der postsynthetischen Off-bead Click Ligation 
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durchgeführt. Die Messungen der Schmelztemperaturen der modifizierten Duplexe zeigten 
eine erhebliche Destabilisierung im Vergleich zu den unmodifizierten Duplexen an, obgleich 
ein photoinduziertes Schalten des Chromophors nicht beobachtet wurde. Die weitere 
Untersuchung durch zeitaufgelöste Spektroskopie könnte zur Aufklärung der Photoprozesse 
beitragen. 
 
Im letzten Teil (Kapitel 4) wird von einer neuartigen und geschickten Methode zur In-situ-
Azid-Bildung und Click-Konjugation von DNA mit fluoreszierenden Label berichtet. Dieser 
Ansatz vervollständigt das Click-Repertoire durch einen komplementären Zugang und 
begründet eine alternative Methode für die kovalente Markierung von Oligonukleotiden auf 
der Festphase. Unter Verwendung der Kupfer(I)-katalysierten Azid-Alkin-Cycloaddition 
wurden Ethinyl-modifizierte Chromophore (Perylen, Nilrot) mit einer Azid-Gruppe 
konjugiert. Die Azid-Gruppe wurde in situ durch den Umsatz von vorsynthetisierten 
Oligonukleotiden, in welche IdU eingebaut war, mit Natriumazid auf der Festphase 
eingeführt. Die methodischen Vorteile basieren auf der Festphasensynthese und den 
vielfältigen Umsetzungen funktioneller ?-Systeme. Die charakteristischen Eigenschaften der 
Nilrot-markierten und über eine Triazolyl-Brücke verknüpften DNA wurden untersucht und 
mit Nilrot-markierter DNA verglichen, bei der der Farbstoff über eine Ethinyl-Brücke 
verknüpft wurde. Die Ergebnisse zeigen klar das große Potential für die weitreichende 
Nutzung dieser Methode auf. Darüber hinaus wurde im letzten Kapitel die Synthese neuer 
Strukturen für Oligonukleotide-Bausteine vorgestellt, speziell die Synthese und der Einbau 
einer Quinolinol-Einheit in DNA für zielgerichtete metall-vermittelnde Anwendungen sowie 
die Synthese und optischen Eigenschaften eines photoschaltbaren Nukleosids.     
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7. Abbreviations 
 
2D   two dimensional 
4-NP  4-Nitrophenyl 
4-NPC  4-Nitrophenylchloroformate 
Å   Angstrøm 
A   absorption 
Ac-dC  Acetyl Deoxycytidine 
AMA  Ammonium hydroxide - Methylamine 
a. u.   arbitrary units 
BDF  Benzo[1,2-b:4,5-b’]difuran 
BEMP  2-tert-Butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-
Diazaphosphorin 
Bz-dC Benzoyl Deoxycytidine 
calcd. calculated 
CD   circular dichroism 
CDI  1,1’-Carbonyldiimidazole 
CI   chemical ionisation 
COSY  correlated spectroscopy 
CPG   Controlled Pore Glass 
CuAAC Copper(I) catalyzed Azide-Alkyne Cycloaddition 
?   chemical shift 
d  days 
DCM  Dichloromethane 
DCC  Dicyclohexylcarbodiimide 
DEPT  Distortionless Enhancement by Polarisation Transfer 
DIPEA  N,N-Diisopropylethylamine 
4-DMAP 4-Dimethylaminopyridine 
DMF   N,N-Dimethylformamide 
DMSO  Dimethylsulfoxide 
DMT   4,4’-Dimethoxytrityl 
DNA   Deoxyribonucleicacid 
dppf  1,1’-Bis(diphenylphosphino)ferrocene 
ds  double strand 
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dU   2’-Deoxyuridine 
EDC  1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
EdU  5-Ethynyl-2’-deoxyuridine 
EI   electron impact ionization 
eq.   equivalents 
ESI   electrospray ionization 
EtOH   Ethanol 
FAB   Fast Atom Bombardment 
FC   Flash chromatography 
GNA  Glycol Nucleic Acid 
h  hours 
HMBC Heteronuclear Multiple Bond Coherence 
HPLC   High Performance Liquid Chromatography 
HPLC-DAD High Performance Liquid Chromatography - diode array detection 
HSQC  Heteronuclear Single Quantum Coherence 
HV   high vaccum 
Hz   Hertz 
I   Intensity 
IdU  5-Iodo-2’-deoxyuridine 
IR  infrared 
J   Coupling constant 
K   Kelvin 
?  wavelength 
LC  Liquid Chromatography 
M   molar, mol/L 
mbar   Millibar 
m/z   Ratio mass / charge 
mdeg   millidegree 
MeCN  Acetonitrile 
MeOH  Methanol 
MHz   Megahertz 
min.   Minutes 
mM   millimolar 
MMFF Merck Molecular Mechanics Force Field 
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µM   micromolar 
MS   mass spectrometry 
Na-Pi   Sodium phosphate buffer 
NBDF  3-Nitro-2-ethyldibenzofuran 
NHS  N-Hydroxysuccinimide 
nm   Nanometer 
NMR   Nuclear Magnetic Resonance 
NOE   Nuclear Overhauser Enhancement 
NOESY  Nuclear Overhauser Enhancement Spectroscopy 
PDB  Protein Data Bank 
POM   Pivaloyloxymethyl 
ppm   parts per million 
Rf   Retention factor 
RP   Reversed Phase 
r.t.   room temperature 
sec.  Seconds 
ss   single strand 
TBAF   Tetrabutylammoniumfluorid 
TBAHS  Tetrabutylammoniumhydrogensulphate 
TBDMS tert-Butyldimethylsilyl 
TBDMSCl tert-Butyldimethylsilyl chloride 
TBTA  Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine 
TFA   Trifluoroacetic acid 
THF   Tetrahydrofuran 
TINA  Twisted Intercalating Nucleic Acid 
TIPDS  Tetraisopropyldisiloxane 
TLC  Thin-layer chromatography 
Tm  Melting temperature 
TMS  Trimethylsilyl   
TMSCl Trimethylsilyl chloride 
Ts  4-toluenesulfonyl 
UV  Ultraviolet 
Vis   Visible 
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8. Appendix 
 
8.1. DNA supporting information 
DNA synthesis was carried out with use of a PerSeptive Expedite 8909 synthesizer from 
Applied Biosystems (ABI). Reagents were purchased from Proligo, ABI and Glen Research. 
Controlled pore glass (500 Å) with loading capacity of 1 µmol was purchased from Proligo. 
Synthesized oligonucleotides were prepared with final trityl-off. A, G, T and C DNA building 
block phosphoramidites were prepared as 0.07 M solutions in acetonitrile (amidite diluent) 
with a standard coupling time of 40 s. Artificial (modified) DNA building blocks were 
prepared as 0.1 M solutions in acetonitrile (amidite diluent) and coupling time was extended 
to 375 s (see DNA synthesizer coding below).  
Dblk: 3 % Dichloroacetic acid in dichloromethane; Wsh, Wsh A: Acetonitrile; Act: 0.45 M 
Tetrazole in acetonitrile; Caps: Acetanhydride in THF / pyridine (Cap A) and N-
Methylimidazole in THF / pyridine; Ox: iodine in water / THF / pyridine. 
 
Coding Function Mode Amount/Arg1 Amount/Arg2
$ Deblocking     
144 Index Fract. Coll. NA 1 0 
0 Default WAIT 0 1.5 
141 Trityl Mon. On/Off NA 1 1 
16 Dblk PULSE 10 0 
16 Dblk PULSE 50 49 
38 Diverted Wsh A PULSE 40 0 
141 Trityl Mon. On/Off NA 0 1 
38 Diverted Wsh A PULSE 40 0 
144 Index Fract. Coll. NA 2 0 
$ Coupling     
1 Wsh PULSE 5 0 
2 Act PULSE 5 0 
23 6 + Act PULSE 6 0 
23 6 + Act PULSE 1 75 
2 Act PULSE 4 300 
1 Wsh PULSE 7 525 
1 Wsh PULSE 8 0 
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$ Capping     
12 Wsh A PULSE 20 0 
13 Caps PULSE 8 0 
12 Wsh A PULSE 6 15 
12 Wsh A PULSE 14 0 
$ Oxidizing     
15 Ox PULSE 15 0 
12 Wsh A PULSE 15 0 
$ Capping     
13 Caps PULSE 7 0 
12 Wsh A PULSE 30 0 
 
 
8.2. X-ray crystal structure data 
Crystals suitable for X-ray analysis were grown by slow evaporation of EtOAc at r.t. from a 
concentrated solution of the purified product. X-Ray structure of (S)-3,4,10,10a-Tetrahydro-
10,10,10a-trimethyl-2H-[1,3]oxazino[3,2-a]indole.  
 
Crystal data and structure refinement for (S)-3,4,10,10a-Tetrahydro-10,10,10a-trimethyl-2H-
[1,3]oxazino[3,2-a]indole: 
Empirical formula  C14 H19 N O  
Formula weight  217.30  
Crystal size  0.280 x 0.180 x 0.140 mm  
Crystal description  prism  
184  Appendix 
 
Crystal colour  colourless  
Crystal system Orthorhombic  
Space group  P b c a  
Unit cell dimensions               a = 11.0171(7) A   alpha = 90 deg.  
                                         b = 8.4841(5) A    beta = 90 deg.  
                                         c = 25.5815(14) A   gamma = 90 deg.  
Volume  2391.1(2) A3  
Z, Calculated density  8,  1.207 Mg/m3  
Absorption coefficient  0.075 mm-1  
F(000)  944  
      Data Collection   
Measurement device type  STOE-IPDS diffractometer  
Measuremnet method  rotation  
Temperature  123(1) K  
Wavelength  0.71073 A  
Monochromator  graphite  
Theta range for data collection  3.13 to 25.87 deg.  
Index ranges  -13<=h<=13, -10<=k<=10, -26<=l<=31  
Reflections collected / unique  13152 / 2303 [R(int) = 0.0288]  
Reflections greater I>2\s(I) 1830  
Absorption correction  None  
Max. and min. transmission  0.989 and 0.979  
      Refinement   
Refinement method  Full-matrix least-squares on F2  
Hydrogen treatment  :  
Data / restraints / parameters  2303 / 0 / 148  
Goodness-of-fit on F2  1.059  
Final R indices [I>2sigma(I)]      R1 = 0.0387, wR2 = 0.0987  
R indices (all data)               R1 = 0.0478, wR2 = 0.1020  
Absolute structure parameter  .  
Largest diff. peak and hole  0.267 and -0.160 e.A-3 
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Atomic coordinates and equivalent isotropic displacement parameters: 
Atom x/a [.104] y/b [.104] z/c [.104] Ueq. / Uiso. [Å
2.103] 
     
O(1) 434(1) 3947(1) 5683(1) 25(1) 
N(1) -711(1) 2959(1) 6415(1) 22(1) 
C(1) 251(1) 2797(1) 6779(1) 23(1) 
C(2) 323(1) 3388(2) 7288(1) 29(1) 
C(3) 1344(1) 2965(2) 7584(1) 36(1) 
C(4) 2250(1) 2003(2) 7386(1) 37(1) 
C(5) 2170(1) 1431(2) 6874(1) 33(1) 
C(6) 1173(1) 1851(1) 6570(1) 26(1) 
C(7) 812(1) 1343(1) 6021(1) 26(1) 
C(8) -200(1) 2590(1) 5894(1) 23(1) 
C(9) -278(1) 5373(1) 5667(1) 28(1) 
C(10) -759(1) 5809(1) 6206(1) 28(1) 
C(11) -1451(1) 4403(1) 6434(1) 26(1) 
C(12) 275(1) -337(2) 6060(1) 32(1) 
C(13) 1856(1) 1352(2) 5623(1) 33(1) 
C(14) -1173(1) 2037(2) 5511(1) 30(1) 
 
 
Anisotropic displacement parameters: 
Atom U11 [Å
2.103] U22 [Å
2.103] U33 [Å
2.103] U23 [Å
2.103] U13 [Å
2.103] U12 [Å
2.103] 
       
O(1) 27(1) 22(1) 27(1) 3(1) 5(1) -1(1) 
N(1) 22(1) 24(1) 22(1) 0(1) 2(1) 0(1) 
C(1) 22(1) 23(1) 25(1) 5(1) 0(1) -5(1) 
C(2) 30(1) 33(1) 25(1) 1(1) 1(1) -7(1) 
C(3) 39(1) 43(1) 26(1) 6(1) -6(1) -15(1) 
C(4) 30(1) 41(1) 40(1) 15(1) -13(1) -8(1) 
C(5) 25(1) 29(1) 44(1) 9(1) -1(1) -1(1) 
C(6) 25(1) 22(1) 31(1) 4(1) 2(1) -4(1) 
C(7) 25(1) 22(1) 30(1) -1(1) 4(1) 0(1) 
C(8) 25(1) 21(1) 23(1) 1(1) 4(1) -3(1) 
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C(9) 31(1) 23(1) 31(1) 5(1) 2(1) 0(1) 
C(10) 26(1) 22(1) 34(1) 1(1) 1(1) 2(1) 
C(11) 22(1) 26(1) 28(1) 0(1) 2(1) 2(1) 
C(12) 35(1) 23(1) 39(1) -1(1) 5(1) -2(1) 
C(13) 30(1) 28(1) 40(1) -4(1) 10(1) 1(1) 
C(14) 33(1) 31(1) 26(1) -2(1) -1(1) -4(1) 
 
 
Hydrogen coordinates and isotropic displacement parameters: 
Atom x/a [.104] y/b [.104] z/c [.104] Ueq. / Uiso. [Å
2.103] 
     
H(2) -294 4048 7427 35 
H(3) 1416 3350 7932 43 
H(4) 2927 1731 7597 45 
H(5) 2786 766 6736 39 
H(9A) -969 5227 5424 34 
H(9B) 229 6246 5532 34 
H(10A) -1306 6731 6178 33 
H(10B) -75 6093 6439 33 
H(11A) -1674 4632 6801 31 
H(11B) -2210 4239 6234 31 
H(12A) 898 -1063 6190 38 
H(12B) 3 -681 5713 38 
H(12C) -416 -332 6301 38 
H(13A) 2257 2383 5628 39 
H(13B) 1533 1147 5273 39 
H(13C) 2444 531 5715 39 
H(14A) -1736 2905 5439 36 
H(14B) -1619 1149 5663 36 
H(14C) -787 1702 5184 36 
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